Name	Gene(s)	Protein change	Condition(s)	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	dbSNP ID	Canonical SPDI	Variant type	Molecular consequence	Germline classification	Germline date last evaluated	Germline review status	Somatic clinical impact	Somatic clinical impact date last evaluated	Somatic clinical impact review status	Oncogenicity classification	Oncogenicity date last evaluated	Oncogenicity review status	
GRCh38/hg38 15q22.2-26.3(chr15:59828460-101920998)x3	LINC00924|LINC00927|LINC00928|LINC00930|LINC00933|LINC01169|LINC01418|LINC01579|LINC01580|LINC01581|LINC01582|LINC01583|LINC01584|LINC01585|LINC01586|LINC02204|LINC02205|LINC02207|LINC02244|LINC02251|LINC02253|LINC02254|LINC02255|LINC02259|LINC02348|LINC02349|LINC02351|LINC02568|LINC02883|LINGO1|LINGO1-AS1|LINGO1-AS2|LINS1|LMAN1L|LOC100129540|LOC100507472|LOC101927310|LOC101928850|LOC101928988|LOC101929333|LOC101929439|LOC101929457|LOC101929586|LOC102723335|LOC102724034|LOC102724452|LOC102724465|LOC103171574|LOC104613533|LOC105369212|LOC105370890|LOC105370947|LOC105370954|LOC105370973|LOC105370980|LOC105370987|LOC105370993|LOC105370997|LOC105371006|LOC105371017|LOC105371031|LOC107984784|LOC107988046|LOC107992387|LOC108251791|LOC108281191|LOC108964933|LOC110120860|LOC110120861|LOC110120917|LOC110121345|LOC110121383|LOC110121430|LOC110121464|LOC110121491|LOC110121492|LOC110467515|LOC110467516|LOC110467517|LOC111365216|LOC111413015|LOC111413032|LOC111413043|LOC111562369|LOC111718493|LOC111822949|LOC112272574|LOC112272602|LOC112272603|LOC112272604|LOC112272605|LOC112272606|LOC112272607|LOC112272608|LOC112272609|LOC112272610|LOC112272613|LOC112272614|LOC112272615|LOC112272616|LOC112272617|LOC112272618|LOC112272619|LOC112272620|LOC112272621|LOC112272622|LOC112272623|LOC112296173|LOC112296174|LOC112296175|LOC112296176|LOC112296177|LOC112296178|LOC113939942|LOC113939945|LOC113939946|LOC113939947|LOC114827858|LOC116268467|LOC116268468|LOC116268471|LOC116268472|LOC116268473|LOC116268474|LOC116268475|LOC116268476|LOC116268477|LOC116268478|LOC116268479|LOC117204000|LOC117204001|LOC120285840|LOC121530585|LOC121530586|LOC121530587|LOC121530588|LOC121530589|LOC121530590|LOC121530591|LOC121530592|LOC121530593|LOC121530594|LOC121530595|LOC121530596|LOC121530597|LOC121530598|LOC121530599|LOC121530600|LOC121530601|LOC121530602|LOC121530603|LOC121530604|LOC121530605|LOC121847953|LOC121847954|LOC121847955|LOC121847956|LOC121847957|LOC121847958|LOC121847959|LOC121847960|LOC121847961|LOC121847962|LOC121847963|LOC121847964|LOC121847965|LOC121847966|LOC125078089|LOC125078090|LOC125078091|LOC125078093|LOC125078094|LOC125078095|LOC125078096|LOC125078097|LOC125078098|LOC125078099|LOC125078100|LOC125078101|LOC125078102|LOC125078103|LOC125078104|LOC125110343|LOC125110344|LOC125110345|LOC125110346|LOC125110347|LOC125110348|LOC125110349|LOC125110350|LOC125110351|LOC125110352|LOC125110353|LOC125110354|LOC125110355|LOC125110356|LOC125110357|LOC125138289|LOC125138290|LOC125138291|LOC125138292|LOC125138293|LOC125138294|LOC125138295|LOC125138296|LOC125138297|LOC125138298|LOC125138299|LOC125138300|LOC125138301|LOC125138302|LOC125138303|LOC125138305|LOC125138306|LOC125138307|LOC125138308|LOC125138309|LOC125146351|LOC125146353|LOC125146354|LOC125146355|LOC125146356|LOC125146357|LOC125146359|LOC125146360|LOC125146361|LOC125146362|LOC125146363|LOC125146364|LOC125146365|LOC125146367|LOC125146368|LOC125146369|LOC125146370|LOC126862143|LOC126862144|LOC126862145|LOC126862146|LOC126862147|LOC126862148|LOC126862149|LOC126862150|LOC126862151|LOC126862152|LOC126862153|LOC126862154|LOC126862155|LOC126862156|LOC126862157|LOC126862158|LOC126862159|LOC126862160|LOC126862161|LOC126862162|LOC126862163|LOC126862164|LOC126862165|LOC126862166|LOC126862167|LOC126862168|LOC126862169|LOC126862170|LOC126862171|LOC126862172|LOC126862173|LOC126862174|LOC126862175|LOC126862176|LOC126862177|LOC126862178|LOC126862179|LOC126862180|LOC126862181|LOC126862182|LOC126862183|LOC126862184|LOC126862185|LOC126862186|LOC126862187|LOC126862188|LOC126862189|LOC126862190|LOC126862191|LOC126862192|LOC126862193|LOC126862194|LOC126862195|LOC126862196|LOC126862197|LOC126862198|LOC126862199|LOC126862200|LOC126862201|LOC126862202|LOC126862203|LOC126862204|LOC126862205|LOC126862206|LOC126862207|LOC126862208|LOC126862209|LOC126862210|LOC126862211|LOC126862212|LOC126862213|LOC126862214|LOC126862215|LOC126862216|LOC126862217|LOC126862218|LOC126862219|LOC126862220|LOC126862221|LOC126862222|LOC126862223|LOC126862224|LOC126862225|LOC126862226|LOC126862227|LOC126862228|LOC126862229|LOC126862230|LOC126862231|LOC126862232|LOC126862233|LOC126862234|LOC126862235|LOC126862236|LOC126862237|LOC126862238|LOC126862239|LOC126862240|LOC126862241|LOC126862242|LOC126862243|LOC126862244|LOC126862245|LOC126862246|LOC126862247|LOC126862248|LOC126862249|LOC126862250|LOC126862251|LOC126862252|LOC126862253|LOC126862254|LOC126862255|LOC126862256|LOC126862257|LOC126862258|LOC126862259|LOC128071545|LOC129390711|LOC129390712|LOC129390713|LOC129390714|LOC129390715|LOC129390716|LOC129390717|LOC129390718|LOC129390719|LOC129390720|LOC129390721|LOC129390722|LOC129390723|LOC129390724|LOC129390725|LOC129390726|LOC129390727|LOC129390728|LOC129390729|LOC129390730|LOC129390731|LOC129390732|LOC129390733|LOC129390734|LOC129390735|LOC129390736|LOC129390737|LOC129390738|LOC129390739|LOC129390740|LOC129390741|LOC129390742|LOC129390743|LOC129390744|LOC129390745|LOC129390746|LOC129390747|LOC129390748|LOC129390749|LOC129390750|LOC129390751|LOC129390752|LOC130057188|LOC130057189|LOC130057190|LOC130057191|LOC130057192|LOC130057193|LOC130057194|LOC130057195|LOC130057196|LOC130057197|LOC130057198|LOC130057199|LOC130057200|LOC130057201|LOC130057202|LOC130057203|LOC130057204|LOC130057205|LOC130057206|LOC130057207|LOC130057208|LOC130057209|LOC130057210|LOC130057211|LOC130057212|LOC130057213|LOC130057214|LOC130057215|LOC130057216|LOC130057217|LOC130057218|LOC130057219|LOC130057220|LOC130057221|LOC130057222|LOC130057223|LOC130057224|LOC130057225|LOC130057226|LOC130057227|LOC130057228|LOC130057229|LOC130057230|LOC130057231|LOC130057232|LOC130057233|LOC130057234|LOC130057235|LOC130057236|LOC130057237|LOC130057238|LOC130057239|LOC130057240|LOC130057241|LOC130057242|LOC130057243|LOC130057244|LOC130057245|LOC130057246|LOC130057247|LOC130057248|LOC130057249|LOC130057250|LOC130057251|LOC130057252|LOC130057253|LOC130057254|LOC130057255|LOC130057256|LOC130057257|LOC130057258|LOC130057259|LOC130057260|LOC130057261|LOC130057262|LOC130057263|LOC130057264|LOC130057265|LOC130057266|LOC130057267|LOC130057268|LOC130057269|LOC130057270|LOC130057271|LOC130057272|LOC130057273|LOC130057274|LOC130057275|LOC130057276|LOC130057277|LOC130057278|LOC130057279|LOC130057280|LOC130057281|LOC130057282|LOC130057283|LOC130057284|LOC130057285|LOC130057286|LOC130057287|LOC130057288|LOC130057289|LOC130057290|LOC130057291|LOC130057292|LOC130057293|LOC130057294|LOC130057295|LOC130057296|LOC130057297|LOC130057298|LOC130057299|LOC130057300|LOC130057301|LOC130057302|LOC130057303|LOC130057304|LOC130057305|LOC130057306|LOC130057307|LOC130057308|LOC130057309|LOC130057310|LOC130057311|LOC130057312|LOC130057313|LOC130057314|LOC130057315|LOC130057316|LOC130057317|LOC130057318|LOC130057319|LOC130057320|LOC130057321|LOC130057322|LOC130057323|LOC130057324|LOC130057325|LOC130057326|LOC130057327|LOC130057328|LOC130057329|LOC130057330|LOC130057331|LOC130057332|LOC130057333|LOC130057334|LOC130057335|LOC130057336|LOC130057337|LOC130057338|LOC130057339|LOC130057340|LOC130057341|LOC130057342|LOC130057343|LOC130057344|LOC130057345|LOC130057346|LOC130057347|LOC130057348|LOC130057349|LOC130057350|LOC130057351|LOC130057352|LOC130057353|LOC130057354|LOC130057355|LOC130057356|LOC130057357|LOC130057358|LOC130057359|LOC130057360|LOC130057361|LOC130057362|LOC130057363|LOC130057364|LOC130057365|LOC130057366|LOC130057367|LOC130057368|LOC130057369|LOC130057370|LOC130057371|LOC130057372|LOC130057373|LOC130057374|LOC130057375|LOC130057376|LOC130057377|LOC130057378|LOC130057379|LOC130057380|LOC130057381|LOC130057382|LOC130057383|LOC130057384|LOC130057385|LOC130057386|LOC130057387|LOC130057388|LOC130057389|LOC130057390|LOC130057391|LOC130057392|LOC130057393|LOC130057394|LOC130057395|LOC130057396|LOC130057397|LOC130057398|LOC130057399|LOC130057400|LOC130057401|LOC130057402|LOC130057403|LOC130057404|LOC130057405|LOC130057406|LOC130057407|LOC130057408|LOC130057409|LOC130057410|LOC130057411|LOC130057412|LOC130057413|LOC130057414|LOC130057415|LOC130057416|LOC130057417|LOC130057418|LOC130057419|LOC130057420|LOC130057421|LOC130057422|LOC130057423|LOC130057424|LOC130057425|LOC130057426|LOC130057427|LOC130057428|LOC130057429|LOC130057430|LOC130057431|LOC130057432|LOC130057433|LOC130057434|LOC130057435|LOC130057436|LOC130057437|LOC130057438|LOC130057439|LOC130057440|LOC130057441|LOC130057442|LOC130057443|LOC130057444|LOC130057445|LOC130057446|LOC130057447|LOC130057448|LOC130057449|LOC130057450|LOC130057451|LOC130057452|LOC130057453|LOC130057454|LOC130057455|LOC130057456|LOC130057457|LOC130057458|LOC130057459|LOC130057460|LOC130057461|LOC130057462|LOC130057463|LOC130057464|LOC130057465|LOC130057466|LOC130057467|LOC130057468|LOC130057469|LOC130057470|LOC130057471|LOC130057472|LOC130057473|LOC130057474|LOC130057475|LOC130057476|LOC130057477|LOC130057478|LOC130057479|LOC130057480|LOC130057481|LOC130057482|LOC130057483|LOC130057484|LOC130057485|LOC130057486|LOC130057487|LOC130057488|LOC130057489|LOC130057490|LOC130057491|LOC130057492|LOC130057493|LOC130057494|LOC130057495|LOC130057496|LOC130057497|LOC130057498|LOC130057499|LOC130057500|LOC130057501|LOC130057502|LOC130057503|LOC130057504|LOC130057505|LOC130057506|LOC130057507|LOC130057508|LOC130057509|LOC130057510|LOC130057511|LOC130057512|LOC130057513|LOC130057514|LOC130057515|LOC130057516|LOC130057517|LOC130057518|LOC130057519|LOC130057520|LOC130057521|LOC130057522|LOC130057523|LOC130057524|LOC130057525|LOC130057526|LOC130057527|LOC130057528|LOC130057529|LOC130057530|LOC130057531|LOC130057532|LOC130057533|LOC130057534|LOC130057535|LOC130057536|LOC130057537|LOC130057538|LOC130057539|LOC130057540|LOC130057541|LOC130057542|LOC130057543|LOC130057544|LOC130057545|LOC130057546|LOC130057547|LOC130057548|LOC130057549|LOC130057550|LOC130057551|LOC130057552|LOC130057553|LOC130057554|LOC130057555|LOC130057556|LOC130057557|LOC130057558|LOC130057559|LOC130057560|LOC130057561|LOC130057562|LOC130057563|LOC130057564|LOC130057565|LOC130057566|LOC130057567|LOC130057568|LOC130057569|LOC130057570|LOC130057571|LOC130057572|LOC130057573|LOC130057574|LOC130057575|LOC130057576|LOC130057577|LOC130057578|LOC130057579|LOC130057580|LOC130057581|LOC130057582|LOC130057583|LOC130057584|LOC130057585|LOC130057586|LOC130057587|LOC130057588|LOC130057589|LOC130057590|LOC130057591|LOC130057592|LOC130057593|LOC130057594|LOC130057595|LOC130057596|LOC130057597|LOC130057598|LOC130057599|LOC130057600|LOC130057601|LOC130057602|LOC130057603|LOC130057604|LOC130057605|LOC130057606|LOC130057607|LOC130057608|LOC130057609|LOC130057610|LOC130057611|LOC130057612|LOC130057613|LOC130057614|LOC130057615|LOC130057616|LOC130057617|LOC130057618|LOC130057619|LOC130057620|LOC130057621|LOC130057622|LOC130057623|LOC130057624|LOC130057625|LOC130057626|LOC130057627|LOC130057628|LOC130057629|LOC130057630|LOC130057631|LOC130057632|LOC130057633|LOC130057634|LOC130057635|LOC130057636|LOC130057637|LOC130057638|LOC130057639|LOC130057640|LOC130057641|LOC130057642|LOC130057643|LOC130057644|LOC130057645|LOC130057646|LOC130057647|LOC130057648|LOC130057649|LOC130057650|LOC130057651|LOC130057652|LOC130057653|LOC130057654|LOC130057655|LOC130057656|LOC130057657|LOC130057658|LOC130057659|LOC130057660|LOC130057661|LOC130057662|LOC130057663|LOC130057664|LOC130057665|LOC130057666|LOC130057667|LOC130057668|LOC130057669|LOC130057670|LOC130057671|LOC130057672|LOC130057673|LOC130057674|LOC130057675|LOC130057676|LOC130057677|LOC130057678|LOC130057679|LOC130057680|LOC130057681|LOC130057682|LOC130057683|LOC130057684|LOC130057685|LOC130057686|LOC130057687|LOC130057688|LOC130057689|LOC130057690|LOC130057691|LOC130057692|LOC130057693|LOC130057694|LOC130057695|LOC130057696|LOC130057697|LOC130057698|LOC130057699|LOC130057700|LOC130057701|LOC130057702|LOC130057703|LOC130057704|LOC130057705|LOC130057706|LOC130057707|LOC130057708|LOC130057709|LOC130057710|LOC130057711|LOC130057712|LOC130057713|LOC130057714|LOC130057715|LOC130057716|LOC130057717|LOC130057718|LOC130057719|LOC130057720|LOC130057721|LOC130057722|LOC130057723|LOC130057724|LOC130057725|LOC130057726|LOC130057727|LOC130057728|LOC130057729|LOC130057730|LOC130057731|LOC130057732|LOC130057733|LOC130057734|LOC130057735|LOC130057736|LOC130057737|LOC130057738|LOC130057739|LOC130057740|LOC130057741|LOC130057742|LOC130057743|LOC130057744|LOC130057745|LOC130057746|LOC130057747|LOC130057748|LOC130057749|LOC130057750|LOC130057751|LOC130057752|LOC130057753|LOC130057754|LOC130057755|LOC130057756|LOC130057757|LOC130057758|LOC130057759|LOC130057760|LOC130057761|LOC130057762|LOC130057763|LOC130057764|LOC130057765|LOC130057766|LOC130057767|LOC130057768|LOC130057769|LOC130057770|LOC130057771|LOC130057772|LOC130057773|LOC130057774|LOC130057775|LOC130057776|LOC130057777|LOC130057778|LOC130057779|LOC130057780|LOC130057781|LOC130057782|LOC130057783|LOC130057784|LOC130057785|LOC130057786|LOC130057787|LOC130057788|LOC130057789|LOC130057790|LOC130057791|LOC130057792|LOC130057793|LOC130057794|LOC130057795|LOC130057796|LOC130057797|LOC130057798|LOC130057799|LOC130057800|LOC130057801|LOC130057802|LOC130057803|LOC130057804|LOC130057805|LOC130057806|LOC130057807|LOC130057808|LOC130057809|LOC130057810|LOC130057811|LOC130057812|LOC130057813|LOC130057814|LOC130057815|LOC130057816|LOC130057817|LOC130057818|LOC130057819|LOC130057820|LOC130057821|LOC130057822|LOC130057823|LOC130057824|LOC130057825|LOC130057826|LOC130057827|LOC130057828|LOC130057829|LOC130057830|LOC130057831|LOC130057832|LOC130057833|LOC130057834|LOC130057835|LOC130057836|LOC130057837|LOC130057838|LOC130057839|LOC130057840|LOC130057841|LOC130057842|LOC130057843|LOC130057844|LOC130057845|LOC130057846|LOC130057847|LOC130057848|LOC130057849|LOC130057850|LOC130057851|LOC130057852|LOC130057853|LOC130057854|LOC130057855|LOC130057856|LOC130057857|LOC130057858|LOC130057859|LOC130057860|LOC130057861|LOC130057862|LOC130057863|LOC130057864|LOC130057865|LOC130057866|LOC130057867|LOC130057868|LOC130057869|LOC130057870|LOC130057871|LOC130057872|LOC130057873|LOC130057874|LOC130057875|LOC130057876|LOC130057877|LOC130057878|LOC130057879|LOC130057880|LOC130057881|LOC130057882|LOC130057883|LOC130057884|LOC130057885|LOC130057886|LOC130057887|LOC130057888|LOC130057889|LOC130057890|LOC130057891|LOC130057892|LOC130057893|LOC130057894|LOC130057895|LOC130057896|LOC130057897|LOC130057898|LOC130057899|LOC130057900|LOC130057901|LOC130057902|LOC130057903|LOC130057904|LOC130057905|LOC130057906|LOC130057907|LOC130057908|LOC130057909|LOC130057910|LOC130057911|LOC130057912|LOC130057913|LOC130057914|LOC130057915|LOC130057916|LOC130057917|LOC130057918|LOC130057919|LOC130057920|LOC130057921|LOC130057922|LOC130057923|LOC130057924|LOC130057925|LOC130057926|LOC130057927|LOC130057928|LOC130057929|LOC130057930|LOC130057931|LOC130057932|LOC130057933|LOC130057934|LOC130057935|LOC130057936|LOC130057937|LOC130057938|LOC130057939|LOC130057940|LOC130057941|LOC130057942|LOC130057943|LOC130057944|LOC130057945|LOC130057946|LOC130057947|LOC130057948|LOC130057949|LOC130057950|LOC130057951|LOC130057952|LOC130057953|LOC130057954|LOC130057955|LOC130057956|LOC130057957|LOC130057958|LOC130057959|LOC130057960|LOC130057961|LOC130057962|LOC130057963|LOC130057964|LOC130057965|LOC130057966|LOC130057967|LOC130057968|LOC130057969|LOC130057970|LOC130057971|LOC130057972|LOC130057973|LOC130057974|LOC130057975|LOC130057976|LOC130057977|LOC130057978|LOC130057979|LOC130057980|LOC130057981|LOC130057982|LOC130057983|LOC130057984|LOC130057985|LOC130057986|LOC130057987|LOC130057988|LOC130057989|LOC130057990|LOC130057991|LOC130057992|LOC130057993|LOC130057994|LOC130057995|LOC130057996|LOC130057997|LOC130057998|LOC130057999|LOC130058000|LOC130058001|LOC130058002|LOC130058003|LOC130058004|LOC130058005|LOC130058006|LOC130058007|LOC130058008|LOC130058009|LOC130058010|LOC130058011|LOC130058012|LOC130058013|LOC130058014|LOC130058015|LOC130058016|LOC130058017|LOC130058018|LOC130058019|LOC130058020|LOC130058021|LOC130058022|LOC130058023|LOC130058024|LOC130058025|LOC130058026|LOC130058027|LOC130058028|LOC130058029|LOC130058030|LOC130058031|LOC130058032|LOC130058033|LOC130058034|LOC130058035|LOC130058036|LOC130058037|LOC130058038|LOC130058039|LOC130058040|LOC130058041|LOC130058042|LOC130058043|LOC130058044|LOC130058045|LOC130058046|LOC130058047|LOC130058048|LOC130058049|LOC130058050|LOC130058051|LOC130058052|LOC130058053|LOC130058054|LOC130058055|LOC130058056|LOC130058057|LOC130058058|LOC130058059|LOC130058060|LOC130058061|LOC130058062|LOC130058063|LOC130058064|LOC130058065|LOC130058066|LOC130058067|LOC130058068|LOC130058069|LOC130058070|LOC130058071|LOC130058072|LOC130058073|LOC130058074|LOC130058075|LOC130058076|LOC130058077|LOC130058078|LOC130058079|LOC130058080|LOC130058081|LOC130058082|LOC132090322|LOC132090323|LOC132090324|LOC132090325|LOC132090326|LOC132090327|LOC132090328|LOC132090329|LOC132090330|LOC132090331|LOC132090332|LOC132090333|LOC132090334|LOC132090335|LOC132090336|LOC132090337|LOC132090338|LOC132090339|LOC132090340|LOC132090341|LOC132090342|LOC132090343|LOC132090344|LOC132090345|LOC132090346|LOC132090347|LOC132090348|LOC132090349|LOC132090350|LOC132090351|LOC132090352|LOC132090353|LOC132090354|LOC132090355|LOC132090356|LOC132090357|LOC132090358|LOC132090359|LOC132090360|LOC132090361|LOC132090362|LOC132090363|LOC132090364|LOC132090365|LOC132090366|LOC132090367|LOC132090368|LOC132090369|LOC132090881|LOC132090882|LOC132090883|LOC132090884|LOC132090885|LOC132090886|LOC283731|LOC91450|LOXL1|LOXL1-AS1|LRRC28|LRRC49|LRRK1|LRRK1-AS1|LUNAR1|LYSMD4|MAN2A2|MAN2C1|MAP2K1|MAP2K5|MAP2K5-DT|MCTP2|MEF2A|MEGF11|MESD|MESP1|MESP2|MEX3B|MFGE8|MGC15885|MINAR1|MIR11181|MIR1179|MIR12135|MIR1272|MIR1276|MIR1469|MIR184|MIR190A|MIR3174|MIR3175|MIR3529|MIR3713|MIR422A|MIR4311|MIR4312|MIR4313|MIR4511|MIR4512|MIR4513|MIR4514|MIR4515|MIR4714|MIR5009|MIR5094|MIR548AP|MIR549A|MIR5572|MIR6085|MIR629|MIR630|MIR631|MIR6766|MIR6881|MIR6882|MIR7-2|MIR7706|MIR8067|MIR9-3|MIR9-3HG|MORF4L1|MPI|MRPL46|MRPS11|MTFMT|MTHFS|MYO9A|NEIL1|NEO1|NGRN|NMB|NOX5|NPTN|NPTN-IT1|NR2E3|NR2F2|NR2F2-AS1|NRG4|NTRK3|NTRK3-AS1|OAZ2|OR4F15|OR4F6|PAQR5|PAQR5-DT|PARP16|PARP6|PCAT29|PCLAF|PCSK6|PCSK6-AS1|PDCD7|PDE8A|PEAK1|PEX11A|PGPEP1L|PIAS1|PIF1|PIRC76|PKM|PLEKHO2|PLIN1|PML|POLG|POLG-DT|POLGARF|PPCDC|PPIB|PRC1|PRC1-AS1|PSMA4|PSTPIP1|PTPN9|RAB11A|RAB8B|RAMAC|RASGRF1|RASL12|RBPMS2|RCCD1|RCCD1-AS1|RCN2|REC114|RGMA|RHCG|RLBP1|RNU5A-1|RNU5B-1|RNU6-1|RORA|RORA-AS1|RORA-AS2|RPL4|RPLP1|RPP25|RPS17|RPS27L|SALRNA2|SALRNA3|SAXO2|SCAMP2|SCAMP5|SCAPER|SCARNA14|SCARNA15|SEC11A|SELENOS|SEMA4B|SEMA7A|SENP8|SH2D7|SH3GL3|SIN3A|SKIC8|SKOR1|SKOR1-AS1|SLC24A1|SLC28A1|SLC51B|SLCO3A1|SMAD3|SMAD3-AS1|SMAD3-DT|SMAD6|SMASR|SNAPC5|SNHG21|SNORA24B|SNORD13E|SNORD16|SNORD18A|SNORD18B|SNORD18C|SNRPA1|SNRPA1-DT|SNUPN|SNX1|SNX22|SNX33|SPATA41|SPATA8|SPATA8-AS1|SPESP1|SPESP1-NOX5|SPG21|ST20|ST20-AS1|ST20-MTHFS|ST8SIA2|STARD5|STOML1|STRA6|SV2B|SYNM|SYNM-AS1|TARS3|TBC1D21|TBC1D2B|THAP10|THSD4|THSD4-AS1|THSD4-AS2|TICRR|TIPIN|TLE3|TLN2|TLNRD1|TM2D3|TM6SF1|TMC3|TMC3-AS1|TMED3|AAGAB|ABHD17C|ABHD2|ACAN|ACSBG1|ADAMTS17|ADAMTS7|ADAMTSL3|ADPGK|ADPGK-AS1|AEN|AGBL1|AGBL1-AS1|AKAP13|ALDH1A3|ALDH1A3-AS1|ALPK3|ANKDD1A|ANKRD34C|ANKRD34C-AS1|ANP32A|ANP32A-IT1|ANPEP|ANXA2|AP3B2|AP3S2|APH1B|ARID3B|ARIH1|ARNT2|ARNT2-DT|ARPIN|ARPIN-AP3S2|ARRDC4|ASB7|BBS4|BCL2A1|BLM|BNC1|BTBD1|C15orf32|C15orf39|C15orf40|C15orf61|C2CD4A|C2CD4B|CA12|CALML4|CARMAL|CCDC33|CD276|CELF6|CEMIP|CERS3|CERS3-AS1|CFAP161|CHASERR|CHD2|CHRNA3|CHRNA5|CHRNB4|CHSY1|CIAO2A|CIB1|CIB2|CILP|CIMAP1C|CLK3|CLN6|CLPX|COMMD4|CORO2B|COX5A|CPEB1|CPEB1-AS1|CPLX3|CRABP1|CRAT37|CRTC3|CRTC3-AS1|CSK|CSNK1G1|CSPG4|CT62|CTSH|CTXND1|CYP11A1|CYP1A1|CYP1A2|DAPK2|DENND4A|DET1|DIS3L|DIS3L-AS1|DNAJA4|DNAJA4-DT|DPP8|DRAIC|EDC3|EFL1|ETFA|EWSAT1|FAH|FAM174B|FAM219B|FANCI|FBXL22|FBXO22|FEM1B|FES|FOXB1|FSD2|FURIN|GCAWKR|GDPGP1|GLCE|GOLGA6A|GOLGA6B|GOLGA6C|GOLGA6D|GOLGA6L10|GOLGA6L4|GOLGA6L9|GRAMD2A|HACD3|HAPLN3|HCN4|HDDC3|HDGFL3|HERC1|HEXA|HEXA-AS1|HIGD2B|HMG20A|HOMER2|HYKK|ICE2|IDH2|IDH2-DT|IDH3A|IGDCC3|IGDCC4|IGF1R|IL16|IMP3|INSYN1|INSYN1-AS1|INTS14|IQCH|IQCH-AS1|IQGAP1|IRAIN|IREB2|ISG20|ISL2|ISLR|ISLR2|ITGA11|KBTBD13|KIF23|KIF23-AS1|KIF7|KLHL25|LACTB|LARP6|LCTL|LETR1|LINC00052|LINC00593|LINC00597|LINC00923|TMEM202|TMEM202-AS1|TMEM266|TPM1|TPM1-AS|TRC-GCA5-1|TRIP4|TRK-CTT1-2|TRQ-CTG1-4|TRR-TCG1-1|TSPAN3|TTC23|TTC23-AS1|TTLL13|UACA|UBAP1L|UBE2Q2|UBL7|UBL7-DT|ULK3|UNC45A|USP3|USP3-AS1|VPS13C|VPS13C-DT|VPS33B|VPS33B-DT|WDR73|WDR93|WHAMM|ZFAND6|ZNF592|ZNF609|ZNF710|ZNF710-AS1|ZNF774|ZSCAN2|ZWILCH		See cases	VCV000154848	15	60120659 - 102461201	15	59828460 - 101920998	154848	164602			copy number gain		Pathogenic	Oct 24, 2012	no assertion criteria provided							
NM_002755.3(MAP2K1):c.-767A>C	LOC130057338|MAP2K1|TIPIN		not provided	VCV000561817	15	66678919	15	66386581	561817	552853	rs11071888	NC_000015.10:66386580:A:C	single nucleotide variant	intron variant	Benign	Jun 19, 2018	criteria provided, single submitter							
NM_002755.3(MAP2K1):c.-695A>T	TIPIN|LOC130057338|MAP2K1		not provided	VCV000561873	15	66678991	15	66386653	561873	552854	rs11631295	NC_000015.10:66386652:A:T	single nucleotide variant	5 prime UTR variant	Benign	Jun 14, 2018	criteria provided, single submitter							
NM_002755.3(MAP2K1):c.-631C>T	MAP2K1|TIPIN		not provided	VCV000561875	15	66679055	15	66386717	561875	552855	rs62013660	NC_000015.10:66386716:C:T	single nucleotide variant	5 prime UTR variant	Benign	Jun 14, 2018	criteria provided, single submitter							
NC_000015.10:g.66386730G>A	MAP2K1		not provided	VCV002645466	15	66679068	15	66386730	2645466	2814248		NC_000015.10:66386729:G:A	single nucleotide variant		Benign	May 1, 2022	criteria provided, single submitter							
NC_000015.10:g.66386775C>T	MAP2K1		not provided	VCV002645467	15	66679113	15	66386775	2645467	2814249		NC_000015.10:66386774:C:T	single nucleotide variant		Uncertain significance	Feb 1, 2023	criteria provided, single submitter							
NM_002755.3(MAP2K1):c.-547C>T	MAP2K1		not provided	VCV000561386	15	66679139	15	66386801	561386	552856	rs77540803	NC_000015.10:66386800:C:T	single nucleotide variant		Likely benign	Jun 16, 2018	criteria provided, multiple submitters, no conflicts							
NM_002755.3(MAP2K1):c.-448C>T	LOC130057339|MAP2K1		not provided	VCV000316831	15	66679238	15	66386900	316831	323117	rs73469977	NC_000015.10:66386899:C:T	single nucleotide variant		Likely benign	Jul 31, 2018	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.-220CG[4]	LOC130057340|MAP2K1		Cardio-facio-cutaneous syndrome|not provided|Noonan syndrome	VCV000316834	15	66679464 - 66679465	15	66387126 - 66387127	316834	332754	rs141005341	NC_000015.10:66387126:GCGCGCG:GCGCGCGCG	Microsatellite	5 prime UTR variant	Likely benign	Oct 16, 2018	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.-105_-99dup	LOC130057340|MAP2K1		not provided	VCV001189560	15	66679574 - 66679575	15	66387236 - 66387237	1189560	1181290	rs575854200	NC_000015.10:66387236:GGCCCGCGGCCCG:GGCCCGCGGCCCGCGGCCCG	Duplication	5 prime UTR variant	Likely benign	Nov 15, 2018	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.-85G>C	LOC130057340|MAP2K1		not provided	VCV001286889	15	66679601	15	66387263	1286889	49174	rs112542693	NC_000015.10:66387262:G:C	single nucleotide variant	5 prime UTR variant	Benign	Mar 3, 2015	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.-43C>T	LOC130057340|MAP2K1		not provided	VCV001321004	15	66679643	15	66387305	1321004	1311248	rs571248158	NC_000015.10:66387304:C:T	single nucleotide variant	5 prime UTR variant	Likely benign	Feb 7, 2021	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.-31dup	LOC130057340|MAP2K1		not specified	VCV000040710	15	66679649 - 66679650	15	66387311 - 66387312	40710	49180	rs730880340	NC_000015.10:66387311:CCCCCC:CCCCCCC	Duplication		Benign	Apr 15, 2014	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.-7G>A	MAP2K1		Melorheostosis|Cardiofaciocutaneous syndrome 3	VCV003577597	15	66679679	15	66387341	3577597	3704197		NC_000015.10:66387340:G:A	single nucleotide variant	5 prime UTR variant	Uncertain significance	Dec 29, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.-2A>G	MAP2K1		Noonan syndrome and Noonan-related syndrome|not specified|not provided|RASopathy|Cardiovascular phenotype	VCV000040738	15	66679684	15	66387346	40738	49208	rs77796976	NC_000015.10:66387345:A:G	single nucleotide variant	5 prime UTR variant	Benign	Nov 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.5C>G (p.Pro2Arg)	MAP2K1	P2R	RASopathy	VCV001995374	15	66679690	15	66387352	1995374	2049874		NC_000015.10:66387351:C:G	single nucleotide variant	missense variant	Uncertain significance	May 17, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.6C>G (p.Pro2=)	MAP2K1		RASopathy|Cardiovascular phenotype	VCV001923833	15	66679691	15	66387353	1923833	1986613		NC_000015.10:66387352:C:G	single nucleotide variant	synonymous variant	Likely benign	Oct 2, 2023	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.6C>T (p.Pro2=)	MAP2K1		Cardiovascular phenotype|not specified|Noonan syndrome and Noonan-related syndrome|not provided|RASopathy	VCV000040739	15	66679691	15	66387353	40739	49209	rs377720622	NC_000015.10:66387352:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Oct 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.9G>A (p.Lys3=)	MAP2K1		not provided|RASopathy	VCV002645468	15	66679694	15	66387356	2645468	2814250		NC_000015.10:66387355:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.11A>G (p.Lys4Arg)	MAP2K1	K4R	not provided|RASopathy	VCV000496174	15	66679696	15	66387358	496174	487644	rs761150136	NC_000015.10:66387357:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.12G>A (p.Lys4=)	MAP2K1		Cardiovascular phenotype|RASopathy	VCV000705062	15	66679697	15	66387359	705062	693722	rs1489477346	NC_000015.10:66387358:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.15G>T (p.Lys5Asn)	MAP2K1	K5N	MAP2K1-related disorder	VCV002631331	15	66679700	15	66387362	2631331	2803482		NC_000015.10:66387361:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 30, 2023	no assertion criteria provided							
NM_002755.4(MAP2K1):c.15G>A (p.Lys5=)	MAP2K1		not specified|RASopathy	VCV001343560	15	66679700	15	66387362	1343560	1335259	rs2140511623	NC_000015.10:66387361:G:A	single nucleotide variant	synonymous variant	Likely benign	May 28, 2022	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.29A>T (p.Gln10Leu)	MAP2K1	Q10L	not specified	VCV000929218	15	66679714	15	66387376	929218	917209	rs2093343985	NC_000015.10:66387375:A:T	single nucleotide variant	missense variant	Uncertain significance	Aug 12, 2019	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.31C>G (p.Leu11Val)	MAP2K1	L11V	RASopathy	VCV002704008	15	66679716	15	66387378	2704008	2856434		NC_000015.10:66387377:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 19, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.33G>A (p.Leu11=)	MAP2K1		RASopathy	VCV002160466	15	66679718	15	66387380	2160466	1884149		NC_000015.10:66387379:G:A	single nucleotide variant	synonymous variant	Likely benign	Jul 14, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.36C>T (p.Asn12=)	MAP2K1		not provided	VCV001210586	15	66679721	15	66387383	1210586	1200585	rs2140511663	NC_000015.10:66387382:C:T	single nucleotide variant	synonymous variant	Likely benign	Jun 25, 2018	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.37C>T (p.Pro13Ser)	MAP2K1	P13S	not provided	VCV002444653	15	66679722	15	66387384	2444653	2418383		NC_000015.10:66387383:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 20, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.39G>A (p.Pro13=)	MAP2K1		RASopathy|not specified	VCV000227537	15	66679724	15	66387386	227537	230597	rs876657503	NC_000015.10:66387385:G:A	single nucleotide variant	synonymous variant	Likely benign	Apr 7, 2022	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.41C>T (p.Ala14Val)	MAP2K1	A14V	RASopathy	VCV002913558	15	66679726	15	66387388	2913558	3076229		NC_000015.10:66387387:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 22, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.45del (p.Asp16fs)	MAP2K1	D16fs	not provided	VCV000591639	15	66679726	15	66387388	591639	582628	rs1566991692	NC_000015.10:66387387:CCCCC:CCCC	Deletion	frameshift variant	Uncertain significance	Sep 16, 2018	no assertion criteria provided							
NM_002755.4(MAP2K1):c.42C>G (p.Ala14=)	MAP2K1		not provided	VCV001317064	15	66679727	15	66387389	1317064	1306882	rs2140511693	NC_000015.10:66387388:C:G	single nucleotide variant	synonymous variant	Uncertain significance	Dec 19, 2019	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.43C>G (p.Pro15Ala)	MAP2K1	P15A	Cardiovascular phenotype|RASopathy	VCV001740302	15	66679728	15	66387390	1740302	1791335		NC_000015.10:66387389:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.43C>T (p.Pro15Ser)	MAP2K1	P15S	RASopathy	VCV001513991	15	66679728	15	66387390	1513991	1491806	rs916502006	NC_000015.10:66387389:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 19, 2021	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.45C>T (p.Pro15=)	MAP2K1		Cardiovascular phenotype	VCV001741790	15	66679730	15	66387392	1741790	1805233		NC_000015.10:66387391:C:T	single nucleotide variant	synonymous variant	Likely benign	Oct 17, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.48C>A (p.Asp16Glu)	MAP2K1	D16E	RASopathy	VCV001005276	15	66679733	15	66387395	1005276	996350	rs1330053912	NC_000015.10:66387394:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 6, 2021	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.53C>G (p.Ser18Cys)	MAP2K1	S18C	not provided	VCV000807276	15	66679738	15	66387400	807276	797183	rs1349988835	NC_000015.10:66387399:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 1, 2019	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.56C>G (p.Ala19Gly)	MAP2K1	A19G	RASopathy|Cardiofaciocutaneous syndrome 3|Melorheostosis|not specified	VCV000177942	15	66679741	15	66387403	177942	176143	rs727504413	NC_000015.10:66387402:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.63C>T (p.Asn21=)	MAP2K1		RASopathy	VCV002878137	15	66679748	15	66387410	2878137	3036105		NC_000015.10:66387409:C:T	single nucleotide variant	synonymous variant	Likely benign	Oct 22, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.65G>A (p.Gly22Glu)	MAP2K1	G22E	not provided	VCV003338718	15	66679750	15	66387412	3338718	3497988		NC_000015.10:66387411:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 10, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.69C>A (p.Thr23=)	MAP2K1		RASopathy	VCV002976418	15	66679754	15	66387416	2976418	3133774		NC_000015.10:66387415:C:A	single nucleotide variant	synonymous variant	Likely benign	Oct 14, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.69C>T (p.Thr23=)	MAP2K1		RASopathy	VCV000138155	15	66679754	15	66387416	138155	141858	rs140749690	NC_000015.10:66387415:C:T	single nucleotide variant	synonymous variant	Likely benign	May 9, 2017	reviewed by expert panel							
NM_002755.4(MAP2K1):c.70A>G (p.Ser24Gly)	MAP2K1	S24G	RASopathy	VCV000964053	15	66679755	15	66387417	964053	948980	rs2093344167	NC_000015.10:66387416:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 5, 2019	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.71G>C (p.Ser24Thr)	MAP2K1	S24T	RASopathy|Cardiofaciocutaneous syndrome 3|Melorheostosis	VCV000854814	15	66679756	15	66387418	854814	842602	rs1290055913	NC_000015.10:66387417:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.76G>A (p.Ala26Thr)	MAP2K1	A26T	not provided	VCV001317376	15	66679761	15	66387423	1317376	1306320	rs1228037386	NC_000015.10:66387422:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 15, 2020	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.77C>T (p.Ala26Val)	MAP2K1	A26V	RASopathy	VCV002419481	15	66679762	15	66387424	2419481	1938302		NC_000015.10:66387423:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 22, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.80+2T>C	MAP2K1		RASopathy	VCV002709627	15	66679767	15	66387429	2709627	2878372		NC_000015.10:66387428:T:C	single nucleotide variant	splice donor variant	Uncertain significance	Jan 16, 2024	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.80+5G>A	MAP2K1		Melorheostosis|Cardiofaciocutaneous syndrome 3	VCV003577598	15	66679770	15	66387432	3577598	3704198		NC_000015.10:66387431:G:A	single nucleotide variant	intron variant	Uncertain significance	Apr 15, 2024	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.80+6T>C	MAP2K1		RASopathy	VCV002857741	15	66679771	15	66387433	2857741	3021636		NC_000015.10:66387432:T:C	single nucleotide variant	intron variant	Uncertain significance	Oct 4, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.80+9G>A	MAP2K1		RASopathy	VCV001130747	15	66679774	15	66387436	1130747	1124479	rs1219385230	NC_000015.10:66387435:G:A	single nucleotide variant	intron variant	Likely benign	Jan 11, 2024	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.80+14G>A	MAP2K1		not provided	VCV000385739	15	66679779	15	66387441	385739	373625	rs1057522314	NC_000015.10:66387440:G:A	single nucleotide variant	intron variant	Likely benign	Apr 22, 2016	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.80+16G>C	MAP2K1		RASopathy	VCV002023254	15	66679781	15	66387443	2023254	2087575		NC_000015.10:66387442:G:C	single nucleotide variant	intron variant	Likely benign	Aug 9, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.80+18_80+19del	MAP2K1		RASopathy	VCV001918867	15	66679783 - 66679784	15	66387445 - 66387446	1918867	1971308		NC_000015.10:66387444:GG:	Deletion	intron variant	Likely benign	Oct 10, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.80+28G>C	MAP2K1		not provided	VCV001270545	15	66679793	15	66387455	1270545	49243	rs374238278	NC_000015.10:66387454:G:C	single nucleotide variant	intron variant	Benign	Mar 3, 2015	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.80+33C>G	MAP2K1		not provided	VCV001242993	15	66679798	15	66387460	1242993	49244	rs56149436	NC_000015.10:66387459:C:G	single nucleotide variant	intron variant	Benign	Mar 3, 2015	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.80+33C>T	MAP2K1		not provided	VCV000040775	15	66679798	15	66387460	40775	49245	rs56149436	NC_000015.10:66387459:C:T	single nucleotide variant	intron variant	Benign	Mar 3, 2015	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.80+54G>C	MAP2K1		not provided	VCV001252321	15	66679819	15	66387481	1252321	49246	rs4483802	NC_000015.10:66387480:G:C	single nucleotide variant	intron variant	Benign	Mar 3, 2015	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.80+85del	MAP2K1		not provided	VCV001250710	15	66679850	15	66387512	1250710	1238519	rs2140512008	NC_000015.10:66387511:T:	Deletion	intron variant	Benign	Mar 3, 2015	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.80+87del	MAP2K1		not provided	VCV001291296	15	66679851	15	66387513	1291296	1281111	rs71447901	NC_000015.10:66387512:GG:G	Deletion	intron variant	Benign	Jun 6, 2019	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.80+195del	MAP2K1		not provided	VCV001296260	15	66679958	15	66387620	1296260	1286055	rs145028363	NC_000015.10:66387619:CCC:CC	Deletion	intron variant	Benign	Jul 27, 2018	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.81-20T>G	MAP2K1		RASopathy	VCV001623255	15	66727345	15	66435007	1623255	1540457	rs373883835	NC_000015.10:66435006:T:G	single nucleotide variant	intron variant	Likely benign	Sep 15, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.81-13del	MAP2K1		RASopathy	VCV003011599	15	66727349	15	66435011	3011599	3177031		NC_000015.10:66435010:CCCC:CCC	Deletion	intron variant	Benign	Oct 25, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.81-13C>T	MAP2K1		RASopathy	VCV002202634	15	66727352	15	66435014	2202634	1928285		NC_000015.10:66435013:C:T	single nucleotide variant	intron variant	Likely benign	Oct 23, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.81-12A>G	MAP2K1		RASopathy	VCV002731711	15	66727353	15	66435015	2731711	2890466		NC_000015.10:66435014:A:G	single nucleotide variant	intron variant	Likely benign	Jul 28, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.81-7G>C	MAP2K1		RASopathy	VCV002702394	15	66727358	15	66435020	2702394	2856111		NC_000015.10:66435019:G:C	single nucleotide variant	intron variant	Likely benign	Dec 12, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.81G>A (p.Glu27=)	MAP2K1		RASopathy	VCV002708327	15	66727365	15	66435027	2708327	2874492		NC_000015.10:66435026:G:A	single nucleotide variant	synonymous variant	Uncertain significance	Jan 8, 2024	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.86A>G (p.Asn29Ser)	MAP2K1	N29S, N7S	RASopathy	VCV002045953	15	66727370	15	66435032	2045953	2099961		NC_000015.10:66435031:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 5, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.87C>T (p.Asn29=)	MAP2K1		RASopathy	VCV002882452	15	66727371	15	66435033	2882452	3043054		NC_000015.10:66435032:C:T	single nucleotide variant	synonymous variant	Likely benign	Mar 9, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.95C>T (p.Ala32Val)	MAP2K1	A10V, A32V	Cardiovascular phenotype|not provided	VCV001767521	15	66727379	15	66435041	1767521	1818172		NC_000015.10:66435040:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.96C>T (p.Ala32=)	MAP2K1		RASopathy	VCV002730799	15	66727380	15	66435042	2730799	2883534		NC_000015.10:66435041:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 6, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.99G>A (p.Leu33=)	MAP2K1		RASopathy	VCV002040290	15	66727383	15	66435045	2040290	2102061		NC_000015.10:66435044:G:A	single nucleotide variant	synonymous variant	Likely benign	Jun 15, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.108G>A (p.Lys36=)	MAP2K1		RASopathy	VCV000751904	15	66727392	15	66435054	751904	770291	rs1269147448	NC_000015.10:66435053:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 11, 2018	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.124C>T (p.Leu42Phe)	MAP2K1	L42F	Cardio-facio-cutaneous syndrome|not specified|RASopathy	VCV000044587	15	66727408	15	66435070	44587	53754	rs397516789	NC_000015.10:66435069:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 14, 2023	criteria provided, conflicting classifications							
NM_002755.4(MAP2K1):c.125T>G (p.Leu42Arg)	MAP2K1	L20R, L42R	not provided	VCV001723651	15	66727409	15	66435071	1723651	1781136		NC_000015.10:66435070:T:G	single nucleotide variant	missense variant	Uncertain significance	May 9, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.126TGA[1] (p.Asp43del)	MAP2K1	D43del	RASopathy	VCV000477666	15	66727410 - 66727412	15	66435072 - 66435074	477666	465048	rs1555416037	NC_000015.10:66435071:TGATGA:TGA	Microsatellite	inframe_deletion	Uncertain significance	Jun 8, 2017	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.130_162del (p.Glu44_Leu54del)	MAP2K1		RASopathy	VCV001429014	15	66727413 - 66727445	15	66435075 - 66435107	1429014	1457978	rs2140578690	NC_000015.10:66435074:TGAGCAGCAGCGAAAGCGCCTTGAGGCCTTTCTT:T	Deletion	inframe_deletion	Uncertain significance	May 20, 2021	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.135G>T (p.Gln45His)	MAP2K1	Q45H	not provided	VCV001693032	15	66727419	15	66435081	1693032	49247	rs2093484116	NC_000015.10:66435080:G:T	single nucleotide variant	missense variant	Uncertain significance	Jun 7, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.137A>T (p.Gln46Leu)	MAP2K1	Q46L	Cardio-facio-cutaneous syndrome	VCV000666418	15	66727421	15	66435083	666418	653977	rs1595860875	NC_000015.10:66435082:A:T	single nucleotide variant	missense variant	Likely pathogenic		no assertion criteria provided							
NM_002755.4(MAP2K1):c.138del (p.Gln46fs)	MAP2K1	Q24fs, Q46fs	RASopathy	VCV002697502	15	66727422	15	66435084	2697502	2864899		NC_000015.10:66435083:G:	Deletion	frameshift variant	Uncertain significance	Nov 19, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.139C>A (p.Arg47=)	MAP2K1		RASopathy	VCV002697509	15	66727423	15	66435085	2697509	2864906		NC_000015.10:66435084:C:A	single nucleotide variant	synonymous variant	Likely benign	Nov 19, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.139C>T (p.Arg47Ter)	MAP2K1	R25*, R47*	not provided|RASopathy	VCV002430928	15	66727423	15	66435085	2430928	2404435		NC_000015.10:66435084:C:T	single nucleotide variant	nonsense	Uncertain significance	Jan 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.140G>A (p.Arg47Gln)	MAP2K1	R47Q	not specified|RASopathy|Neoplasm	VCV000633293	15	66727424	15	66435086	633293	621517	rs1567009054	NC_000015.10:66435085:G:A	single nucleotide variant	missense variant	Uncertain significance	May 22, 2023	criteria provided, multiple submitters, no conflicts				Likely oncogenic	Jul 31, 2024	criteria provided, single submitter	
NM_002755.4(MAP2K1):c.147_149dup (p.Leu50_Glu51insLeu)	MAP2K1		Cardiofaciocutaneous syndrome 3	VCV003256896	15	66727430 - 66727431	15	66435092 - 66435093	3256896	3415652		NC_000015.10:66435092:CCT:CCTCCT	Duplication	inframe_insertion	Likely pathogenic	Jul 3, 2024	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.146G>A (p.Arg49His)	MAP2K1	R27H, R49H	RASopathy	VCV002185892	15	66727430	15	66435092	2185892	1910826		NC_000015.10:66435091:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 12, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.147C>A (p.Arg49=)	MAP2K1		RASopathy	VCV001634020	15	66727431	15	66435093	1634020	1661421	rs756073029	NC_000015.10:66435092:C:A	single nucleotide variant	synonymous variant	Likely benign	Jun 17, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.149T>C (p.Leu50Pro)	MAP2K1	L50P	not provided|RASopathy	VCV001206943	15	66727433	15	66435095	1206943	1198669	rs2140578834	NC_000015.10:66435094:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 1, 2023	criteria provided, conflicting classifications							
NM_002755.4(MAP2K1):c.153G>A (p.Glu51=)	MAP2K1		RASopathy	VCV001996699	15	66727437	15	66435099	1996699	2053774		NC_000015.10:66435098:G:A	single nucleotide variant	synonymous variant	Likely benign	May 20, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.154G>A (p.Ala52Thr)	MAP2K1	A30T, A52T	Cardiofaciocutaneous syndrome 3	VCV003066213	15	66727438	15	66435100	3066213	3226226		NC_000015.10:66435099:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 27, 2024	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.155C>T (p.Ala52Val)	MAP2K1	A30V, A52V	RASopathy	VCV003617258	15	66727439	15	66435101	3617258	3759030		NC_000015.10:66435100:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 31, 2024	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.156C>G (p.Ala52=)	MAP2K1		not specified|not provided|Cardiovascular phenotype	VCV000507455	15	66727440	15	66435102	507455	505127	rs147489724	NC_000015.10:66435101:C:G	single nucleotide variant	synonymous variant	Likely benign	Jul 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.156C>T (p.Ala52=)	MAP2K1		Cardiovascular phenotype|RASopathy|not specified|not provided	VCV000040778	15	66727440	15	66435102	40778	49248	rs147489724	NC_000015.10:66435101:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.157T>G (p.Phe53Val)	MAP2K1	F53V	Neoplasm	VCV000376446	15	66727441	15	66435103	376446	363325	rs1057519728	NC_000015.10:66435102:T:G	single nucleotide variant	missense variant							Oncogenic	Jul 31, 2024	criteria provided, single submitter	
NM_002755.4(MAP2K1):c.158T>C (p.Phe53Ser)	MAP2K1	F53S	RASopathy	VCV000013350	15	66727442	15	66435104	13350	28389	rs121908594	NC_000015.10:66435103:T:C	single nucleotide variant	missense variant	Likely pathogenic	Sep 17, 2024	reviewed by expert panel							
NM_002755.4(MAP2K1):c.161T>C (p.Leu54Pro)	MAP2K1	L54P	RASopathy	VCV001506502	15	66727445	15	66435107	1506502	1430427	rs2140578916	NC_000015.10:66435106:T:C	single nucleotide variant	missense variant	Pathogenic	Oct 17, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.165_179del (p.Gln56_Val60del)	MAP2K1		Vascular malformation	VCV002672091	15	66727449 - 66727463	15	66435111 - 66435125	2672091	2839619		NC_000015.10:66435110:CCAGAAGCAGAAGGT:	Deletion	inframe_deletion	Likely pathogenic	Sep 11, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.167A>C (p.Gln56Pro)	MAP2K1	Q56P	not provided|Non-small cell lung carcinoma	VCV000375978	15	66727451	15	66435113	375978	362857	rs1057519729	NC_000015.10:66435112:A:C	single nucleotide variant	missense variant	Pathogenic	Jul 2, 2021	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.169A>G (p.Lys57Glu)	MAP2K1	K57E	Melorheostosis	VCV000376173	15	66727453	15	66435115	376173	363052	rs397516790	NC_000015.10:66435114:A:G	single nucleotide variant	missense variant	Pathogenic	Jun 23, 2020	no assertion criteria provided							
NM_002755.4(MAP2K1):c.169A>C (p.Lys57Gln)	MAP2K1	K57Q	RASopathy	VCV000040779	15	66727453	15	66435115	40779	49249	rs397516790	NC_000015.10:66435114:A:C	single nucleotide variant	missense variant	Likely pathogenic	May 9, 2017	reviewed by expert panel							
NM_002755.4(MAP2K1):c.170A>T (p.Lys57Met)	MAP2K1	K35M, K57M	not provided	VCV001708637	15	66727454	15	66435116	1708637	1706991		NC_000015.10:66435115:A:T	single nucleotide variant	missense variant	Pathogenic	Mar 31, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.171G>T (p.Lys57Asn)	MAP2K1	K57N	not provided	VCV000223140	15	66727455	15	66435117	223140	224866	rs869025608	NC_000015.10:66435116:G:T	single nucleotide variant	missense variant	Pathogenic	Apr 26, 2021	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.173_187del (p.Gln58_Glu62del)	MAP2K1		Parkes Weber syndrome|Vascular malformation	VCV001691383	15	66727456 - 66727470	15	66435118 - 66435132	1691383	1683862	rs2140579005	NC_000015.10:66435117:CAGAAGGTGGGAGAAC:C	Deletion	inframe_deletion	Pathogenic/Likely pathogenic	Aug 26, 2023	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.173A>G (p.Gln58Arg)	MAP2K1	Q36R, Q58R	RASopathy	VCV002880468	15	66727457	15	66435119	2880468	3033961		NC_000015.10:66435118:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 31, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.175_177del (p.Lys59del)	MAP2K1	K59del	RASopathy|not provided	VCV000222074	15	66727457 - 66727459	15	66435119 - 66435121	222074	223772	rs869025339	NC_000015.10:66435118:AGAAG:AG	Deletion	inframe_deletion	Likely pathogenic	Apr 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.174G>T (p.Gln58His)	MAP2K1	Q58H	Cardiofaciocutaneous syndrome 3	VCV000834058	15	66727458	15	66435120	834058	822305	rs2093484335	NC_000015.10:66435119:G:T	single nucleotide variant	missense variant	Uncertain significance		no assertion criteria provided							
NM_002755.4(MAP2K1):c.179_193del (p.Val60_Lys64del)	MAP2K1		not provided	VCV000372926	15	66727458 - 66727472	15	66435120 - 66435134	372926	360190	rs1057518078	NC_000015.10:66435119:GAAGGTGGGAGAACTGAAGG:GAAGG	Deletion	inframe_deletion	Likely pathogenic	Mar 8, 2016	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.177G>A (p.Lys59=)	MAP2K1		not specified|RASopathy	VCV000378100	15	66727461	15	66435123	378100	373629	rs773928828	NC_000015.10:66435122:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Aug 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.179T>G (p.Val60Gly)	MAP2K1	V60G	not provided	VCV000040780	15	66727463	15	66435125	40780	49250	rs730880501	NC_000015.10:66435124:T:G	single nucleotide variant	missense variant	Uncertain significance	Jul 10, 2012	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.186_200del (p.Glu62_Asp66del)	MAP2K1		not provided	VCV000372929	15	66727468 - 66727482	15	66435130 - 66435144	372929	360104	rs1057518080	NC_000015.10:66435129:GAACTGAAGGATGACGA:GA	Deletion	inframe_deletion	Likely pathogenic	Mar 8, 2016	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.187C>T (p.Leu63=)	MAP2K1		not provided	VCV002645469	15	66727471	15	66435133	2645469	2814251		NC_000015.10:66435132:C:T	single nucleotide variant	synonymous variant	Likely benign	Feb 1, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.198C>A (p.Asp66Glu)	MAP2K1	D66E	RASopathy	VCV001502584	15	66727482	15	66435144	1502584	1504353	rs56200325	NC_000015.10:66435143:C:A	single nucleotide variant	missense variant	Uncertain significance	Apr 3, 2021	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.198C>T (p.Asp66=)	MAP2K1		RASopathy|Noonan syndrome and Noonan-related syndrome|Cardiovascular phenotype	VCV001334250	15	66727482	15	66435144	1334250	1325110	rs56200325	NC_000015.10:66435143:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Aug 25, 2023	criteria provided, conflicting classifications							
NM_002755.4(MAP2K1):c.199G>A (p.Asp67Asn)	MAP2K1	D67N	Cardio-facio-cutaneous syndrome	VCV000040781	15	66727483	15	66435145	40781	49251	rs727504317	NC_000015.10:66435144:G:A	single nucleotide variant	missense variant	Pathogenic	May 9, 2017	reviewed by expert panel							
NM_002755.4(MAP2K1):c.200A>G (p.Asp67Gly)	MAP2K1	D45G, D67G	Melorheostosis|Cardiofaciocutaneous syndrome 3	VCV003577599	15	66727484	15	66435146	3577599	3704199		NC_000015.10:66435145:A:G	single nucleotide variant	missense variant	Likely pathogenic	Apr 9, 2024	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.205G>A (p.Glu69Lys)	MAP2K1	E69K	RASopathy	VCV000857990	15	66727489	15	66435151	857990	842603	rs2093484413	NC_000015.10:66435150:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 5, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.212T>C (p.Ile71Thr)	MAP2K1	I71T	RASopathy	VCV001494111	15	66727496	15	66435158	1494111	1349854	rs2140579455	NC_000015.10:66435157:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 31, 2021	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.212T>G (p.Ile71Ser)	MAP2K1	I71S	RASopathy	VCV001395763	15	66727496	15	66435158	1395763	1425162	rs2140579455	NC_000015.10:66435157:T:G	single nucleotide variant	missense variant	Uncertain significance	Mar 18, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.215G>A (p.Ser72Asn)	MAP2K1	S50N, S72N	RASopathy	VCV002419895	15	66727499	15	66435161	2419895	1948586		NC_000015.10:66435160:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.234T>C (p.Asn78=)	MAP2K1		RASopathy	VCV001116766	15	66727518	15	66435180	1116766	1103047	rs1326124619	NC_000015.10:66435179:T:C	single nucleotide variant	synonymous variant	Likely benign	Nov 6, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.237C>T (p.Gly79=)	MAP2K1		RASopathy|Noonan syndrome and Noonan-related syndrome|Cardiofaciocutaneous syndrome 3|Noonan syndrome 1|Melorheostosis|Cardiovascular phenotype|not specified|not provided	VCV000040782	15	66727521	15	66435183	40782	49252	rs148656020	NC_000015.10:66435182:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Apr 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.238G>A (p.Gly80Ser)	MAP2K1	G80S	RASopathy	VCV001440001	15	66727522	15	66435184	1440001	1368451	rs2140579691	NC_000015.10:66435183:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 17, 2021	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.239G>A (p.Gly80Asp)	MAP2K1	G58D, G80D	RASopathy	VCV002759901	15	66727523	15	66435185	2759901	2910713		NC_000015.10:66435184:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 10, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.247T>C (p.Phe83Leu)	MAP2K1	F61L, F83L	RASopathy	VCV002894476	15	66727531	15	66435193	2894476	3056117		NC_000015.10:66435192:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 14, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.251A>G (p.Lys84Arg)	MAP2K1	K84R	not specified|Noonan syndrome and Noonan-related syndrome|not provided|RASopathy	VCV000503541	15	66727535	15	66435197	503541	494974	rs774932586	NC_000015.10:66435196:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.255C>A (p.Val85=)	MAP2K1		RASopathy	VCV001661449	15	66727539	15	66435201	1661449	1607811	rs1052147663	NC_000015.10:66435200:C:A	single nucleotide variant	synonymous variant	Likely benign	Dec 14, 2020	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.255C>T (p.Val85=)	MAP2K1		RASopathy|Cardiovascular phenotype	VCV001105938	15	66727539	15	66435201	1105938	1103048	rs1052147663	NC_000015.10:66435200:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.256T>A (p.Ser86Thr)	MAP2K1	S64T, S86T	RASopathy	VCV001719165	15	66727540	15	66435202	1719165	1774469		NC_000015.10:66435201:T:A	single nucleotide variant	missense variant	Uncertain significance	Sep 10, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.263A>G (p.Lys88Arg)	MAP2K1	K88R	Cardiovascular phenotype|not specified	VCV000667260	15	66727547	15	66435209	667260	654780	rs762354445	NC_000015.10:66435208:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 24, 2023	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.264G>A (p.Lys88=)	MAP2K1		Cardiovascular phenotype|RASopathy|not provided|not specified	VCV001078549	15	66727548	15	66435210	1078549	1081233	rs7494832	NC_000015.10:66435209:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.265C>T (p.Pro89Ser)	MAP2K1	P67S, P89S	RASopathy	VCV001946865	15	66727549	15	66435211	1946865	1995829		NC_000015.10:66435210:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 8, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.265C>A (p.Pro89Thr)	MAP2K1	P89T	Cardiofaciocutaneous syndrome 3	VCV001299563	15	66727549	15	66435211	1299563	1289618	rs1265809314	NC_000015.10:66435210:C:A	single nucleotide variant	missense variant	Likely pathogenic	Aug 10, 2021	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.275T>G (p.Leu92Arg)	MAP2K1	L92R	RASopathy	VCV000044588	15	66727559	15	66435221	44588	53755	rs397516791	NC_000015.10:66435220:T:G	single nucleotide variant	missense variant	Pathogenic	Sep 17, 2024	reviewed by expert panel							
NM_002755.4(MAP2K1):c.276G>C (p.Leu92=)	MAP2K1		RASopathy|not provided	VCV000040783	15	66727560	15	66435222	40783	49253	rs377323150	NC_000015.10:66435221:G:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Oct 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.277G>A (p.Val93Ile)	MAP2K1	V93I	Cardiovascular phenotype|not provided|RASopathy	VCV000180896	15	66727561	15	66435223	180896	179784	rs151207265	NC_000015.10:66435222:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 22, 2024	criteria provided, conflicting classifications							
NM_002755.4(MAP2K1):c.279C>T (p.Val93=)	MAP2K1		Cardiovascular phenotype|RASopathy	VCV001082796	15	66727563	15	66435225	1082796	1081234	rs140387057	NC_000015.10:66435224:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.280A>G (p.Met94Val)	MAP2K1	M94V, M72V	RASopathy|Cardiovascular phenotype	VCV001796301	15	66727564	15	66435226	1796301	1852736		NC_000015.10:66435225:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.288A>G (p.Arg96=)	MAP2K1		RASopathy	VCV001088011	15	66727572	15	66435234	1088011	1081235	rs2140580028	NC_000015.10:66435233:A:G	single nucleotide variant	synonymous variant	Likely benign	Oct 3, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.291+9G>T	MAP2K1		RASopathy	VCV002965175	15	66727584	15	66435246	2965175	3117742		NC_000015.10:66435245:G:T	single nucleotide variant	intron variant	Likely benign	Nov 17, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.291+14_291+16del	MAP2K1		RASopathy	VCV002419571	15	66727588 - 66727590	15	66435250 - 66435252	2419571	1938391		NC_000015.10:66435249:TGAT:T	Deletion	intron variant	Likely benign	Feb 3, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.291+14_291+19delinsTCTCAC	MAP2K1		not specified	VCV002691459	15	66727589 - 66727594	15	66435251 - 66435256	2691459	2852483		NC_000015.10:66435250:GATTAA:TCTCAC	Indel	intron variant	Uncertain significance	Dec 4, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.291+14G>T	MAP2K1		RASopathy	VCV001593570	15	66727589	15	66435251	1593570	1589641	rs1217523374	NC_000015.10:66435250:G:T	single nucleotide variant	intron variant	Likely benign	Jan 30, 2024	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.291+14_291+15inv	MAP2K1		not specified	VCV000987855	15	66727589 - 66727590	15	66435251 - 66435252	987855	975825		NC_000015.10:66435250:GA:TC	Inversion	intron variant	Likely benign	Jul 29, 2024	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.291+14_291+20delinsTCTCACCAATCACCA	MAP2K1		not provided|Cardiofaciocutaneous syndrome 3|Melorheostosis|Noonan syndrome 1|RASopathy|not specified	VCV000421851	15	66727589 - 66727595	15	66435251 - 66435257	421851	409321	rs1064795401	NC_000015.10:66435250:GATTAAC:TCTCACCAATCACCA	Indel	intron variant	Likely benign	Jan 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.291+15A>C	MAP2K1		not specified|RASopathy	VCV001659912	15	66727590	15	66435252	1659912	1606283	rs1337930990	NC_000015.10:66435251:A:C	single nucleotide variant	intron variant	Likely benign	Jul 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.291+17T>C	MAP2K1		not specified|RASopathy	VCV000987854	15	66727592	15	66435254	987854	975826	rs1294983448	NC_000015.10:66435253:T:C	single nucleotide variant	intron variant	Likely benign	Jan 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.291+18A>T	MAP2K1		not specified|RASopathy	VCV000515007	15	66727593	15	66435255	515007	504917	rs577549188	NC_000015.10:66435254:A:T	single nucleotide variant	intron variant	Benign	Nov 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.291+19A>C	MAP2K1		not specified|RASopathy	VCV000987856	15	66727594	15	66435256	987856	975827	rs752759395	NC_000015.10:66435255:A:C	single nucleotide variant	intron variant	Likely benign	Jan 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.291+20C>T	MAP2K1		RASopathy	VCV001561327	15	66727595	15	66435257	1561327	1554752	rs756056132	NC_000015.10:66435256:C:T	single nucleotide variant	intron variant	Likely benign	Dec 8, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.291+22G>C	MAP2K1		not provided|not specified|Cardiofaciocutaneous syndrome 3	VCV000040784	15	66727597	15	66435259	40784	49254	rs16949924	NC_000015.10:66435258:G:C	single nucleotide variant		Benign	Sep 5, 2021	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.291+127_291+129dup	MAP2K1		not provided	VCV001227182	15	66727689 - 66727690	15	66435351 - 66435352	1227182	1215868	rs71139499	NC_000015.10:66435351:TTTTTTTTTTTTTTT:TTTTTTTTTTTTTTTTTT	Duplication	intron variant	Benign	Nov 14, 2019	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.291+128_291+129dup	MAP2K1		not provided	VCV001178395	15	66727689 - 66727690	15	66435351 - 66435352	1178395	1168333	rs71139499	NC_000015.10:66435351:TTTTTTTTTTTTTTT:TTTTTTTTTTTTTTTTT	Duplication	intron variant	Benign	Nov 14, 2019	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.291+199C>T	MAP2K1		not provided	VCV001229318	15	66727774	15	66435436	1229318	1220574	rs66975215	NC_000015.10:66435435:C:T	single nucleotide variant	intron variant	Benign	Jun 26, 2018	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.292-133A>C	MAP2K1		not provided	VCV000561383	15	66728951	15	66436613	561383	552857	rs11637556	NC_000015.10:66436612:A:C	single nucleotide variant	intron variant	Benign	Jun 15, 2018	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.292-20T>C	MAP2K1		RASopathy	VCV002805796	15	66729064	15	66436726	2805796	2974158		NC_000015.10:66436725:T:C	single nucleotide variant	intron variant	Likely benign	Oct 29, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.292-18T>C	MAP2K1		RASopathy	VCV002099715	15	66729066	15	66436728	2099715	2147273		NC_000015.10:66436727:T:C	single nucleotide variant	intron variant	Likely benign	Feb 19, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.292-13del	MAP2K1		RASopathy	VCV002905373	15	66729070	15	66436732	2905373	3065478		NC_000015.10:66436731:CC:C	Deletion	intron variant	Benign	Dec 4, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.292-8T>A	MAP2K1		RASopathy|Noonan syndrome and Noonan-related syndrome	VCV001334205	15	66729076	15	66436738	1334205	1325065	rs966429123	NC_000015.10:66436737:T:A	single nucleotide variant	intron variant	Likely benign	May 31, 2021	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.292-4C>G	MAP2K1		not specified|RASopathy	VCV000227536	15	66729080	15	66436742	227536	230598	rs771407622	NC_000015.10:66436741:C:G	single nucleotide variant	intron variant	Likely benign	Jul 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.292-3C>T	MAP2K1		RASopathy|not provided|not specified|Cardiovascular phenotype	VCV000216570	15	66729081	15	66436743	216570	213138	rs55694358	NC_000015.10:66436742:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Nov 2, 2023	criteria provided, conflicting classifications							
NM_002755.4(MAP2K1):c.292-2A>G	MAP2K1		not specified	VCV003068994	15	66729082	15	66436744	3068994	3228319		NC_000015.10:66436743:A:G	single nucleotide variant	splice acceptor variant	Uncertain significance	Feb 14, 2024	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.303_308del (p.Glu102_Ile103del)	MAP2K1		not provided	VCV001691385	15	66729094 - 66729099	15	66436756 - 66436761	1691385	1683864	rs2140583355	NC_000015.10:66436755:TGGAGAT:T	Deletion	inframe_deletion	Pathogenic	Apr 12, 2021	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.306_311del (p.Ile103_Lys104del)	MAP2K1		Vascular malformation|not provided	VCV002672096	15	66729097 - 66729102	15	66436759 - 66436764	2672096	2839624		NC_000015.10:66436758:AGATCAA:A	Deletion	inframe_deletion	Pathogenic/Likely pathogenic	Oct 18, 2023	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.305A>T (p.Glu102Val)	MAP2K1	E102V, E80V	RASopathy	VCV001991575	15	66729097	15	66436759	1991575	2037817		NC_000015.10:66436758:A:T	single nucleotide variant	missense variant	Likely pathogenic	Jun 29, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.305A>G (p.Glu102Gly)	MAP2K1		RASopathy	VCV000190378	15	66729097	15	66436759	190378	188202	rs797044593	NC_000015.10:66436758:A:G	single nucleotide variant	missense variant	Pathogenic	Sep 17, 2021	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.308T>C (p.Ile103Thr)	MAP2K1	I103T	Noonan syndrome	VCV000981553	15	66729100	15	66436762	981553	969693		NC_000015.10:66436761:T:C	single nucleotide variant	missense variant	Likely pathogenic		no assertion criteria provided							
NM_002755.4(MAP2K1):c.308T>G (p.Ile103Ser)	MAP2K1	I103S	not provided	VCV000040785	15	66729100	15	66436762	40785	49255	rs730880502	NC_000015.10:66436761:T:G	single nucleotide variant	missense variant	Uncertain significance	Jul 19, 2012	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.314C>G (p.Pro105Arg)	MAP2K1	P105R, P83R	Cardiovascular phenotype	VCV003292968	15	66729106	15	66436768	3292968	3446439		NC_000015.10:66436767:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 9, 2024	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.315C>T (p.Pro105=)	MAP2K1		RASopathy	VCV000044589	15	66729107	15	66436769	44589	53756	rs144166521	NC_000015.10:66436768:C:T	single nucleotide variant	synonymous variant	Benign	May 9, 2017	reviewed by expert panel							
NM_002755.4(MAP2K1):c.319A>G (p.Ile107Val)	MAP2K1	I107V	Cardiovascular phenotype|RASopathy	VCV001366968	15	66729111	15	66436773	1366968	1338133	rs1567009717	NC_000015.10:66436772:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.322C>T (p.Arg108Trp)	MAP2K1	R108W	Noonan syndrome	VCV000666419	15	66729114	15	66436776	666419	653978	rs1298033161	NC_000015.10:66436775:C:T	single nucleotide variant	missense variant	Likely benign		no assertion criteria provided							
NM_002755.4(MAP2K1):c.323G>T (p.Arg108Leu)	MAP2K1	R108L	RASopathy	VCV000280446	15	66729115	15	66436777	280446	264875	rs727504819	NC_000015.10:66436776:G:T	single nucleotide variant	missense variant	Pathogenic	Jun 25, 2020	reviewed by expert panel							
NM_002755.4(MAP2K1):c.323G>A (p.Arg108Gln)	MAP2K1	R108Q	not specified|RASopathy|not provided|Cardiovascular phenotype	VCV000179368	15	66729115	15	66436777	179368	176000	rs727504819	NC_000015.10:66436776:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.327C>T (p.Asn109=)	MAP2K1		Cardiovascular phenotype	VCV003222780	15	66729119	15	66436781	3222780	3386418		NC_000015.10:66436780:C:T	single nucleotide variant	synonymous variant	Likely benign	Nov 1, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.333_335del (p.Ile112del)	MAP2K1	I112del, I90del	MAP2K1-related disorder	VCV003355185	15	66729123 - 66729125	15	66436785 - 66436787	3355185	3514404		NC_000015.10:66436784:ATCAT:AT	Deletion	inframe_deletion	Likely pathogenic	May 29, 2024	no assertion criteria provided							
NM_002755.4(MAP2K1):c.332T>C (p.Ile111Thr)	MAP2K1	I111T, I89T	not provided	VCV003390795	15	66729124	15	66436786	3390795	3549924		NC_000015.10:66436785:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 12, 2024	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.332T>A (p.Ile111Asn)	MAP2K1	I111N	RASopathy	VCV000376194	15	66729124	15	66436786	376194	363073	rs1057519730	NC_000015.10:66436785:T:A	single nucleotide variant	missense variant	Pathogenic	Oct 25, 2019	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.333C>T (p.Ile111=)	MAP2K1		RASopathy	VCV002124149	15	66729125	15	66436787	2124149	2184611		NC_000015.10:66436786:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 19, 2021	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.342G>A (p.Glu114=)	MAP2K1		RASopathy	VCV000779576	15	66729134	15	66436796	779576	714561	rs939141868	NC_000015.10:66436795:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 17, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.343C>G (p.Leu115Val)	MAP2K1	L115V	Cardiovascular phenotype|Noonan syndrome and Noonan-related syndrome	VCV000040740	15	66729135	15	66436797	40740	49210	rs1428775799	NC_000015.10:66436796:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 13, 2020	criteria provided, conflicting classifications							
NM_002755.4(MAP2K1):c.355C>T (p.His119Tyr)	MAP2K1	H119Y	MAP2K1-related rasopathy-like syndrome|not provided|RASopathy	VCV000040741	15	66729147	15	66436809	40741	49211	rs730880503	NC_000015.10:66436808:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 17, 2021	criteria provided, conflicting classifications							
NM_002755.4(MAP2K1):c.364A>G (p.Asn122Asp)	MAP2K1	N122D	RASopathy	VCV000228273	15	66729156	15	66436818	228273	230599	rs876657651	NC_000015.10:66436817:A:G	single nucleotide variant	missense variant	Pathogenic	Mar 16, 2020	reviewed by expert panel							
NM_002755.4(MAP2K1):c.365A>G (p.Asn122Ser)	MAP2K1	N122S, N100S	RASopathy	VCV002004312	15	66729157	15	66436819	2004312	2062247		NC_000015.10:66436818:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 10, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.366C>T (p.Asn122=)	MAP2K1		RASopathy|Noonan syndrome and Noonan-related syndrome	VCV001334251	15	66729158	15	66436820	1334251	1325111	rs990673168	NC_000015.10:66436819:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jun 13, 2022	criteria provided, conflicting classifications							
NM_002755.4(MAP2K1):c.370C>G (p.Pro124Ala)	MAP2K1	P124A	Cardiofaciocutaneous syndrome 3	VCV001697313	15	66729162	15	66436824	1697313	1689706	rs1057519732	NC_000015.10:66436823:C:G	single nucleotide variant	missense variant	Likely pathogenic	Jul 15, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.370C>T (p.Pro124Ser)	MAP2K1	P124S	RASopathy	VCV000375981	15	66729162	15	66436824	375981	362860	rs1057519732	NC_000015.10:66436823:C:T	single nucleotide variant	missense variant	Pathogenic	Jul 2, 2020	reviewed by expert panel							
NM_002755.4(MAP2K1):c.370C>A (p.Pro124Thr)	MAP2K1	P124T	Cardiofaciocutaneous syndrome 3	VCV000040742	15	66729162	15	66436824	40742	49212	rs1057519732	NC_000015.10:66436823:C:A	single nucleotide variant	missense variant	Uncertain significance	Sep 1, 2017	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.371C>G (p.Pro124Arg)	MAP2K1	P124R	not provided	VCV000372636	15	66729163	15	66436825	372636	360217	rs397516792	NC_000015.10:66436824:C:G	single nucleotide variant	missense variant	Pathogenic	Jun 11, 2015	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.371C>T (p.Pro124Leu)	MAP2K1	P124L	not provided|Noonan syndrome and Noonan-related syndrome|RASopathy|Cardio-facio-cutaneous syndrome|Cardiofaciocutaneous syndrome 3	VCV000040744	15	66729163	15	66436825	40744	49214	rs397516792	NC_000015.10:66436824:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	May 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.371C>A (p.Pro124Gln)	MAP2K1	P124Q	Cardiofaciocutaneous syndrome 3	VCV000040743	15	66729163	15	66436825	40743	49213	rs397516792	NC_000015.10:66436824:C:A	single nucleotide variant	missense variant	Pathogenic	Jul 1, 2007	no assertion criteria provided							
NM_002755.4(MAP2K1):c.372G>A (p.Pro124=)	MAP2K1		Cardiovascular phenotype|RASopathy	VCV001548351	15	66729164	15	66436826	1548351	1657719	rs750270430	NC_000015.10:66436825:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.374A>G (p.Tyr125Cys)	MAP2K1	Y125C	Cardio-facio-cutaneous syndrome	VCV000810771	15	66729166	15	66436828	810771	799020	rs1595861880	NC_000015.10:66436827:A:G	single nucleotide variant	missense variant	not provided		no classification provided							
NM_002755.4(MAP2K1):c.378C>T (p.Ile126=)	MAP2K1		not specified|RASopathy|Cardiovascular phenotype	VCV000509643	15	66729170	15	66436832	509643	505128	rs369401783	NC_000015.10:66436831:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.379G>A (p.Val127Met)	MAP2K1	V127M	RASopathy	VCV001424722	15	66729171	15	66436833	1424722	1438598	rs1013906172	NC_000015.10:66436832:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 31, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.383del (p.Gly128fs)	MAP2K1	G128fs	RASopathy	VCV002048931	15	66729173	15	66436835	2048931	2114574		NC_000015.10:66436834:GGG:GG	Deletion	frameshift variant	Uncertain significance	Nov 22, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.383G>A (p.Gly128Asp)	MAP2K1	G128D	RASopathy	VCV003609725	15	66729175	15	66436837	3609725	49216	rs121908596	NC_000015.10:66436836:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 18, 2024	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.383G>C (p.Gly128Ala)	MAP2K1	G128A	Cardiofaciocutaneous syndrome 3	VCV001297058	15	66729175	15	66436837	1297058	1286848	rs121908596	NC_000015.10:66436836:G:C	single nucleotide variant	missense variant	Pathogenic	Aug 17, 2021	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.383_384delinsTT (p.Gly128Val)	MAP2K1	G128V	RASopathy	VCV000040745	15	66729175 - 66729176	15	66436837 - 66436838	40745	49215	rs730880508	NC_000015.10:66436836:GC:TT	Indel	missense variant	Pathogenic	Nov 4, 2012	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.383G>T (p.Gly128Val)	MAP2K1	G128V	RASopathy|Cardio-facio-cutaneous syndrome|not provided	VCV000013352	15	66729175	15	66436837	13352	28391	rs121908596	NC_000015.10:66436836:G:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jun 12, 2023	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.388T>A (p.Tyr130Asn)	MAP2K1	Y130N	Cardiofaciocutaneous syndrome 3	VCV000636238	15	66729180	15	66436842	636238	624057	rs397516793	NC_000015.10:66436841:T:A	single nucleotide variant	missense variant	Pathogenic	Jul 13, 2018	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.388T>C (p.Tyr130His)	MAP2K1	Y130H	Cardio-facio-cutaneous syndrome	VCV000040747	15	66729180	15	66436842	40747	49217	rs397516793	NC_000015.10:66436841:T:C	single nucleotide variant	missense variant	Likely pathogenic	May 9, 2017	reviewed by expert panel							
NM_002755.4(MAP2K1):c.389A>G (p.Tyr130Cys)	MAP2K1	Y130C	Cardio-facio-cutaneous syndrome	VCV000013351	15	66729181	15	66436843	13351	28390	rs121908595	NC_000015.10:66436842:A:G	single nucleotide variant	missense variant	Pathogenic	May 9, 2017	reviewed by expert panel							
NM_002755.4(MAP2K1):c.395C>T (p.Ala132Val)	MAP2K1	A110V, A132V	not provided	VCV003338747	15	66729187	15	66436849	3338747	3498017		NC_000015.10:66436848:C:T	single nucleotide variant	missense variant	Likely pathogenic	Jan 19, 2024	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.396G>C (p.Ala132=)	MAP2K1		RASopathy	VCV002902674	15	66729188	15	66436850	2902674	3058269		NC_000015.10:66436849:G:C	single nucleotide variant	synonymous variant	Likely benign	Dec 9, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.396G>T (p.Ala132=)	MAP2K1		RASopathy	VCV000747680	15	66729188	15	66436850	747680	754631	rs139364105	NC_000015.10:66436849:G:T	single nucleotide variant	synonymous variant	Likely benign	Aug 24, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.396G>A (p.Ala132=)	MAP2K1		RASopathy|not provided|Cardiovascular phenotype	VCV000040748	15	66729188	15	66436850	40748	49218	rs139364105	NC_000015.10:66436849:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Aug 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.404G>A (p.Ser135Asn)	MAP2K1	S113N, S135N	RASopathy	VCV002906867	15	66729196	15	66436858	2906867	3065673		NC_000015.10:66436857:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 7, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.405C>T (p.Ser135=)	MAP2K1		not specified|Cardiovascular phenotype|RASopathy	VCV000929217	15	66729197	15	66436859	929217	917210	rs767989355	NC_000015.10:66436858:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.411C>G (p.Gly137=)	MAP2K1		RASopathy	VCV002151497	15	66729203	15	66436865	2151497	1881664		NC_000015.10:66436864:C:G	single nucleotide variant	synonymous variant	Likely benign	Aug 30, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.411C>T (p.Gly137=)	MAP2K1		RASopathy	VCV000572172	15	66729203	15	66436865	572172	569559	rs146415623	NC_000015.10:66436864:C:T	single nucleotide variant	synonymous variant	Likely benign	Nov 5, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.412G>A (p.Glu138Lys)	MAP2K1	E138K	not provided	VCV000180901	15	66729204	15	66436866	180901	179785	rs730880504	NC_000015.10:66436865:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 13, 2017	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.420T>C (p.Ser140=)	MAP2K1		RASopathy	VCV001114181	15	66729212	15	66436874	1114181	1103049	rs2140584315	NC_000015.10:66436873:T:C	single nucleotide variant	synonymous variant	Likely benign	Feb 4, 2019	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.421A>G (p.Ile141Val)	MAP2K1	I141V	RASopathy	VCV001398555	15	66729213	15	66436875	1398555	1427622	rs1189360966	NC_000015.10:66436874:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 4, 2021	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.424T>C (p.Cys142Arg)	MAP2K1	C120R, C142R	not provided	VCV003338730	15	66729216	15	66436878	3338730	3498000		NC_000015.10:66436877:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 27, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.427A>C (p.Met143Leu)	MAP2K1	M121L, M143L	Melorheostosis|Cardiofaciocutaneous syndrome 3	VCV003577600	15	66729219	15	66436881	3577600	3704200		NC_000015.10:66436880:A:C	single nucleotide variant	missense variant	Uncertain significance	Apr 28, 2024	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.427A>G (p.Met143Val)	MAP2K1	M143V	RASopathy|Cardiofaciocutaneous syndrome 3|Melorheostosis	VCV000998038	15	66729219	15	66436881	998038	985750	rs533695080	NC_000015.10:66436880:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.428T>C (p.Met143Thr)	MAP2K1	M121T, M143T	Melorheostosis|Cardiofaciocutaneous syndrome 3	VCV003577601	15	66729220	15	66436882	3577601	3704202		NC_000015.10:66436881:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 28, 2024	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.435C>T (p.His145=)	MAP2K1		not provided	VCV001691384	15	66729227	15	66436889	1691384	1683863	rs1369638918	NC_000015.10:66436888:C:T	single nucleotide variant	synonymous variant	Uncertain significance		criteria provided, single submitter							
NM_002755.4(MAP2K1):c.438+1_438+5del	MAP2K1		not provided	VCV001704022	15	66729228 - 66729232	15	66436890 - 66436894	1704022	1696499		NC_000015.10:66436889:ATGGTATG:ATG	Deletion	splice donor variant	Uncertain significance	May 26, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.438+4T>A	MAP2K1		RASopathy	VCV002167262	15	66729234	15	66436896	2167262	1906383		NC_000015.10:66436895:T:A	single nucleotide variant	intron variant	Uncertain significance	Aug 18, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.438+8A>T	MAP2K1		RASopathy	VCV000389759	15	66729238	15	66436900	389759	374265	rs550240942	NC_000015.10:66436899:A:T	single nucleotide variant	intron variant	Benign	May 9, 2017	reviewed by expert panel							
NM_002755.4(MAP2K1):c.438+9C>T	MAP2K1		RASopathy	VCV002805555	15	66729239	15	66436901	2805555	2964081		NC_000015.10:66436900:C:T	single nucleotide variant	intron variant	Likely benign	Dec 21, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.438+9C>A	MAP2K1		RASopathy	VCV002765429	15	66729239	15	66436901	2765429	2926176		NC_000015.10:66436900:C:A	single nucleotide variant	intron variant	Likely benign	Oct 4, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.438+11_438+18del	MAP2K1		RASopathy	VCV002747252	15	66729239 - 66729246	15	66436901 - 66436908	2747252	2908012		NC_000015.10:66436900:CACCCTCTCA:CA	Deletion	intron variant	Likely benign	Jun 6, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.438+13C>T	MAP2K1		RASopathy	VCV002911033	15	66729243	15	66436905	2911033	3070458		NC_000015.10:66436904:C:T	single nucleotide variant	intron variant	Likely benign	Jan 11, 2024	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.438+16_438+17del	MAP2K1		RASopathy	VCV002751343	15	66729243 - 66729244	15	66436905 - 66436906	2751343	2908639		NC_000015.10:66436904:CTCTC:CTC	Microsatellite	intron variant	Likely benign	Oct 9, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.438+15C>T	MAP2K1		RASopathy	VCV001625715	15	66729245	15	66436907	1625715	1607275	rs1170337728	NC_000015.10:66436906:C:T	single nucleotide variant	intron variant	Likely benign	Sep 2, 2024	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.438+20C>T	MAP2K1		not provided|Cardiofaciocutaneous syndrome 3|RASopathy|not specified	VCV000040749	15	66729250	15	66436912	40749	49219	rs16949939	NC_000015.10:66436911:C:T	single nucleotide variant	intron variant	Benign	Feb 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.438+192C>T	MAP2K1		not provided	VCV000561434	15	66729422	15	66437084	561434	552858	rs16949944	NC_000015.10:66437083:C:T	single nucleotide variant	intron variant	Likely benign	Jun 16, 2018	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.439-168G>A	MAP2K1		not provided	VCV001205681	15	66735450	15	66443112	1205681	1194979	rs187650018	NC_000015.10:66443111:G:A	single nucleotide variant	intron variant	Likely benign	Jul 17, 2018	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.439-67C>T	MAP2K1		not provided	VCV001224838	15	66735551	15	66443213	1224838	49220	rs6494573	NC_000015.10:66443212:C:T	single nucleotide variant	intron variant	Benign	Mar 3, 2015	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.439-19C>G	MAP2K1		Melorheostosis|Cardiofaciocutaneous syndrome 3	VCV003577602	15	66735599	15	66443261	3577602	3704203		NC_000015.10:66443260:C:G	single nucleotide variant	intron variant	Uncertain significance	Jan 22, 2024	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.439-19C>A	MAP2K1		not specified|not provided|RASopathy	VCV000383502	15	66735599	15	66443261	383502	374267	rs766207567	NC_000015.10:66443260:C:A	single nucleotide variant	intron variant	Benign/Likely benign	Jan 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.439-18T>C	MAP2K1		not provided	VCV000384908	15	66735600	15	66443262	384908	376560	rs751155864	NC_000015.10:66443261:T:C	single nucleotide variant	intron variant	Likely benign	Mar 17, 2016	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.439-16G>T	MAP2K1		not specified	VCV003375437	15	66735602	15	66443264	3375437	3534625		NC_000015.10:66443263:G:T	single nucleotide variant	intron variant	Likely benign	Sep 17, 2024	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.439-14A>G	MAP2K1		not specified	VCV001329010	15	66735604	15	66443266	1329010	1319697	rs754725417	NC_000015.10:66443265:A:G	single nucleotide variant	intron variant	Uncertain significance	Nov 21, 2021	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.439-9C>T	MAP2K1		RASopathy	VCV001979036	15	66735609	15	66443271	1979036	2038213		NC_000015.10:66443270:C:T	single nucleotide variant	intron variant	Likely benign	Mar 14, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.439-8G>C	MAP2K1		RASopathy	VCV002196875	15	66735610	15	66443272	2196875	1929934		NC_000015.10:66443271:G:C	single nucleotide variant	intron variant	Likely benign	Mar 25, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.439-8G>T	MAP2K1		RASopathy	VCV000764385	15	66735610	15	66443272	764385	776024	rs747709090	NC_000015.10:66443271:G:T	single nucleotide variant	intron variant	Likely benign	Aug 1, 2018	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.439-8G>A	MAP2K1		not provided|RASopathy|not specified	VCV000040751	15	66735610	15	66443272	40751	49221	rs747709090	NC_000015.10:66443271:G:A	single nucleotide variant	intron variant	Benign/Likely benign	Aug 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.439-7A>T	MAP2K1		RASopathy	VCV001534133	15	66735611	15	66443273	1534133	1647701	rs964442363	NC_000015.10:66443272:A:T	single nucleotide variant	intron variant	Likely benign	Dec 6, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.441T>C (p.Asp147=)	MAP2K1		Cardiovascular phenotype	VCV003292966	15	66735620	15	66443282	3292966	3446437		NC_000015.10:66443281:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	May 26, 2024	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.451C>T (p.Leu151=)	MAP2K1		RASopathy	VCV002867987	15	66735630	15	66443292	2867987	3024172		NC_000015.10:66443291:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 25, 2024	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.460G>A (p.Val154Ile)	MAP2K1	V154I	RASopathy	VCV002788415	15	66735639	15	66443301	2788415	2939623		NC_000015.10:66443300:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 28, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.462C>T (p.Val154=)	MAP2K1		Cardiovascular phenotype	VCV003222781	15	66735641	15	66443303	3222781	3386419		NC_000015.10:66443302:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 8, 2024	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.481A>G (p.Ile161Val)	MAP2K1	I161V	Noonan syndrome and Noonan-related syndrome	VCV001334252	15	66735660	15	66443322	1334252	1325112	rs2140598087	NC_000015.10:66443321:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 30, 2017	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.482T>C (p.Ile161Thr)	MAP2K1	I161T	RASopathy	VCV001061846	15	66735661	15	66443323	1061846	1049045	rs2140598095	NC_000015.10:66443322:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 17, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.488A>G (p.Glu163Gly)	MAP2K1	E163G	not provided	VCV002430477	15	66735667	15	66443329	2430477	2403984		NC_000015.10:66443328:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 15, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.490C>A (p.Gln164Lys)	MAP2K1	Q164K	RASopathy|not provided	VCV001318017	15	66735669	15	66443331	1318017	1309111	rs1891772126	NC_000015.10:66443330:C:A	single nucleotide variant	missense variant	Uncertain significance	Nov 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.492A>G (p.Gln164=)	MAP2K1		RASopathy|Cardiovascular phenotype	VCV001408248	15	66735671	15	66443333	1408248	1421895	rs140822439	NC_000015.10:66443332:A:G	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 3, 2021	criteria provided, conflicting classifications							
NM_002755.4(MAP2K1):c.503A>G (p.Lys168Arg)	MAP2K1	K168R	not provided|Cardiovascular phenotype|RASopathy	VCV001320746	15	66735682	15	66443344	1320746	341106	rs886051366	NC_000015.10:66443343:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 8, 2022	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.509G>A (p.Ser170Asn)	MAP2K1	S170N	RASopathy	VCV002807486	15	66735688	15	66443350	2807486	2974558		NC_000015.10:66443349:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 17, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.510C>T (p.Ser170=)	MAP2K1		RASopathy|Melorheostosis|Cardiofaciocutaneous syndrome 3	VCV003577603	15	66735689	15	66443351	3577603	3704204		NC_000015.10:66443350:C:T	single nucleotide variant	synonymous variant|intron variant	Uncertain significance	Jun 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.516+3_516+10dup	MAP2K1		RASopathy	VCV003620367	15	66735694 - 66735695	15	66443356 - 66443357	3620367	3750751		NC_000015.10:66443356:TGTGAGTATGT:TGTGAGTATGTGAGTATGT	Duplication	splice donor variant|intron variant	Uncertain significance	Nov 12, 2024	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.516+1G>A	MAP2K1		Cardiofaciocutaneous syndrome 3|not provided|RASopathy	VCV001053438	15	66735696	15	66443358	1053438	1049046	rs1240248728	NC_000015.10:66443357:G:A	single nucleotide variant	splice donor variant|intron variant	Uncertain significance	Apr 25, 2023	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.516+2T>C	MAP2K1		not specified	VCV000372835	15	66735697	15	66443359	372835	360288	rs1057518013	NC_000015.10:66443358:T:C	single nucleotide variant	splice donor variant|intron variant	Uncertain significance	Dec 24, 2015	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.516+3G>A	MAP2K1		Melorheostosis|Cardiofaciocutaneous syndrome 3|RASopathy	VCV002911450	15	66735698	15	66443360	2911450	3078802		NC_000015.10:66443359:G:A	single nucleotide variant	intron variant	Uncertain significance	Apr 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.516+9G>C	MAP2K1		RASopathy	VCV001919323	15	66735704	15	66443366	1919323	1968309		NC_000015.10:66443365:G:C	single nucleotide variant	intron variant	Likely benign	Oct 15, 2024	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.516+11del	MAP2K1		RASopathy	VCV002866013	15	66735705	15	66443367	2866013	3023486		NC_000015.10:66443366:TT:T	Deletion	intron variant	Likely benign	Jun 17, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.516+12A>G	MAP2K1		RASopathy	VCV003608914	15	66735707	15	66443369	3608914	3737740		NC_000015.10:66443368:A:G	single nucleotide variant	intron variant	Likely benign	Feb 29, 2024	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.516+12A>T	MAP2K1		RASopathy	VCV001896866	15	66735707	15	66443369	1896866	1952801		NC_000015.10:66443368:A:T	single nucleotide variant	intron variant	Likely benign	May 23, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.516+13T>A	MAP2K1		RASopathy	VCV003603824	15	66735708	15	66443370	3603824	3746298		NC_000015.10:66443369:T:A	single nucleotide variant	intron variant	Likely benign	Jan 23, 2025	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.516+13T>C	MAP2K1		RASopathy	VCV002155140	15	66735708	15	66443370	2155140	1882709		NC_000015.10:66443369:T:C	single nucleotide variant	intron variant	Likely benign	Dec 14, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.516+16A>G	MAP2K1		RASopathy	VCV001617924	15	66735711	15	66443373	1617924	1614777	rs1001637882	NC_000015.10:66443372:A:G	single nucleotide variant	intron variant	Likely benign	Apr 16, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.516+17G>A	MAP2K1		RASopathy	VCV001671613	15	66735712	15	66443374	1671613	1583851	rs2140598431	NC_000015.10:66443373:G:A	single nucleotide variant	intron variant	Likely benign	Jul 13, 2021	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.516+28A>G	MAP2K1		not provided	VCV001293728	15	66735723	15	66443385	1293728	1283529	rs184208600	NC_000015.10:66443384:A:G	single nucleotide variant	intron variant	Benign	Dec 23, 2019	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.516+176A>G	MAP2K1		not provided	VCV001211803	15	66735871	15	66443533	1211803	1201800	rs148929309	NC_000015.10:66443532:A:G	single nucleotide variant	intron variant	Likely benign	Nov 5, 2018	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.516+191G>A	MAP2K1		not provided	VCV001292067	15	66735886	15	66443548	1292067	1281880	rs17201019	NC_000015.10:66443547:G:A	single nucleotide variant	intron variant	Benign	Jun 26, 2018	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.516+230_516+231insAG	MAP2K1		not provided	VCV000561540	15	66735925 - 66735926	15	66443587 - 66443588	561540	552859	rs72531931	NC_000015.10:66443587::AG	Insertion	intron variant	Benign	Nov 19, 2019	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.516+283G>A	MAP2K1		not provided	VCV001213350	15	66735978	15	66443640	1213350	1203344	rs192620467	NC_000015.10:66443639:G:A	single nucleotide variant	intron variant	Likely benign	Jul 7, 2018	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.517-311C>A	MAP2K1		not provided	VCV000561816	15	66736683	15	66444345	561816	552860	rs112381615	NC_000015.10:66444344:C:A	single nucleotide variant	intron variant	Benign	Jun 18, 2018	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.517-253C>T	MAP2K1		not provided	VCV000561818	15	66736741	15	66444403	561818	552861	rs6494574	NC_000015.10:66444402:C:T	single nucleotide variant	intron variant	Benign	Jun 14, 2018	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.517-230A>C	MAP2K1		not provided	VCV000561628	15	66736764	15	66444426	561628	552862	rs141721809	NC_000015.10:66444425:A:C	single nucleotide variant	intron variant	Likely benign	Jun 14, 2018	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.517-139G>T	MAP2K1		not provided	VCV001217440	15	66736855	15	66444517	1217440	1207424	rs138624109	NC_000015.10:66444516:G:T	single nucleotide variant	intron variant	Likely benign	Jun 23, 2018	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.517-16A>T	MAP2K1		RASopathy	VCV002800360	15	66736978	15	66444640	2800360	2952418		NC_000015.10:66444639:A:T	single nucleotide variant	intron variant	Likely benign	Dec 12, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.517-13C>G	MAP2K1		RASopathy	VCV002075190	15	66736981	15	66444643	2075190	2134305		NC_000015.10:66444642:C:G	single nucleotide variant	intron variant	Likely benign	Dec 2, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.517-10T>C	MAP2K1		RASopathy	VCV002835461	15	66736984	15	66444646	2835461	2999119		NC_000015.10:66444645:T:C	single nucleotide variant	intron variant	Likely benign	Feb 8, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.517-9T>A	MAP2K1		RASopathy|not provided	VCV001315731	15	66736985	15	66444647	1315731	1305990	rs758986316	NC_000015.10:66444646:T:A	single nucleotide variant	intron variant	Likely benign	Nov 10, 2022	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.517-4C>T	MAP2K1		not specified|RASopathy	VCV000380658	15	66736990	15	66444652	380658	376569	rs200197244	NC_000015.10:66444651:C:T	single nucleotide variant	intron variant	Likely benign	Feb 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.517-2A>T	MAP2K1		not provided	VCV000502026	15	66736992	15	66444654	502026	493450	rs1555416876	NC_000015.10:66444653:A:T	single nucleotide variant	splice acceptor variant	Uncertain significance	May 17, 2017	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.517-1G>T	MAP2K1		RASopathy	VCV002738672	15	66736993	15	66444655	2738672	2905910		NC_000015.10:66444654:G:T	single nucleotide variant	splice acceptor variant	Uncertain significance	Jun 27, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.519A>T (p.Val173=)	MAP2K1		RASopathy|not specified	VCV000632878	15	66736996	15	66444658	632878	621518	rs1471931068	NC_000015.10:66444657:A:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Sep 10, 2018	criteria provided, conflicting classifications							
NM_002755.4(MAP2K1):c.520A>G (p.Ile174Val)	MAP2K1	I174V	not provided	VCV001189400	15	66736997	15	66444659	1189400	1181291	rs1891814988	NC_000015.10:66444658:A:G	single nucleotide variant	missense variant	Uncertain significance	May 31, 2019	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.525A>G (p.Lys175=)	MAP2K1		RASopathy	VCV000477667	15	66737002	15	66444664	477667	464426	rs1555416880	NC_000015.10:66444663:A:G	single nucleotide variant	synonymous variant	Likely benign	Jun 10, 2017	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.528C>T (p.Gly176=)	MAP2K1		RASopathy|Melorheostosis|Cardiofaciocutaneous syndrome 3	VCV003577604	15	66737005	15	66444667	3577604	3704205		NC_000015.10:66444666:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 13, 2024	criteria provided, conflicting classifications							
NM_002755.4(MAP2K1):c.528C>G (p.Gly176=)	MAP2K1		RASopathy	VCV002141443	15	66737005	15	66444667	2141443	1872434		NC_000015.10:66444666:C:G	single nucleotide variant	synonymous variant	Likely benign	Mar 31, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.529C>A (p.Leu177Met)	MAP2K1	L129M, L177M	RASopathy	VCV002699741	15	66737006	15	66444668	2699741	2862014		NC_000015.10:66444667:C:A	single nucleotide variant	missense variant	Uncertain significance	Nov 29, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.529C>G (p.Leu177Val)	MAP2K1	L177V	Inborn genetic diseases	VCV000985210	15	66737006	15	66444668	985210	973966	rs1891815342	NC_000015.10:66444667:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 14, 2018	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.537T>C (p.Tyr179=)	MAP2K1		RASopathy|not provided|Cardiovascular phenotype	VCV001212589	15	66737014	15	66444676	1212589	1202583	rs1188803242	NC_000015.10:66444675:T:C	single nucleotide variant	synonymous variant	Likely benign	Nov 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.546G>A (p.Glu182=)	MAP2K1		RASopathy|not specified	VCV000933176	15	66737023	15	66444685	933176	921484	rs1567012356	NC_000015.10:66444684:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 27, 2022	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.549G>A (p.Lys183=)	MAP2K1		RASopathy|not specified	VCV001589469	15	66737026	15	66444688	1589469	1607491	rs747352922	NC_000015.10:66444687:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.551A>T (p.His184Leu)	MAP2K1	H136L, H184L	RASopathy	VCV002113714	15	66737028	15	66444690	2113714	2161249		NC_000015.10:66444689:A:T	single nucleotide variant	missense variant	Uncertain significance	Jan 8, 2024	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.553A>G (p.Lys185Glu)	MAP2K1	K185E, K137E	RASopathy	VCV001982497	15	66737030	15	66444692	1982497	2039056		NC_000015.10:66444691:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 4, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.556A>G (p.Ile186Val)	MAP2K1	I186V, I138V	RASopathy	VCV002695344	15	66737033	15	66444695	2695344	2854204		NC_000015.10:66444694:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 14, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.564C>T (p.His188=)	MAP2K1		RASopathy	VCV002911998	15	66737041	15	66444703	2911998	3073157		NC_000015.10:66444702:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 20, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.565A>C (p.Arg189=)	MAP2K1		RASopathy	VCV001121960	15	66737042	15	66444704	1121960	1124480	rs776763061	NC_000015.10:66444703:A:C	single nucleotide variant	synonymous variant	Likely benign	Mar 9, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.568+1G>A	MAP2K1		not specified|not provided	VCV000180902	15	66737046	15	66444708	180902	179786	rs730880505	NC_000015.10:66444707:G:A	single nucleotide variant	splice donor variant	Uncertain significance	Apr 25, 2023	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.568+2T>C	MAP2K1		Melorheostosis|Cardiofaciocutaneous syndrome 3	VCV003577606	15	66737047	15	66444709	3577606	3704206		NC_000015.10:66444708:T:C	single nucleotide variant	splice donor variant	Uncertain significance	Feb 20, 2024	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.568+4A>G	MAP2K1		Cardiofaciocutaneous syndrome 3	VCV002577894	15	66737049	15	66444711	2577894	2742782		NC_000015.10:66444710:A:G	single nucleotide variant	intron variant	Uncertain significance	May 23, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.568+6A>G	MAP2K1		not specified|RASopathy	VCV000632879	15	66737051	15	66444713	632879	621838	rs1430324310	NC_000015.10:66444712:A:G	single nucleotide variant	intron variant	Uncertain significance	Mar 19, 2023	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.568+9T>A	MAP2K1		RASopathy	VCV001668976	15	66737054	15	66444716	1668976	1602862	rs748379069	NC_000015.10:66444715:T:A	single nucleotide variant	intron variant	Likely benign	Nov 15, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.568+9T>C	MAP2K1		not provided|RASopathy	VCV000378987	15	66737054	15	66444716	378987	374273	rs748379069	NC_000015.10:66444715:T:C	single nucleotide variant	intron variant	Likely benign	Apr 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.568+11A>T	MAP2K1		not provided|RASopathy	VCV000391970	15	66737056	15	66444718	391970	373637	rs769848510	NC_000015.10:66444717:A:T	single nucleotide variant	intron variant	Likely benign	Aug 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.568+198C>T	MAP2K1		not provided	VCV001211049	15	66737243	15	66444905	1211049	1201047	rs116786504	NC_000015.10:66444904:C:T	single nucleotide variant	intron variant	Likely benign	Jun 26, 2018	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.568+14001A>G	MAP2K1		not provided	VCV002645470	15	66751046	15	66458708	2645470	2814252		NC_000015.10:66458707:A:G	single nucleotide variant	intron variant	Uncertain significance	Sep 1, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.568+14010_568+14032del	MAP2K1		not provided	VCV003027419	15	66751050 - 66751072	15	66458712 - 66458734	3027419	3187728		NC_000015.10:66458711:GGTCTCTCTCTGTTGCCCAGGTTGGTCT:GGTCT	Deletion	intron variant	Uncertain significance	Feb 1, 2024	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.568+14005G>A	MAP2K1		not provided	VCV003026635	15	66751050	15	66458712	3026635	3186945		NC_000015.10:66458711:G:A	single nucleotide variant	intron variant	Likely benign	Dec 1, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.569-118G>A	MAP2K1		not provided	VCV000561384	15	66773975	15	66481637	561384	552863	rs41277720	NC_000015.10:66481636:G:A	single nucleotide variant	intron variant	Benign	Jun 15, 2018	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.569-49_569-6del	MAP2K1		RASopathy	VCV002854703	15	66774034 - 66774077	15	66481696 - 66481739	2854703	3007239		NC_000015.10:66481695:TTCTCTTCCCCAATCTACCTGTGTCAGTTCCCTCCTTTTCTATTTTCTCTTCCC:TTCTCTTCCC	Deletion	intron variant	Likely benign	Apr 19, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.569-19T>A	MAP2K1		RASopathy|not specified	VCV000378101	15	66774074	15	66481736	378101	374677	rs371099866	NC_000015.10:66481735:T:A	single nucleotide variant	intron variant	Benign/Likely benign	Jan 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.569-18A>G	MAP2K1		RASopathy	VCV001650938	15	66774075	15	66481737	1650938	1663720	rs886539818	NC_000015.10:66481736:A:G	single nucleotide variant	intron variant	Likely benign	Feb 18, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.569-13C>T	MAP2K1		not specified|RASopathy|not provided	VCV001259466	15	66774080	15	66481742	1259466	1250229	rs770040428	NC_000015.10:66481741:C:T	single nucleotide variant	intron variant	Benign	Dec 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.569-11C>T	MAP2K1		RASopathy	VCV001621938	15	66774082	15	66481744	1621938	1593141	rs1892919708	NC_000015.10:66481743:C:T	single nucleotide variant	intron variant	Likely benign	Oct 27, 2024	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.569-8C>T	MAP2K1		RASopathy|not specified	VCV000517177	15	66774085	15	66481747	517177	497252	rs375614631	NC_000015.10:66481746:C:T	single nucleotide variant	intron variant	Likely benign	Jan 21, 2023	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.569-4G>A	MAP2K1		RASopathy	VCV001616040	15	66774089	15	66481751	1616040	1613760	rs2140667203	NC_000015.10:66481750:G:A	single nucleotide variant	intron variant	Likely benign	Nov 8, 2021	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.573C>G (p.Val191=)	MAP2K1		Cardiovascular phenotype	VCV001749367	15	66774097	15	66481759	1749367	1800395		NC_000015.10:66481758:C:G	single nucleotide variant	synonymous variant	Likely benign	Jul 14, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.577C>G (p.Pro193Ala)	MAP2K1	P193A	Noonan syndrome	VCV000666420	15	66774101	15	66481763	666420	653979	rs1595884713	NC_000015.10:66481762:C:G	single nucleotide variant	missense variant	Likely benign		no assertion criteria provided							
NM_002755.4(MAP2K1):c.578C>T (p.Pro193Leu)	MAP2K1	P145L, P193L	not provided	VCV003373528	15	66774102	15	66481764	3373528	3532717		NC_000015.10:66481763:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 7, 2024	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.585C>T (p.Asn195=)	MAP2K1		RASopathy	VCV001582228	15	66774109	15	66481771	1582228	1654189	rs1437805160	NC_000015.10:66481770:C:T	single nucleotide variant	synonymous variant	Likely benign	Feb 26, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.586A>G (p.Ile196Val)	MAP2K1	I196V	not specified	VCV001172873	15	66774110	15	66481772	1172873	1162075	rs2140667372	NC_000015.10:66481771:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 14, 2021	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.589C>T (p.Leu197=)	MAP2K1		RASopathy	VCV002169745	15	66774113	15	66481775	2169745	1899768		NC_000015.10:66481774:C:T	single nucleotide variant	synonymous variant	Likely benign	Aug 28, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.596A>G (p.Asn199Ser)	MAP2K1	N151S, N199S	RASopathy	VCV001923133	15	66774120	15	66481782	1923133	1979879		NC_000015.10:66481781:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 13, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.600C>T (p.Ser200=)	MAP2K1		RASopathy	VCV002914946	15	66774124	15	66481786	2914946	3079684		NC_000015.10:66481785:C:T	single nucleotide variant	synonymous variant	Likely benign	Oct 13, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.602G>A (p.Arg201His)	MAP2K1	R153H, R201H	not provided	VCV001810126	15	66774126	15	66481788	1810126	1867130		NC_000015.10:66481787:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 27, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.603T>C (p.Arg201=)	MAP2K1		RASopathy	VCV002895850	15	66774127	15	66481789	2895850	3056625		NC_000015.10:66481788:T:C	single nucleotide variant	synonymous variant	Likely benign	Dec 6, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.606G>A (p.Gly202=)	MAP2K1		RASopathy	VCV002973700	15	66774130	15	66481792	2973700	3140119		NC_000015.10:66481791:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 23, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.607G>C (p.Glu203Gln)	MAP2K1	E203Q	Cardiofaciocutaneous syndrome 3	VCV001328146	15	66774131	15	66481793	1328146	1318764	rs1057519733	NC_000015.10:66481792:G:C	single nucleotide variant	missense variant	Pathogenic	Sep 16, 2021	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.607G>A (p.Glu203Lys)	MAP2K1	E203K	Inborn genetic diseases|Cardiofaciocutaneous syndrome 3	VCV000375982	15	66774131	15	66481793	375982	362861	rs1057519733	NC_000015.10:66481792:G:A	single nucleotide variant	missense variant	Likely pathogenic	Jul 2, 2018	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.608A>T (p.Glu203Val)	MAP2K1	E155V, E203V	not provided	VCV003375745	15	66774132	15	66481794	3375745	3534925		NC_000015.10:66481793:A:T	single nucleotide variant	missense variant	Pathogenic	May 7, 2024	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.608A>C (p.Glu203Ala)	MAP2K1	E203A	RASopathy	VCV000981554	15	66774132	15	66481794	981554	969694		NC_000015.10:66481793:A:C	single nucleotide variant	missense variant	Likely pathogenic	Mar 18, 2021	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.608A>G (p.Glu203Gly)	MAP2K1		RASopathy	VCV000167260	15	66774132	15	66481794	167260	177413	rs727503996	NC_000015.10:66481793:A:G	single nucleotide variant	missense variant	Pathogenic	May 18, 2020	reviewed by expert panel							
NM_002755.4(MAP2K1):c.612C>A (p.Ile204=)	MAP2K1		not specified	VCV001677018	15	66774136	15	66481798	1677018	1668650	rs2140667598	NC_000015.10:66481797:C:A	single nucleotide variant	synonymous variant	Likely benign	Mar 5, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.612C>G (p.Ile204Met)	MAP2K1	I204M	RASopathy	VCV001473963	15	66774136	15	66481798	1473963	1387959	rs2140667598	NC_000015.10:66481797:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 9, 2021	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.618C>T (p.Leu206=)	MAP2K1		Cardiovascular phenotype	VCV003222782	15	66774142	15	66481804	3222782	3386420		NC_000015.10:66481803:C:T	single nucleotide variant	synonymous variant	Likely benign	Sep 15, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.628G>C (p.Gly210Arg)	MAP2K1	G210R	not provided	VCV001316067	15	66774152	15	66481814	1316067	1308470	rs2140667730	NC_000015.10:66481813:G:C	single nucleotide variant	missense variant	Uncertain significance	Feb 7, 2020	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.630G>A (p.Gly210=)	MAP2K1		RASopathy|Cardiovascular phenotype	VCV001563544	15	66774154	15	66481816	1563544	1620048	rs1595884752	NC_000015.10:66481815:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 1, 2022	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.631G>A (p.Val211Ile)	MAP2K1	V211I	not specified|RASopathy	VCV000179898	15	66774155	15	66481817	179898	176144	rs727505206	NC_000015.10:66481816:G:A	single nucleotide variant	missense variant	Uncertain significance	May 24, 2017	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.633C>G (p.Val211=)	MAP2K1		RASopathy	VCV002056522	15	66774157	15	66481819	2056522	2109225		NC_000015.10:66481818:C:G	single nucleotide variant	synonymous variant	Uncertain significance	Mar 25, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.635G>C (p.Ser212Thr)	MAP2K1	S164T, S212T	Male infertility with azoospermia or oligozoospermia due to single gene mutation	VCV002686012	15	66774159	15	66481821	2686012	2847047		NC_000015.10:66481820:G:C	single nucleotide variant	missense variant	Likely pathogenic	Dec 1, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.636C>T (p.Ser212=)	MAP2K1		not specified|Cardiovascular phenotype|RASopathy	VCV000138156	15	66774160	15	66481822	138156	141859	rs138466751	NC_000015.10:66481821:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.637G>A (p.Gly213Arg)	MAP2K1	G165R, G213R	RASopathy	VCV002905812	15	66774161	15	66481823	2905812	3062260		NC_000015.10:66481822:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 30, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.645C>G (p.Leu215=)	MAP2K1		not specified	VCV001172898	15	66774169	15	66481831	1172898	1162076	rs2140667933	NC_000015.10:66481830:C:G	single nucleotide variant	synonymous variant	Likely benign	May 29, 2021	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.646A>G (p.Ile216Val)	MAP2K1	I168V, I216V	Cardiofaciocutaneous syndrome 3	VCV003237379	15	66774170	15	66481832	3237379	3396500		NC_000015.10:66481831:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 9, 2024	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.647T>C (p.Ile216Thr)	MAP2K1	I216T, I168T	RASopathy	VCV002901688	15	66774171	15	66481833	2901688	3064392		NC_000015.10:66481832:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 25, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.648C>T (p.Ile216=)	MAP2K1		RASopathy	VCV000044590	15	66774172	15	66481834	44590	53757	rs148968935	NC_000015.10:66481833:C:T	single nucleotide variant	synonymous variant	Benign	May 9, 2017	reviewed by expert panel							
NM_002755.4(MAP2K1):c.649G>A (p.Asp217Asn)	MAP2K1	D169N, D217N	RASopathy	VCV002828735	15	66774173	15	66481835	2828735	2987254		NC_000015.10:66481834:G:A	single nucleotide variant	missense variant	Uncertain significance	May 22, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.652T>C (p.Ser218Pro)	MAP2K1	S218P	not provided	VCV001677490	15	66774176	15	66481838	1677490	1669180	rs2140668016	NC_000015.10:66481837:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 3, 2021	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.657G>C (p.Met219Ile)	MAP2K1	M219I	not provided	VCV000040752	15	66774181	15	66481843	40752	49222	rs730880506	NC_000015.10:66481842:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 22, 2012	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.665C>A (p.Ser222Tyr)	MAP2K1	S222Y	not provided	VCV001321043	15	66774189	15	66481851	1321043	1311287	rs2140668182	NC_000015.10:66481850:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 12, 2019	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.666C>T (p.Ser222=)	MAP2K1		RASopathy	VCV002893375	15	66774190	15	66481852	2893375	3055881		NC_000015.10:66481851:C:T	single nucleotide variant	synonymous variant	Likely benign	Sep 22, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.669C>T (p.Phe223=)	MAP2K1		RASopathy	VCV002852668	15	66774193	15	66481855	2852668	3010311		NC_000015.10:66481854:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 31, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.672G>A (p.Val224=)	MAP2K1		MAP2K1-related disorder	VCV002635574	15	66774196	15	66481858	2635574	2799579		NC_000015.10:66481857:G:A	single nucleotide variant	synonymous variant	Uncertain significance	Nov 10, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.681G>T (p.Arg227Ser)	MAP2K1	R227S	not provided	VCV001677929	15	66774205	15	66481867	1677929	1669619	rs2140668342	NC_000015.10:66481866:G:T	single nucleotide variant	missense variant	Uncertain significance	Feb 17, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.692C>G (p.Ser231Trp)	MAP2K1	S231W, S183W	RASopathy	VCV002846662	15	66774216	15	66481878	2846662	3005188		NC_000015.10:66481877:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 6, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.692C>T (p.Ser231Leu)	MAP2K1	S231L	not provided	VCV001315628	15	66774216	15	66481878	1315628	1305888	rs1473690179	NC_000015.10:66481877:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 18, 2019	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.693+4T>C	MAP2K1		RASopathy	VCV002139867	15	66774221	15	66481883	2139867	1868700		NC_000015.10:66481882:T:C	single nucleotide variant	intron variant	Uncertain significance	Mar 26, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.693+4T>G	MAP2K1		not specified	VCV000382032	15	66774221	15	66481883	382032	373639	rs184151283	NC_000015.10:66481882:T:G	single nucleotide variant	intron variant	Likely benign	Dec 8, 2015	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.693+10G>C	MAP2K1		RASopathy	VCV002107252	15	66774227	15	66481889	2107252	2170306		NC_000015.10:66481888:G:C	single nucleotide variant	intron variant	Likely benign	Mar 6, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.693+10G>A	MAP2K1		RASopathy|not specified	VCV000180716	15	66774227	15	66481889	180716	178885	rs377034924	NC_000015.10:66481888:G:A	single nucleotide variant	intron variant	Likely benign	Dec 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.693+11A>G	MAP2K1		RASopathy	VCV002853385	15	66774228	15	66481890	2853385	3016855		NC_000015.10:66481889:A:G	single nucleotide variant	intron variant	Likely benign	Apr 7, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.693+14T>G	MAP2K1		RASopathy	VCV002726356	15	66774231	15	66481893	2726356	2888990		NC_000015.10:66481892:T:G	single nucleotide variant	intron variant	Likely benign	Jan 1, 2024	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.693+20T>C	MAP2K1		RASopathy|Cardiofaciocutaneous syndrome 3|Melorheostosis|Noonan syndrome 1	VCV001634362	15	66774237	15	66481899	1634362	1632449	rs753107656	NC_000015.10:66481898:T:C	single nucleotide variant	intron variant	Likely benign	Jan 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.693+50G>C	MAP2K1		not provided	VCV001227674	15	66774267	15	66481929	1227674	49223	rs58205072	NC_000015.10:66481928:G:C	single nucleotide variant	intron variant	Benign	Mar 3, 2015	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.693+234C>A	MAP2K1		not provided	VCV001217068	15	66774451	15	66482113	1217068	1207048	rs142760272	NC_000015.10:66482112:C:A	single nucleotide variant	intron variant	Likely benign	Jul 7, 2018	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.693+275T>A	MAP2K1		not provided	VCV000561896	15	66774492	15	66482154	561896	552864	rs75586043	NC_000015.10:66482153:T:A	single nucleotide variant	intron variant	Benign	Jun 19, 2018	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.694-148G>C	MAP2K1		not provided	VCV000561549	15	66777180	15	66484842	561549	552865	rs73471746	NC_000015.10:66484841:G:C	single nucleotide variant	intron variant	Likely benign	Jun 16, 2018	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.694-20del	MAP2K1		RASopathy	VCV001533856	15	66777308	15	66484970	1533856	1584346	rs1404899700	NC_000015.10:66484969:A:	Deletion	intron variant	Likely benign	Oct 29, 2024	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.694-13_694-10del	MAP2K1		RASopathy	VCV002957078	15	66777309 - 66777312	15	66484971 - 66484974	2957078	3125682		NC_000015.10:66484970:CTGTCTGTCT:CTGTCT	Microsatellite	intron variant	Likely benign	Dec 2, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.694-19C>T	MAP2K1		RASopathy	VCV002050589	15	66777309	15	66484971	2050589	2114934		NC_000015.10:66484970:C:T	single nucleotide variant	intron variant	Likely benign	May 21, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.694-16T>C	MAP2K1		RASopathy	VCV002834958	15	66777312	15	66484974	2834958	3002010		NC_000015.10:66484973:T:C	single nucleotide variant	intron variant	Likely benign	Feb 6, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.694-16T>A	MAP2K1		RASopathy	VCV002802273	15	66777312	15	66484974	2802273	2962958		NC_000015.10:66484973:T:A	single nucleotide variant	intron variant	Likely benign	Jul 8, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.694-12TC[4]	MAP2K1		RASopathy	VCV000094082	15	66777315 - 66777316	15	66484977 - 66484978	94082	99984	rs113913469	NC_000015.10:66484977:TCTCTC:TCTCTCTC	Microsatellite	intron variant	Benign	Sep 17, 2024	reviewed by expert panel							
NM_002755.4(MAP2K1):c.694-11C>T	MAP2K1		RASopathy	VCV002095273	15	66777317	15	66484979	2095273	2153179		NC_000015.10:66484978:C:T	single nucleotide variant	intron variant	Likely benign	Feb 8, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.694-9C>T	MAP2K1		RASopathy	VCV001674639	15	66777319	15	66484981	1674639	1532645	rs768336682	NC_000015.10:66484980:C:T	single nucleotide variant	intron variant	Likely benign	Jun 16, 2021	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.694-7C>T	MAP2K1		RASopathy	VCV002890395	15	66777321	15	66484983	2890395	3047950		NC_000015.10:66484982:C:T	single nucleotide variant	intron variant	Likely benign	Dec 16, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.694-5T>G	MAP2K1		RASopathy|not provided	VCV001315919	15	66777323	15	66484985	1315919	1306177	rs1054274808	NC_000015.10:66484984:T:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications							
NM_002755.4(MAP2K1):c.709G>A (p.Gly237Arg)	MAP2K1	G189R, G237R	not provided|RASopathy	VCV002155318	15	66777343	15	66485005	2155318	1882886		NC_000015.10:66485004:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 18, 2023	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.711G>A (p.Gly237=)	MAP2K1		RASopathy	VCV000040754	15	66777345	15	66485007	40754	49224	rs17586159	NC_000015.10:66485006:G:A	single nucleotide variant	synonymous variant	Benign	May 9, 2017	reviewed by expert panel							
NM_002755.4(MAP2K1):c.714T>C (p.Thr238=)	MAP2K1		RASopathy	VCV003625665	15	66777348	15	66485010	3625665	3752152		NC_000015.10:66485009:T:C	single nucleotide variant	synonymous variant	Likely benign	May 16, 2024	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.724G>A (p.Val242Met)	MAP2K1	V194M, V242M	RASopathy	VCV002198290	15	66777358	15	66485020	2198290	1933517		NC_000015.10:66485019:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 22, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.726G>A (p.Val242=)	MAP2K1		RASopathy	VCV002821169	15	66777360	15	66485022	2821169	2988245		NC_000015.10:66485021:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 31, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.726G>T (p.Val242=)	MAP2K1		not specified|RASopathy|not provided|Cardiovascular phenotype	VCV000044591	15	66777360	15	66485022	44591	53758	rs373745627	NC_000015.10:66485021:G:T	single nucleotide variant	synonymous variant	Likely benign	Dec 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.729G>A (p.Gln243=)	MAP2K1		Cardiovascular phenotype|not provided|RASopathy	VCV001112737	15	66777363	15	66485025	1112737	1103050	rs772752167	NC_000015.10:66485024:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.729G>T (p.Gln243His)	MAP2K1	Q243H	RASopathy|not specified|not provided	VCV000228847	15	66777363	15	66485025	228847	230600	rs772752167	NC_000015.10:66485024:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 14, 2022	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.730T>A (p.Ser244Thr)	MAP2K1	S196T, S244T	not provided	VCV001878870	15	66777364	15	66485026	1878870	1935623		NC_000015.10:66485025:T:A	single nucleotide variant	missense variant	Likely pathogenic	Jul 18, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.730T>G (p.Ser244Ala)	MAP2K1	S244A	not provided	VCV000040755	15	66777364	15	66485026	40755	49225	rs730880507	NC_000015.10:66485025:T:G	single nucleotide variant	missense variant	Likely pathogenic	Oct 20, 2017	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.731C>G (p.Ser244Ter)	MAP2K1	S244*	MAP2K1-related disorder	VCV000632243	15	66777365	15	66485027	632243	620526	rs1007782463	NC_000015.10:66485026:C:G	single nucleotide variant	nonsense	Uncertain significance	Apr 27, 2017	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.733G>A (p.Asp245Asn)	MAP2K1	D197N, D245N	not provided	VCV003253409	15	66777367	15	66485029	3253409	3412203		NC_000015.10:66485028:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 11, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.739T>C (p.Trp247Arg)	MAP2K1	W247R	not provided	VCV001320926	15	66777373	15	66485035	1320926	1311170	rs2140674116	NC_000015.10:66485034:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 23, 2020	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.753G>A (p.Leu251=)	MAP2K1		Cardiovascular phenotype	VCV001759435	15	66777387	15	66485049	1759435	1816342		NC_000015.10:66485048:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 26, 2020	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.754T>G (p.Ser252Ala)	MAP2K1	S204A, S252A	not provided|RASopathy	VCV002575691	15	66777388	15	66485050	2575691	2740587		NC_000015.10:66485049:T:G	single nucleotide variant	missense variant	Uncertain significance	Aug 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.763G>A (p.Glu255Lys)	MAP2K1	E255K	not provided	VCV001318907	15	66777397	15	66485059	1318907	1307419	rs760016123	NC_000015.10:66485058:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 4, 2021	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.767T>C (p.Met256Thr)	MAP2K1	M208T, M256T	Cardiofaciocutaneous syndrome 3	VCV002572546	15	66777401	15	66485063	2572546	2737492		NC_000015.10:66485062:T:C	single nucleotide variant	missense variant	Likely pathogenic		criteria provided, single submitter							
NM_002755.4(MAP2K1):c.770C>T (p.Ala257Val)	MAP2K1	A257V	RASopathy	VCV001444858	15	66777404	15	66485066	1444858	1384948	rs1334665647	NC_000015.10:66485065:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 11, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.771G>A (p.Ala257=)	MAP2K1		RASopathy|Cardiovascular phenotype|not provided	VCV000702661	15	66777405	15	66485067	702661	693723	rs767965126	NC_000015.10:66485066:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.772G>T (p.Val258Phe)	MAP2K1	V258F, V210F	RASopathy	VCV001952604	15	66777406	15	66485068	1952604	2017914		NC_000015.10:66485067:G:T	single nucleotide variant	missense variant	Uncertain significance	Aug 23, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.772G>A (p.Val258Ile)	MAP2K1	V258I	RASopathy	VCV001057213	15	66777406	15	66485068	1057213	1049047	rs753236280	NC_000015.10:66485067:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 3, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.774T>C (p.Val258=)	MAP2K1		RASopathy	VCV002693869	15	66777408	15	66485070	2693869	2854002		NC_000015.10:66485069:T:C	single nucleotide variant	synonymous variant	Likely benign	Dec 23, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.792T>G (p.Pro264=)	MAP2K1		RASopathy|Cardiovascular phenotype|not provided	VCV001205498	15	66777426	15	66485088	1205498	1194980	rs764379969	NC_000015.10:66485087:T:G	single nucleotide variant	synonymous variant	Likely benign	Dec 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.794_860dup (p.Pro287_Pro288insSerArgCysGlnGlyAlaGlyAlaAspValTrpValProGlyGlyArgArgCysGlyTer)	MAP2K1		not specified	VCV000917818	15	66777426 - 66777427	15	66485088 - 66485089	917818	906100	rs1893005622		Duplication	nonsense|inframe_insertion	Uncertain significance	Apr 13, 2020	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.793C>T (p.Pro265Ser)	MAP2K1	P265S	not provided|RASopathy	VCV000561346	15	66777427	15	66485089	561346	552866	rs1567025858	NC_000015.10:66485088:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.800A>T (p.Asp267Val)	MAP2K1	D219V, D267V	RASopathy	VCV002055758	15	66777434	15	66485096	2055758	2116210		NC_000015.10:66485095:A:T	single nucleotide variant	missense variant	Uncertain significance	Dec 23, 2021	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.801T>A (p.Asp267Glu)	MAP2K1	D219E, D267E	Melorheostosis|Cardiofaciocutaneous syndrome 3|Cardiovascular phenotype	VCV001761697	15	66777435	15	66485097	1761697	1823639		NC_000015.10:66485096:T:A	single nucleotide variant	missense variant	Uncertain significance	Jan 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.802G>A (p.Ala268Thr)	MAP2K1	A268T	not specified	VCV000496172	15	66777436	15	66485098	496172	487650	rs1555420656	NC_000015.10:66485097:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 16, 2020	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.803C>T (p.Ala268Val)	MAP2K1	A268V	not specified	VCV000228848	15	66777437	15	66485099	228848	230601	rs757459909	NC_000015.10:66485098:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 11, 2015	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.804C>G (p.Ala268=)	MAP2K1		RASopathy	VCV000044592	15	66777438	15	66485100	44592	53759	rs371652992	NC_000015.10:66485099:C:G	single nucleotide variant	synonymous variant	Benign	May 9, 2017	reviewed by expert panel							
NM_002755.4(MAP2K1):c.810G>A (p.Glu270=)	MAP2K1		RASopathy	VCV000544001	15	66777444	15	66485106	544001	529579	rs745891583	NC_000015.10:66485105:G:A	single nucleotide variant	synonymous variant	Likely benign	Apr 8, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.811C>G (p.Leu271Val)	MAP2K1	L223V, L271V	RASopathy	VCV002892726	15	66777445	15	66485107	2892726	3045527		NC_000015.10:66485106:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 24, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.812T>G (p.Leu271Arg)	MAP2K1	L271R	not provided	VCV000496175	15	66777446	15	66485108	496175	487652	rs1555420658	NC_000015.10:66485107:T:G	single nucleotide variant	missense variant	Uncertain significance	Nov 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.828G>A (p.Gly276=)	MAP2K1		RASopathy	VCV002909239	15	66777462	15	66485124	2909239	3063092		NC_000015.10:66485123:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 7, 2024	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.834G>A (p.Gln278=)	MAP2K1		not provided|RASopathy|Cardiovascular phenotype	VCV000378874	15	66777468	15	66485130	378874	376572	rs148151221	NC_000015.10:66485129:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.836T>C (p.Val279Ala)	MAP2K1	V231A, V279A	RASopathy	VCV002136449	15	66777470	15	66485132	2136449	1867917		NC_000015.10:66485131:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 7, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.842_844del (p.Gly281del)	MAP2K1	G281del, G233del	RASopathy|Cardiovascular phenotype	VCV002191063	15	66777474 - 66777476	15	66485136 - 66485138	2191063	1912107		NC_000015.10:66485135:AGGAG:AG	Deletion	inframe_indel|inframe_deletion	Uncertain significance	Aug 26, 2022	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.840A>G (p.Glu280=)	MAP2K1		RASopathy|Cardiovascular phenotype	VCV001763272	15	66777474	15	66485136	1763272	1823996		NC_000015.10:66485135:A:G	single nucleotide variant	synonymous variant	Likely benign	Oct 13, 2022	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.848C>T (p.Ala283Val)	MAP2K1	A283V	RASopathy	VCV000040756	15	66777482	15	66485144	40756	49226	rs144080051	NC_000015.10:66485143:C:T	single nucleotide variant	missense variant	Benign	May 9, 2017	reviewed by expert panel							
NM_002755.4(MAP2K1):c.849G>A (p.Ala283=)	MAP2K1		RASopathy|Cardiovascular phenotype	VCV001763609	15	66777483	15	66485145	1763609	1824333		NC_000015.10:66485144:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.851C>A (p.Ala284Asp)	MAP2K1	A236D, A284D	RASopathy	VCV002979649	15	66777485	15	66485147	2979649	3134413		NC_000015.10:66485146:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 17, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.853G>A (p.Glu285Lys)	MAP2K1	E285K	RASopathy	VCV000835232	15	66777487	15	66485149	835232	842604	rs1893007795	NC_000015.10:66485148:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 2, 2024	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.861A>G (p.Pro287=)	MAP2K1		Cardiovascular phenotype	VCV003542701	15	66777495	15	66485157	3542701	3699983		NC_000015.10:66485156:A:G	single nucleotide variant	synonymous variant	Likely benign	Nov 13, 2024	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.864C>G (p.Pro288=)	MAP2K1		RASopathy	VCV002789224	15	66777498	15	66485160	2789224	2956832		NC_000015.10:66485159:C:G	single nucleotide variant	synonymous variant	Likely benign	Feb 21, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.868C>A (p.Pro290Thr)	MAP2K1	P242T, P290T	RASopathy	VCV002084673	15	66777502	15	66485164	2084673	2143888		NC_000015.10:66485163:C:A	single nucleotide variant	missense variant	Uncertain significance	Jan 16, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.871A>G (p.Arg291Gly)	MAP2K1	R291G	not specified|Cardiovascular phenotype|RASopathy	VCV000372605	15	66777505	15	66485167	372605	360219	rs747807884	NC_000015.10:66485166:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 15, 2023	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.872G>A (p.Arg291Lys)	MAP2K1	R291K	Noonan syndrome	VCV000666421	15	66777506	15	66485168	666421	653980	rs1595886354	NC_000015.10:66485167:G:A	single nucleotide variant	missense variant	Likely benign		no assertion criteria provided							
NM_002755.4(MAP2K1):c.873G>A (p.Arg291=)	MAP2K1		RASopathy	VCV002904875	15	66777507	15	66485169	2904875	3069069		NC_000015.10:66485168:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 19, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.875C>T (p.Thr292Ile)	MAP2K1	T292I	not specified|RASopathy	VCV000503539	15	66777509	15	66485171	503539	494975	rs397516794	NC_000015.10:66485170:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 3, 2023	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.875C>G (p.Thr292Ser)	MAP2K1	T292S	Melorheostosis|Cardiofaciocutaneous syndrome 3|RASopathy|not specified	VCV000044593	15	66777509	15	66485171	44593	53760	rs397516794	NC_000015.10:66485170:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.877C>G (p.Pro293Ala)	MAP2K1	P245A, P293A	Cardiovascular phenotype	VCV001764633	15	66777511	15	66485173	1764633	1814454		NC_000015.10:66485172:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 29, 2021	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.877C>T (p.Pro293Ser)	MAP2K1	P293S	not provided	VCV001205507	15	66777511	15	66485173	1205507	1194981	rs918690546	NC_000015.10:66485172:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 1, 2019	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.879C>G (p.Pro293=)	MAP2K1		RASopathy	VCV001096000	15	66777513	15	66485175	1096000	1081236	rs370521459	NC_000015.10:66485174:C:G	single nucleotide variant	synonymous variant	Likely benign	Jul 12, 2020	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.879C>T (p.Pro293=)	MAP2K1		RASopathy|not specified	VCV000044594	15	66777513	15	66485175	44594	53761	rs370521459	NC_000015.10:66485174:C:T	single nucleotide variant	synonymous variant	Likely benign	Apr 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.883A>G (p.Arg295Gly)	MAP2K1	R247G, R295G	Cardiovascular phenotype	VCV003222783	15	66777517	15	66485179	3222783	3386421		NC_000015.10:66485178:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 5, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.885G>T (p.Arg295Ser)	MAP2K1	R247S, R295S	RASopathy	VCV001903178	15	66777519	15	66485181	1903178	1961255		NC_000015.10:66485180:G:T	single nucleotide variant	missense variant	Uncertain significance	Aug 4, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.893G>C (p.Ser298Thr)	MAP2K1	S250T, S298T	Melorheostosis|Cardiofaciocutaneous syndrome 3	VCV003577607	15	66777527	15	66485189	3577607	3704207		NC_000015.10:66485188:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 24, 2024	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.894C>T (p.Ser298=)	MAP2K1		RASopathy	VCV001478764	15	66777528	15	66485190	1478764	1429999	rs2140675493	NC_000015.10:66485189:C:T	single nucleotide variant	synonymous variant	Uncertain significance	Feb 27, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.895+12G>A	MAP2K1		RASopathy	VCV001410057	15	66777541	15	66485203	1410057	1435312	rs2140675512	NC_000015.10:66485202:G:A	single nucleotide variant	intron variant	Likely benign	Sep 13, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.895+13G>A	MAP2K1		RASopathy	VCV002044474	15	66777542	15	66485204	2044474	2095899		NC_000015.10:66485203:G:A	single nucleotide variant	intron variant	Likely benign	Jun 7, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.895+15G>A	MAP2K1		RASopathy	VCV001918555	15	66777544	15	66485206	1918555	1974882		NC_000015.10:66485205:G:A	single nucleotide variant	intron variant	Uncertain significance	Oct 1, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.895+19C>T	MAP2K1		RASopathy	VCV002864584	15	66777548	15	66485210	2864584	3023347		NC_000015.10:66485209:C:T	single nucleotide variant	intron variant	Likely benign	May 22, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.895+19C>A	MAP2K1		RASopathy	VCV001991293	15	66777548	15	66485210	1991293	2041334		NC_000015.10:66485209:C:A	single nucleotide variant	intron variant	Uncertain significance	Dec 4, 2024	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.895+42G>A	MAP2K1		not provided	VCV001218488	15	66777571	15	66485233	1218488	1208469	rs200724966	NC_000015.10:66485232:G:A	single nucleotide variant	intron variant	Likely benign	Feb 24, 2020	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.895+181A>G	MAP2K1		not provided	VCV000561365	15	66777710	15	66485372	561365	552867	rs77824107	NC_000015.10:66485371:A:G	single nucleotide variant	intron variant	Benign	Jun 19, 2018	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.896-291G>C	MAP2K1		not provided	VCV000561876	15	66779275	15	66486937	561876	552868	rs36047146	NC_000015.10:66486936:G:C	single nucleotide variant	intron variant	Benign	Jun 14, 2018	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.896-284dup	MAP2K1		not provided	VCV001189987	15	66779279 - 66779280	15	66486941 - 66486942	1189987	1181292	rs144137205	NC_000015.10:66486941:AAA:AAAA	Duplication	intron variant	Likely benign	Jun 12, 2019	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.896-283G>A	MAP2K1		not provided	VCV001199009	15	66779283	15	66486945	1199009	1188270	rs189306997	NC_000015.10:66486944:G:A	single nucleotide variant	intron variant	Likely benign	Jul 3, 2018	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.896-5del	MAP2K1		RASopathy	VCV001563692	15	66779559	15	66487221	1563692	1620196	rs748946786	NC_000015.10:66487220:TTT:TT	Deletion	intron variant	Likely benign	Jun 3, 2021	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.896-7T>C	MAP2K1		RASopathy|not specified	VCV000372733	15	66779559	15	66487221	372733	360294	rs772786705	NC_000015.10:66487220:T:C	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 5, 2024	criteria provided, conflicting classifications							
NM_002755.4(MAP2K1):c.896-6T>A	MAP2K1		RASopathy	VCV003626454	15	66779560	15	66487222	3626454	3758285		NC_000015.10:66487221:T:A	single nucleotide variant	intron variant	Likely benign	Nov 13, 2024	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.896-6T>C	MAP2K1		RASopathy	VCV002093529	15	66779560	15	66487222	2093529	2152733		NC_000015.10:66487221:T:C	single nucleotide variant	intron variant	Likely benign	Feb 5, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.896-5T>C	MAP2K1		RASopathy	VCV000448948	15	66779561	15	66487223	448948	442537	rs748953467	NC_000015.10:66487222:T:C	single nucleotide variant	intron variant	Likely benign	May 9, 2017	reviewed by expert panel							
NM_002755.4(MAP2K1):c.896-3T>C	MAP2K1		RASopathy	VCV001364097	15	66779563	15	66487225	1364097	1386036	rs2140678872	NC_000015.10:66487224:T:C	single nucleotide variant	intron variant	Uncertain significance	Nov 1, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.899A>G (p.Tyr300Cys)	MAP2K1	Y300C, Y252C	RASopathy	VCV002843145	15	66779569	15	66487231	2843145	2994017		NC_000015.10:66487230:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 28, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.902dup (p.Met302fs)	MAP2K1	M254fs, M302fs	not provided	VCV003367787	15	66779570 - 66779571	15	66487232 - 66487233	3367787	3526986		NC_000015.10:66487232:GG:GGG	Duplication	frameshift variant	Uncertain significance	Jan 14, 2024	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.900C>T (p.Tyr300=)	MAP2K1		RASopathy|not provided|Cardiovascular phenotype	VCV001260568	15	66779570	15	66487232	1260568	49227	rs147333830	NC_000015.10:66487231:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Nov 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.901G>A (p.Gly301Arg)	MAP2K1	G301R	RASopathy|not specified	VCV001217250	15	66779571	15	66487233	1217250	1207230	rs773890369	NC_000015.10:66487232:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.902G>A (p.Gly301Glu)	MAP2K1	G253E, G301E	RASopathy	VCV003626779	15	66779572	15	66487234	3626779	3755420		NC_000015.10:66487233:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 31, 2025	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.904A>C (p.Met302Leu)	MAP2K1	M302L	MAP2K1-related disorder|Cardiovascular phenotype|RASopathy	VCV001003468	15	66779574	15	66487236	1003468	996351	rs1023593707	NC_000015.10:66487235:A:C	single nucleotide variant	missense variant	Uncertain significance	Dec 29, 2023	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.906G>T (p.Met302Ile)	MAP2K1	M254I, M302I	RASopathy	VCV002149044	15	66779576	15	66487238	2149044	1877492		NC_000015.10:66487237:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 3, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.909C>T (p.Asp303=)	MAP2K1		Cardiovascular phenotype	VCV001765763	15	66779579	15	66487241	1765763	1817713		NC_000015.10:66487240:C:T	single nucleotide variant	synonymous variant	Likely benign	Feb 8, 2021	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.914G>A (p.Arg305Gln)	MAP2K1	R305Q	Cardiofaciocutaneous syndrome 3|Melorheostosis|RASopathy|not provided	VCV000691444	15	66779584	15	66487246	691444	679127	rs1595887104	NC_000015.10:66487245:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.917C>T (p.Pro306Leu)	MAP2K1	P306L	RASopathy	VCV000543980	15	66779587	15	66487249	543980	529581	rs1555420826	NC_000015.10:66487248:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2017	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.920C>T (p.Pro307Leu)	MAP2K1	P307L	not provided	VCV001700523	15	66779590	15	66487252	1700523	1692916	rs2140678942	NC_000015.10:66487251:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 4, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.922A>T (p.Met308Leu)	MAP2K1	M308L	not provided	VCV001320837	15	66779592	15	66487254	1320837	1311081	rs2140678957	NC_000015.10:66487253:A:T	single nucleotide variant	missense variant	Uncertain significance	Jul 22, 2019	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.927A>T (p.Ala309=)	MAP2K1		RASopathy	VCV000040758	15	66779597	15	66487259	40758	49228	rs146869577	NC_000015.10:66487258:A:T	single nucleotide variant	synonymous variant	Benign	May 9, 2017	reviewed by expert panel							
NM_002755.4(MAP2K1):c.928A>G (p.Ile310Val)	MAP2K1	I262V, I310V	RASopathy|not provided	VCV002645471	15	66779598	15	66487260	2645471	2814253		NC_000015.10:66487259:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.930T>G (p.Ile310Met)	MAP2K1	I262M, I310M	Cardiovascular phenotype	VCV002269750	15	66779600	15	66487262	2269750	2257422		NC_000015.10:66487261:T:G	single nucleotide variant	missense variant	Uncertain significance	Feb 8, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.937T>C (p.Leu313=)	MAP2K1		Cardiovascular phenotype	VCV002565494	15	66779607	15	66487269	2565494	2730450		NC_000015.10:66487268:T:C	single nucleotide variant	synonymous variant	Likely benign	May 27, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.939G>A (p.Leu313=)	MAP2K1		RASopathy	VCV002813730	15	66779609	15	66487271	2813730	2969680		NC_000015.10:66487270:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 12, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.939G>C (p.Leu313Phe)	MAP2K1	L313F	not specified|RASopathy	VCV000503540	15	66779609	15	66487271	503540	494976	rs1361965478	NC_000015.10:66487270:G:C	single nucleotide variant	missense variant	Uncertain significance	Jul 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.940T>C (p.Leu314=)	MAP2K1		RASopathy	VCV001926991	15	66779610	15	66487272	1926991	1991055		NC_000015.10:66487271:T:C	single nucleotide variant	synonymous variant	Likely benign	Oct 18, 2024	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.949A>G (p.Ile317Val)	MAP2K1	I317V, I269V	Cardiovascular phenotype	VCV002269752	15	66779619	15	66487281	2269752	2257424		NC_000015.10:66487280:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 4, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.950T>C (p.Ile317Thr)	MAP2K1	I317T, I269T	Cardiovascular phenotype	VCV001767225	15	66779620	15	66487282	1767225	1821566		NC_000015.10:66487281:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 10, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.957C>T (p.Asn319=)	MAP2K1		Cardiovascular phenotype|not provided|RASopathy|not specified	VCV000050934	15	66779627	15	66487289	50934	65595	rs143019052	NC_000015.10:66487288:C:T	single nucleotide variant	synonymous variant	Likely benign	Nov 12, 2023	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.960+1G>T	MAP2K1		RASopathy	VCV002882054	15	66779631	15	66487293	2882054	3034243		NC_000015.10:66487292:G:T	single nucleotide variant	splice donor variant	Uncertain significance	Feb 22, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.960+5G>A	MAP2K1		RASopathy	VCV002024833	15	66779635	15	66487297	2024833	2087874		NC_000015.10:66487296:G:A	single nucleotide variant	intron variant	Uncertain significance	Aug 10, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.960+7dup	MAP2K1		RASopathy	VCV001113348	15	66779636 - 66779637	15	66487298 - 66487299	1113348	1103051	rs1438742251	NC_000015.10:66487298:A:AA	Duplication	intron variant	Likely benign	Jul 13, 2020	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.960+12C>T	MAP2K1		RASopathy	VCV002416272	15	66779642	15	66487304	2416272	1947491		NC_000015.10:66487303:C:T	single nucleotide variant	intron variant	Likely benign	Jul 14, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.960+14G>A	MAP2K1		RASopathy	VCV001590423	15	66779644	15	66487306	1590423	1642316	rs200963333	NC_000015.10:66487305:G:A	single nucleotide variant	intron variant	Likely benign	Apr 18, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.960+68C>T	MAP2K1		not provided	VCV001242412	15	66779698	15	66487360	1242412	49229	rs41315964	NC_000015.10:66487359:C:T	single nucleotide variant	intron variant	Benign	Mar 3, 2015	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.960+297A>G	MAP2K1		not provided	VCV001220360	15	66779927	15	66487589	1220360	1210336	rs565603514	NC_000015.10:66487588:A:G	single nucleotide variant	intron variant	Likely benign	Aug 15, 2019	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.961-254_961-251del	MAP2K1		not provided	VCV000561877	15	66781299 - 66781302	15	66488961 - 66488964	561877	552869	rs34067330	NC_000015.10:66488960:AAGT:	Deletion	intron variant	Benign	Jun 14, 2018	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.961-61_997dup	MAP2K1		not specified	VCV000917828	15	66781488 - 66781489	15	66489150 - 66489151	917828	906144	rs1893152621		Duplication	splice acceptor variant	Uncertain significance	Apr 28, 2020	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.961-19T>C	MAP2K1		RASopathy	VCV002967970	15	66781534	15	66489196	2967970	3128359		NC_000015.10:66489195:T:C	single nucleotide variant	intron variant	Likely benign	Mar 16, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.961-18C>T	MAP2K1		RASopathy	VCV001575432	15	66781535	15	66489197	1575432	1638716	rs2140682866	NC_000015.10:66489196:C:T	single nucleotide variant	intron variant	Likely benign	Sep 19, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.961-8_961-7del	MAP2K1		RASopathy	VCV002036522	15	66781542 - 66781543	15	66489204 - 66489205	2036522	2090578		NC_000015.10:66489203:TGTGT:TGT	Microsatellite	intron variant	Likely benign	Jan 22, 2024	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.961-10G>C	MAP2K1		RASopathy|Melorheostosis|Cardiofaciocutaneous syndrome 3	VCV001138943	15	66781543	15	66489205	1138943	1124481	rs2140682882	NC_000015.10:66489204:G:C	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Mar 10, 2024	criteria provided, conflicting classifications							
NM_002755.4(MAP2K1):c.961-8G>T	MAP2K1		RASopathy	VCV001996256	15	66781545	15	66489207	1996256	2056766		NC_000015.10:66489206:G:T	single nucleotide variant	intron variant	Likely benign	May 19, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.961-6T>C	MAP2K1		RASopathy	VCV002785993	15	66781547	15	66489209	2785993	2941955		NC_000015.10:66489208:T:C	single nucleotide variant	intron variant	Likely benign	Oct 17, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.961-2A>G	MAP2K1		RASopathy	VCV001487567	15	66781551	15	66489213	1487567	1481602	rs2140682916	NC_000015.10:66489212:A:G	single nucleotide variant	splice acceptor variant	Uncertain significance	Aug 9, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.961C>T (p.Pro321Ser)	MAP2K1	P321S	not provided|Cardiofaciocutaneous syndrome 3|Noonan syndrome 1|RASopathy|Cardiovascular phenotype	VCV000582017	15	66781553	15	66489215	582017	569565	rs771613524	NC_000015.10:66489214:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 5, 2024	criteria provided, conflicting classifications							
NM_002755.4(MAP2K1):c.967C>T (p.Pro323Ser)	MAP2K1	P275S, P323S	Cardiovascular phenotype	VCV001767767	15	66781559	15	66489221	1767767	1818418		NC_000015.10:66489220:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 4, 2021	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.969A>G (p.Pro323=)	MAP2K1		Cardiovascular phenotype	VCV001767829	15	66781561	15	66489223	1767829	1818480		NC_000015.10:66489222:A:G	single nucleotide variant	synonymous variant	Likely benign	Sep 21, 2019	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.969A>C (p.Pro323=)	MAP2K1		Cardiovascular phenotype	VCV001767822	15	66781561	15	66489223	1767822	1818473		NC_000015.10:66489222:A:C	single nucleotide variant	synonymous variant	Likely benign	Jul 6, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.970A>C (p.Lys324Gln)	MAP2K1	K324Q	RASopathy|not specified	VCV000996232	15	66781562	15	66489224	996232	983992	rs762436311	NC_000015.10:66489223:A:C	single nucleotide variant	missense variant	Uncertain significance	Apr 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.978C>A (p.Pro326=)	MAP2K1		Cardiovascular phenotype	VCV002450873	15	66781570	15	66489232	2450873	2433132		NC_000015.10:66489231:C:A	single nucleotide variant	synonymous variant	Likely benign	Feb 12, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.983_987del (p.Gly328fs)	MAP2K1	G328fs, G280fs	RASopathy	VCV002908803	15	66781571 - 66781575	15	66489233 - 66489237	2908803	3066311		NC_000015.10:66489232:AGTGGAGTG:AGTG	Deletion	frameshift variant	Uncertain significance	Jul 28, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.980G>A (p.Ser327Asn)	MAP2K1	S279N, S327N	RASopathy	VCV003628658	15	66781572	15	66489234	3628658	3755989		NC_000015.10:66489233:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 25, 2024	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.984A>T (p.Gly328=)	MAP2K1		Cardiovascular phenotype	VCV002450872	15	66781576	15	66489238	2450872	2433131		NC_000015.10:66489237:A:T	single nucleotide variant	synonymous variant	Likely benign	Dec 23, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.984A>C (p.Gly328=)	MAP2K1		Cardiovascular phenotype|not provided	VCV000393145	15	66781576	15	66489238	393145	376575	rs773755873	NC_000015.10:66489237:A:C	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Oct 17, 2022	criteria provided, conflicting classifications							
NM_002755.4(MAP2K1):c.987G>T (p.Val329=)	MAP2K1		RASopathy|Cardiovascular phenotype	VCV001768480	15	66781579	15	66489241	1768480	1828889		NC_000015.10:66489240:G:T	single nucleotide variant	synonymous variant	Likely benign	Sep 30, 2023	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.991A>G (p.Ser331Gly)	MAP2K1	S283G, S331G	not provided	VCV002502775	15	66781583	15	66489245	2502775	2667881		NC_000015.10:66489244:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 19, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.995T>A (p.Leu332Gln)	MAP2K1	L332Q	RASopathy	VCV001513858	15	66781587	15	66489249	1513858	1469045	rs1316044036	NC_000015.10:66489248:T:A	single nucleotide variant	missense variant	Uncertain significance	Jan 1, 2021	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.995T>G (p.Leu332Arg)	MAP2K1	L332R	not provided	VCV000451946	15	66781587	15	66489249	451946	445405	rs1316044036	NC_000015.10:66489248:T:G	single nucleotide variant	missense variant	Uncertain significance	Sep 8, 2017	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.1000T>G (p.Phe334Val)	MAP2K1	F286V, F334V	Cardiovascular phenotype	VCV003542697	15	66781592	15	66489254	3542697	3699979		NC_000015.10:66489253:T:G	single nucleotide variant	missense variant	Uncertain significance	Aug 19, 2024	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.1003C>T (p.Gln335Ter)	MAP2K1	Q287*, Q335*	not provided	VCV002504246	15	66781595	15	66489257	2504246	2669202		NC_000015.10:66489256:C:T	single nucleotide variant	nonsense	Uncertain significance	Nov 29, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.1004A>G (p.Gln335Arg)	MAP2K1	Q335R	RASopathy	VCV001462176	15	66781596	15	66489258	1462176	1507503	rs2140683019	NC_000015.10:66489257:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 21, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.1005A>G (p.Gln335=)	MAP2K1		not provided|RASopathy|not specified|Noonan syndrome and Noonan-related syndrome|Cardiovascular phenotype	VCV000380356	15	66781597	15	66489259	380356	373641	rs1057520833	NC_000015.10:66489258:A:G	single nucleotide variant	synonymous variant	Likely benign	Oct 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.1008T>G (p.Asp336Glu)	MAP2K1	D288E, D336E	RASopathy	VCV002079598	15	66781600	15	66489262	2079598	2142685		NC_000015.10:66489261:T:G	single nucleotide variant	missense variant	Uncertain significance	May 1, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.1022+6T>G	MAP2K1		Cardiofaciocutaneous syndrome 3|Melorheostosis|RASopathy	VCV001987933	15	66781620	15	66489282	1987933	2036781		NC_000015.10:66489281:T:G	single nucleotide variant	intron variant	Uncertain significance	Dec 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.1022+10C>T	MAP2K1		not specified|RASopathy	VCV000044585	15	66781624	15	66489286	44585	53751	rs397516787	NC_000015.10:66489285:C:T	single nucleotide variant	intron variant	Likely benign	Dec 31, 2021	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.1022+12C>T	MAP2K1		RASopathy	VCV001575895	15	66781626	15	66489288	1575895	1551923	rs753580791	NC_000015.10:66489287:C:T	single nucleotide variant	intron variant	Likely benign	Dec 11, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.1022+16G>A	MAP2K1		RASopathy	VCV001585359	15	66781630	15	66489292	1585359	1627294	rs757073344	NC_000015.10:66489291:G:A	single nucleotide variant	intron variant	Likely benign	Aug 27, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.1023-201del	MAP2K1		not provided	VCV001207487	15	66781855	15	66489517	1207487	1198670	rs149355772	NC_000015.10:66489516:C:	Deletion	intron variant	Likely benign	Jul 8, 2018	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.1023-43C>T	MAP2K1		not provided	VCV001247036	15	66782013	15	66489675	1247036	1235699	rs146169356	NC_000015.10:66489674:C:T	single nucleotide variant	intron variant	Benign	Dec 10, 2019	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.1023-20C>T	MAP2K1		RASopathy|not specified	VCV000258797	15	66782036	15	66489698	258797	255334	rs200542677	NC_000015.10:66489697:C:T	single nucleotide variant	intron variant	Likely benign	Jun 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.1023-17G>C	MAP2K1		not provided|RASopathy	VCV000381507	15	66782039	15	66489701	381507	374687	rs759861076	NC_000015.10:66489700:G:C	single nucleotide variant	intron variant	Likely benign	Jan 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.1023-11_1023-4del	MAP2K1		RASopathy	VCV002068937	15	66782041 - 66782048	15	66489703 - 66489710	2068937	2122908		NC_000015.10:66489702:CTTTCTTCCTTT:CTTT	Deletion	intron variant	Uncertain significance	Jan 1, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.1023-8C>T	MAP2K1		RASopathy	VCV000040760	15	66782048	15	66489710	40760	49230	rs41306345	NC_000015.10:66489709:C:T	single nucleotide variant	intron variant	Benign	May 9, 2017	reviewed by expert panel							
NM_002755.4(MAP2K1):c.1023-4T>A	MAP2K1		Cardiofaciocutaneous syndrome 3|RASopathy	VCV002672171	15	66782052	15	66489714	2672171	2839699		NC_000015.10:66489713:T:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Oct 26, 2023	criteria provided, conflicting classifications							
NM_002755.4(MAP2K1):c.1023-4T>G	MAP2K1		Noonan syndrome and Noonan-related syndrome	VCV001334253	15	66782052	15	66489714	1334253	1325113	rs1462240441	NC_000015.10:66489713:T:G	single nucleotide variant	intron variant	Uncertain significance	Feb 1, 2020	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.1024T>G (p.Leu342Val)	MAP2K1	L294V, L342V	not provided	VCV001707080	15	66782057	15	66489719	1707080	1705391		NC_000015.10:66489718:T:G	single nucleotide variant	missense variant	Uncertain significance	Mar 25, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.1031_1034del (p.Lys344fs)	MAP2K1	K344fs	RASopathy	VCV002180190	15	66782062 - 66782065	15	66489724 - 66489727	2180190	1912775		NC_000015.10:66489723:AAAAAA:AA	Deletion	frameshift variant	Uncertain significance	Oct 4, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.1030A>C (p.Lys344Gln)	MAP2K1	K344Q, K296Q	RASopathy|Cardiofaciocutaneous syndrome 3|Melorheostosis	VCV002198544	15	66782063	15	66489725	2198544	1933768		NC_000015.10:66489724:A:C	single nucleotide variant	missense variant	Uncertain significance	Dec 29, 2023	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.1034A>G (p.Asn345Ser)	MAP2K1	N345S	RASopathy	VCV001432564	15	66782067	15	66489729	1432564	1480819	rs760766158	NC_000015.10:66489728:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 24, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.1035C>T (p.Asn345=)	MAP2K1		RASopathy	VCV002153776	15	66782068	15	66489730	2153776	1892551		NC_000015.10:66489729:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 26, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.1038C>T (p.Pro346=)	MAP2K1		Cardiovascular phenotype|RASopathy	VCV001087058	15	66782071	15	66489733	1087058	1081237	rs547178339	NC_000015.10:66489732:C:T	single nucleotide variant	synonymous variant	Likely benign	Oct 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.1039G>A (p.Ala347Thr)	MAP2K1	A347T	RASopathy|not specified	VCV000228846	15	66782072	15	66489734	228846	230602	rs746354996	NC_000015.10:66489733:G:A	single nucleotide variant	missense variant	Uncertain significance	May 13, 2021	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.1045A>C (p.Arg349=)	MAP2K1		RASopathy	VCV000760786	15	66782078	15	66489740	760786	770292	rs1595888749	NC_000015.10:66489739:A:C	single nucleotide variant	synonymous variant	Likely benign	May 8, 2019	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.1046G>C (p.Arg349Thr)	MAP2K1	R301T, R349T	Cardiovascular phenotype	VCV003292969	15	66782079	15	66489741	3292969	3446440		NC_000015.10:66489740:G:C	single nucleotide variant	missense variant	Uncertain significance	May 10, 2024	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.1047A>C (p.Arg349Ser)	MAP2K1	R349S	RASopathy	VCV001025225	15	66782080	15	66489742	1025225	1011577	rs1177367316	NC_000015.10:66489741:A:C	single nucleotide variant	missense variant	Uncertain significance	Sep 19, 2021	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.1053T>A (p.Asp351Glu)	MAP2K1|SNAPC5	D303E, D351E	RASopathy	VCV002836006	15	66782086	15	66489748	2836006	2995838		NC_000015.10:66489747:T:A	single nucleotide variant	3 prime UTR variant|non-coding transcript variant|missense variant	Uncertain significance	Feb 18, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.1054T>G (p.Leu352Val)	MAP2K1|SNAPC5	L304V, L352V	RASopathy	VCV002770394	15	66782087	15	66489749	2770394	2927244		NC_000015.10:66489748:T:G	single nucleotide variant	3 prime UTR variant|non-coding transcript variant|missense variant	Uncertain significance	Oct 20, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.1056G>A (p.Leu352=)	MAP2K1|SNAPC5		Cardiovascular phenotype	VCV001778632	15	66782089	15	66489751	1778632	1834603		NC_000015.10:66489750:G:A	single nucleotide variant	3 prime UTR variant|non-coding transcript variant|synonymous variant	Likely benign	Mar 16, 2020	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.1062A>C (p.Gln354His)	MAP2K1|SNAPC5	Q354H, Q306H	RASopathy|Melorheostosis|Cardiofaciocutaneous syndrome 3	VCV000040761	15	66782095	15	66489757	40761	49231	rs750035241	NC_000015.10:66489756:A:C	single nucleotide variant	3 prime UTR variant|non-coding transcript variant|missense variant	Uncertain significance	Aug 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.1066A>G (p.Met356Val)	MAP2K1|SNAPC5	M356V, M308V	not specified|RASopathy|Cardiovascular phenotype	VCV000372936	15	66782099	15	66489761	372936	360220	rs1009731985	NC_000015.10:66489760:A:G	single nucleotide variant	3 prime UTR variant|non-coding transcript variant|missense variant	Uncertain significance	Dec 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.1067T>C (p.Met356Thr)	MAP2K1|SNAPC5	M308T, M356T	Cardiovascular phenotype|RASopathy	VCV002565491	15	66782100	15	66489762	2565491	2730447		NC_000015.10:66489761:T:C	single nucleotide variant	3 prime UTR variant|non-coding transcript variant|missense variant	Uncertain significance	Mar 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.1068_1068+1delinsCA	MAP2K1|SNAPC5		not provided	VCV002571919	15	66782101 - 66782102	15	66489763 - 66489764	2571919	2736866		NC_000015.10:66489762:GG:CA	Indel	3 prime UTR variant|non-coding transcript variant|splice donor variant	Uncertain significance	Jan 9, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.1068+5G>A	MAP2K1|SNAPC5		Melorheostosis|Cardiofaciocutaneous syndrome 3	VCV003577608	15	66782106	15	66489768	3577608	3704209		NC_000015.10:66489767:G:A	single nucleotide variant	3 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	May 4, 2024	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.1068+12_1068+15del	MAP2K1|SNAPC5		RASopathy	VCV000044586	15	66782109 - 66782112	15	66489771 - 66489774	44586	53753	rs397516788	NC_000015.10:66489770:TATTTATT:TATT	Microsatellite	3 prime UTR variant|non-coding transcript variant|intron variant	Benign	May 9, 2017	reviewed by expert panel							
NM_002755.4(MAP2K1):c.1068+9A>G	MAP2K1|SNAPC5		RASopathy	VCV000180895	15	66782110	15	66489772	180895	179789	rs368800650	NC_000015.10:66489771:A:G	single nucleotide variant	3 prime UTR variant|non-coding transcript variant|intron variant	Likely benign	Sep 24, 2019	reviewed by expert panel							
NM_002755.4(MAP2K1):c.1068+13_1068+15del	MAP2K1|SNAPC5		RASopathy	VCV001587367	15	66782112 - 66782114	15	66489774 - 66489776	1587367	1541883	rs2140684503	NC_000015.10:66489773:TTATT:TT	Deletion	3 prime UTR variant|non-coding transcript variant|intron variant	Likely benign	Sep 27, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.1068+17C>T	MAP2K1|SNAPC5		RASopathy	VCV001610157	15	66782118	15	66489780	1610157	1519511	rs566984700	NC_000015.10:66489779:C:T	single nucleotide variant	3 prime UTR variant|non-coding transcript variant|intron variant	Likely benign	Nov 24, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.1068+18G>A	MAP2K1|SNAPC5		not specified|RASopathy|not provided	VCV000378102	15	66782119	15	66489781	378102	374698	rs369137482	NC_000015.10:66489780:G:A	single nucleotide variant	3 prime UTR variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Dec 6, 2023	criteria provided, conflicting classifications							
NM_002755.4(MAP2K1):c.1068+19G>A	MAP2K1|SNAPC5		RASopathy|not specified	VCV000917701	15	66782120	15	66489782	917701	906059	rs188235318	NC_000015.10:66489781:G:A	single nucleotide variant	3 prime UTR variant|non-coding transcript variant|intron variant	Benign/Likely benign	Jan 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.1068+159C>G	MAP2K1|SNAPC5		not provided	VCV000561441	15	66782260	15	66489922	561441	552870	rs79240084	NC_000015.10:66489921:C:G	single nucleotide variant	3 prime UTR variant|non-coding transcript variant|intron variant	Likely benign	Jun 14, 2018	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.1069-145C>T	MAP2K1|SNAPC5		not provided	VCV001202855	15	66782695	15	66490357	1202855	1194982	rs761802630	NC_000015.10:66490356:C:T	single nucleotide variant	3 prime UTR variant|non-coding transcript variant|intron variant	Likely benign	Dec 4, 2019	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.1069-144C>T	MAP2K1|SNAPC5		not provided	VCV001245180	15	66782696	15	66490358	1245180	1235133	rs76511608	NC_000015.10:66490357:C:T	single nucleotide variant	3 prime UTR variant|non-coding transcript variant|intron variant	Benign	Jan 12, 2020	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.1069-142C>G	MAP2K1|SNAPC5		not provided	VCV001318561	15	66782698	15	66490360	1318561	1308345	rs754961763	NC_000015.10:66490359:C:G	single nucleotide variant	3 prime UTR variant|non-coding transcript variant|intron variant	Likely benign	Feb 23, 2021	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.1069-113C>T	MAP2K1|SNAPC5		not provided	VCV001239027	15	66782727	15	66490389	1239027	1226864	rs41315966	NC_000015.10:66490388:C:T	single nucleotide variant	3 prime UTR variant|non-coding transcript variant|intron variant	Benign	Dec 7, 2019	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.1069-17C>T	MAP2K1|SNAPC5		RASopathy	VCV001576514	15	66782823	15	66490485	1576514	1586845	rs201274410	NC_000015.10:66490484:C:T	single nucleotide variant	3 prime UTR variant|non-coding transcript variant|intron variant	Likely benign	Nov 4, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.1069-16G>A	SNAPC5|MAP2K1		RASopathy|not provided|not specified	VCV000918091	15	66782824	15	66490486	918091	915091	rs146942812	NC_000015.10:66490485:G:A	single nucleotide variant	3 prime UTR variant|non-coding transcript variant|intron variant	Benign	Jan 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.1069-12C>A	MAP2K1|SNAPC5		RASopathy	VCV001902241	15	66782828	15	66490490	1902241	339717	rs781412352	NC_000015.10:66490489:C:A	single nucleotide variant	3 prime UTR variant|non-coding transcript variant|intron variant	Likely benign	Nov 4, 2024	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.1069-11C>A	MAP2K1|SNAPC5		RASopathy	VCV001978835	15	66782829	15	66490491	1978835	2038012		NC_000015.10:66490490:C:A	single nucleotide variant	3 prime UTR variant|non-coding transcript variant|intron variant	Likely benign	Jul 18, 2024	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.1069-8A>T	MAP2K1|SNAPC5		RASopathy	VCV002791786	15	66782832	15	66490494	2791786	2950329		NC_000015.10:66490493:A:T	single nucleotide variant	3 prime UTR variant|non-coding transcript variant|intron variant	Likely benign	Jul 25, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.1069-7del	MAP2K1|SNAPC5		RASopathy	VCV002816225	15	66782833	15	66490495	2816225	2976895		NC_000015.10:66490494:C:	Deletion	3 prime UTR variant|non-coding transcript variant|intron variant	Likely benign	Nov 25, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.1069-6A>G	MAP2K1|SNAPC5		RASopathy	VCV002967006	15	66782834	15	66490496	2967006	3128260		NC_000015.10:66490495:A:G	single nucleotide variant	3 prime UTR variant|non-coding transcript variant|intron variant	Likely benign	Jan 22, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.1069-3C>T	MAP2K1|SNAPC5		RASopathy	VCV002781425	15	66782837	15	66490499	2781425	2937823		NC_000015.10:66490498:C:T	single nucleotide variant	3 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Nov 27, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.1072C>T (p.His358Tyr)	MAP2K1|SNAPC5	H358Y, H310Y	RASopathy	VCV000666422	15	66782843	15	66490505	666422	653981	rs1595889532	NC_000015.10:66490504:C:T	single nucleotide variant	3 prime UTR variant|non-coding transcript variant|missense variant	Uncertain significance	Jul 7, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.1081_1084delinsG (p.Ile361_Lys362delinsGlu)	MAP2K1|SNAPC5		not provided	VCV002501899	15	66782852 - 66782855	15	66490514 - 66490517	2501899	2534111		NC_000015.10:66490513:ATCA:G	Indel	3 prime UTR variant|non-coding transcript variant|inframe_indel	Uncertain significance	Nov 9, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.1086G>A (p.Lys362=)	MAP2K1|SNAPC5		RASopathy	VCV002133334	15	66782857	15	66490519	2133334	2190023		NC_000015.10:66490518:G:A	single nucleotide variant	3 prime UTR variant|non-coding transcript variant|synonymous variant	Likely benign	Nov 17, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.1091C>A (p.Ser364Tyr)	MAP2K1|SNAPC5	S316Y, S364Y	Cardiovascular phenotype	VCV003292965	15	66782862	15	66490524	3292965	3446436		NC_000015.10:66490523:C:A	single nucleotide variant	3 prime UTR variant|non-coding transcript variant|missense variant	Uncertain significance	May 17, 2024	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.1091C>T (p.Ser364Phe)	MAP2K1|SNAPC5	S316F, S364F	not provided	VCV002413054	15	66782862	15	66490524	2413054	2401781		NC_000015.10:66490523:C:T	single nucleotide variant	3 prime UTR variant|non-coding transcript variant|missense variant	Uncertain significance	Jul 27, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.1098T>C (p.Ala366=)	MAP2K1|SNAPC5		RASopathy	VCV000448949	15	66782869	15	66490531	448949	442538	rs200293968	NC_000015.10:66490530:T:C	single nucleotide variant	3 prime UTR variant|non-coding transcript variant|synonymous variant	Likely benign	May 9, 2017	reviewed by expert panel							
NM_002755.4(MAP2K1):c.1101G>A (p.Glu367=)	MAP2K1|SNAPC5		RASopathy	VCV002891616	15	66782872	15	66490534	2891616	3055425		NC_000015.10:66490533:G:A	single nucleotide variant	3 prime UTR variant|non-coding transcript variant|synonymous variant	Likely benign	Mar 26, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.1107G>A (p.Val369=)	MAP2K1|SNAPC5		RASopathy	VCV002893312	15	66782878	15	66490540	2893312	3055818		NC_000015.10:66490539:G:A	single nucleotide variant	3 prime UTR variant|non-coding transcript variant|synonymous variant	Likely benign	Nov 24, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.1110T>C (p.Asp370=)	MAP2K1|SNAPC5		RASopathy	VCV001963559	15	66782881	15	66490543	1963559	2017230		NC_000015.10:66490542:T:C	single nucleotide variant	3 prime UTR variant|non-coding transcript variant|synonymous variant	Likely benign	Jul 19, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.1113T>G (p.Phe371Leu)	MAP2K1|SNAPC5	F323L, F371L	RASopathy	VCV002997336	15	66782884	15	66490546	2997336	3166681		NC_000015.10:66490545:T:G	single nucleotide variant	3 prime UTR variant|non-coding transcript variant|missense variant	Uncertain significance	Jul 7, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.1115C>T (p.Ala372Val)	MAP2K1|SNAPC5	A372V, A324V	not provided|RASopathy	VCV001326437	15	66782886	15	66490548	1326437	1316797	rs1893220987	NC_000015.10:66490547:C:T	single nucleotide variant	3 prime UTR variant|non-coding transcript variant|missense variant	Uncertain significance	Jul 29, 2023	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.1116A>T (p.Ala372=)	MAP2K1|SNAPC5		RASopathy	VCV002762237	15	66782887	15	66490549	2762237	2930733		NC_000015.10:66490548:A:T	single nucleotide variant	3 prime UTR variant|non-coding transcript variant|synonymous variant	Likely benign	Sep 22, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.1119T>C (p.Gly373=)	MAP2K1|SNAPC5		Cardiovascular phenotype	VCV001797130	15	66782890	15	66490552	1797130	1855704		NC_000015.10:66490551:T:C	single nucleotide variant	3 prime UTR variant|non-coding transcript variant|synonymous variant	Likely benign	Jul 30, 2021	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.1123C>A (p.Leu375Ile)	MAP2K1|SNAPC5	L375I, L327I	not specified|RASopathy|Cardiovascular phenotype	VCV000543994	15	66782894	15	66490556	543994	529402	rs752538915	NC_000015.10:66490555:C:A	single nucleotide variant	3 prime UTR variant|non-coding transcript variant|missense variant	Likely benign	Oct 2, 2023	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.1125C>G (p.Leu375=)	MAP2K1|SNAPC5		RASopathy|Cardiovascular phenotype	VCV002706922	15	66782896	15	66490558	2706922	2870495		NC_000015.10:66490557:C:G	single nucleotide variant	3 prime UTR variant|non-coding transcript variant|synonymous variant	Likely benign	Jun 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.1130C>T (p.Ser377Phe)	MAP2K1|SNAPC5	S377F, S329F	RASopathy|Noonan syndrome and Noonan-related syndrome	VCV001334254	15	66782901	15	66490563	1334254	339723	rs371140798	NC_000015.10:66490562:C:T	single nucleotide variant	3 prime UTR variant|non-coding transcript variant|missense variant	Uncertain significance	Aug 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.1134C>T (p.Thr378=)	MAP2K1|SNAPC5		Cardiovascular phenotype	VCV002565492	15	66782905	15	66490567	2565492	2730448		NC_000015.10:66490566:C:T	single nucleotide variant	3 prime UTR variant|non-coding transcript variant|synonymous variant	Likely benign	Apr 1, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.1135A>G (p.Ile379Val)	MAP2K1|SNAPC5	I379V, I331V	Cardiofaciocutaneous syndrome 3|Melorheostosis|Cardiovascular phenotype|RASopathy	VCV000659397	15	66782906	15	66490568	659397	643475	rs373794940	NC_000015.10:66490567:A:G	single nucleotide variant	3 prime UTR variant|non-coding transcript variant|missense variant	Uncertain significance	Oct 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.1137C>T (p.Ile379=)	MAP2K1|SNAPC5		RASopathy	VCV000040762	15	66782908	15	66490570	40762	49232	rs150841154	NC_000015.10:66490569:C:T	single nucleotide variant	3 prime UTR variant|non-coding transcript variant|synonymous variant	Benign	May 9, 2017	reviewed by expert panel							
NM_002755.4(MAP2K1):c.1138G>A (p.Gly380Ser)	MAP2K1|SNAPC5	G380S, G332S	Noonan syndrome and Noonan-related syndrome|RASopathy	VCV001334255	15	66782909	15	66490571	1334255	1325114	rs750934083	NC_000015.10:66490570:G:A	single nucleotide variant	3 prime UTR variant|non-coding transcript variant|missense variant	Uncertain significance	May 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.1140C>A (p.Gly380=)	MAP2K1|SNAPC5		RASopathy	VCV002848760	15	66782911	15	66490573	2848760	3015657		NC_000015.10:66490572:C:A	single nucleotide variant	3 prime UTR variant|non-coding transcript variant|synonymous variant	Likely benign	Mar 23, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.1140C>T (p.Gly380=)	MAP2K1|SNAPC5		Cardiovascular phenotype|RASopathy	VCV001626003	15	66782911	15	66490573	1626003	1575218	rs1278357327	NC_000015.10:66490572:C:T	single nucleotide variant	3 prime UTR variant|non-coding transcript variant|synonymous variant	Likely benign	Jul 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.1143T>A (p.Leu381=)	MAP2K1|SNAPC5		RASopathy	VCV001978836	15	66782914	15	66490576	1978836	2038013		NC_000015.10:66490575:T:A	single nucleotide variant	3 prime UTR variant|non-coding transcript variant|synonymous variant	Likely benign	Jul 18, 2024	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.1146C>A (p.Asn382Lys)	MAP2K1|SNAPC5	N334K, N382K	Cardiovascular phenotype	VCV002319773	15	66782917	15	66490579	2319773	2313860		NC_000015.10:66490578:C:A	single nucleotide variant	3 prime UTR variant|non-coding transcript variant|missense variant	Uncertain significance	Oct 26, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.1146C>T (p.Asn382=)	MAP2K1|SNAPC5		RASopathy	VCV001613726	15	66782917	15	66490579	1613726	1536481	rs2140687038	NC_000015.10:66490578:C:T	single nucleotide variant	3 prime UTR variant|non-coding transcript variant|synonymous variant	Likely benign	Oct 28, 2021	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.1152del (p.Ser385fs)	MAP2K1|SNAPC5	S337fs, S385fs	Cardiovascular phenotype	VCV003542698	15	66782921	15	66490583	3542698	3699980		NC_000015.10:66490582:CCC:CC	Deletion	3 prime UTR variant|non-coding transcript variant|frameshift variant	Uncertain significance	Oct 29, 2024	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.1153A>G (p.Ser385Gly)	MAP2K1|SNAPC5	S337G, S385G	RASopathy	VCV002888506	15	66782924	15	66490586	2888506	3051250		NC_000015.10:66490585:A:G	single nucleotide variant	3 prime UTR variant|non-coding transcript variant|missense variant	Uncertain significance	Sep 8, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.1157C>T (p.Thr386Ile)	MAP2K1|SNAPC5	T338I, T386I	RASopathy	VCV002884338	15	66782928	15	66490590	2884338	3053349		NC_000015.10:66490589:C:T	single nucleotide variant	3 prime UTR variant|non-coding transcript variant|missense variant	Uncertain significance	Mar 18, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.1161A>C (p.Pro387=)	MAP2K1|SNAPC5		Cardiovascular phenotype	VCV003542700	15	66782932	15	66490594	3542700	3699982		NC_000015.10:66490593:A:C	single nucleotide variant	3 prime UTR variant|non-coding transcript variant|synonymous variant	Likely benign	Oct 24, 2024	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.1166A>G (p.His389Arg)	MAP2K1|SNAPC5	H341R, H389R	Melorheostosis|Cardiofaciocutaneous syndrome 3	VCV003577609	15	66782937	15	66490599	3577609	3704210		NC_000015.10:66490598:A:G	single nucleotide variant	3 prime UTR variant|non-coding transcript variant|missense variant	Uncertain significance	Jun 18, 2024	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.1168G>A (p.Ala390Thr)	MAP2K1|SNAPC5	A390T, A342T	not provided|RASopathy|MAP2K1-related disorder	VCV000180900	15	66782939	15	66490601	180900	179790	rs730880500	NC_000015.10:66490600:G:A	single nucleotide variant	3 prime UTR variant|non-coding transcript variant|missense variant	Conflicting classifications of pathogenicity	Jan 19, 2024	criteria provided, conflicting classifications							
NM_002755.4(MAP2K1):c.1170T>G (p.Ala390=)	MAP2K1|SNAPC5		Cardiovascular phenotype	VCV003542699	15	66782941	15	66490603	3542699	3699981		NC_000015.10:66490602:T:G	single nucleotide variant	3 prime UTR variant|non-coding transcript variant|synonymous variant	Likely benign	Oct 24, 2024	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.1172C>T (p.Ala391Val)	MAP2K1|SNAPC5	A391V, A343V	not provided|RASopathy|Cardiovascular phenotype	VCV000372567	15	66782943	15	66490605	372567	360295	rs896594939	NC_000015.10:66490604:C:T	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Dec 1, 2023	criteria provided, conflicting classifications							
NM_002755.4(MAP2K1):c.1176C>T (p.Gly392=)	MAP2K1|SNAPC5		RASopathy|not specified|Cardiovascular phenotype	VCV000974990	15	66782947	15	66490609	974990	963297	rs781328871	NC_000015.10:66490608:C:T	single nucleotide variant	3 prime UTR variant|non-coding transcript variant|synonymous variant	Likely benign	Jul 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.1177G>A (p.Val393Ile)	MAP2K1|SNAPC5	V393I, V345I	RASopathy|not provided|Melorheostosis|Cardiofaciocutaneous syndrome 3	VCV001214837	15	66782948	15	66490610	1214837	1204820	rs200442489	NC_000015.10:66490609:G:A	single nucleotide variant	3 prime UTR variant|non-coding transcript variant|missense variant	Conflicting classifications of pathogenicity	Jun 25, 2024	criteria provided, conflicting classifications							
NM_002755.4(MAP2K1):c.1180_1181dup (p.Ter394TyrextTer?)	MAP2K1|SNAPC5		not provided	VCV003343301	15	66782950 - 66782951	15	66490612 - 66490613	3343301	3502533		NC_000015.10:66490612:TA:TATA	Duplication	3 prime UTR variant|non-coding transcript variant|frameshift variant|stop lost	Uncertain significance	May 5, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.1180dup (p.Ter394LeuextTer?)	MAP2K1|SNAPC5		RASopathy	VCV000950974	15	66782950 - 66782951	15	66490612 - 66490613	950974	927398	rs1893223775	NC_000015.10:66490612:T:TT	Duplication	3 prime UTR variant|non-coding transcript variant|frameshift variant|stop lost	Uncertain significance	Jan 19, 2022	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.1181_*2del (p.Ter394CysextTer?)	SNAPC5|MAP2K1		RASopathy	VCV000659036	15	66782951 - 66782954	15	66490613 - 66490616	659036	643476	rs1595889609	NC_000015.10:66490612:TAAGT:T	Deletion	3 prime UTR variant|non-coding transcript variant|frameshift variant|stop lost	Uncertain significance	Oct 3, 2018	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.*17A>T	MAP2K1|SNAPC5		Melorheostosis|Cardiofaciocutaneous syndrome 3	VCV003577610	15	66782970	15	66490632	3577610	3704211		NC_000015.10:66490631:A:T	single nucleotide variant	3 prime UTR variant|non-coding transcript variant	Uncertain significance	Jan 23, 2024	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.*50G>A	SNAPC5|MAP2K1		not provided	VCV001259846	15	66783003	15	66490665	1259846	1249331	rs766828156	NC_000015.10:66490664:G:A	single nucleotide variant	3 prime UTR variant|non-coding transcript variant	Benign	Jan 13, 2020	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.*63C>T	MAP2K1|SNAPC5		not provided	VCV002645472	15	66783016	15	66490678	2645472	2814254		NC_000015.10:66490677:C:T	single nucleotide variant	3 prime UTR variant|non-coding transcript variant	Uncertain significance	Sep 1, 2023	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.*148_*149del	MAP2K1|SNAPC5		Noonan syndrome|Cardio-facio-cutaneous syndrome	VCV000316839	15	66783101 - 66783102	15	66490763 - 66490764	316839	332756	rs745540522	NC_000015.10:66490762:TT:	Deletion	3 prime UTR variant|intron variant	Uncertain significance	Jun 14, 2016	criteria provided, single submitter							
NM_002755.4(MAP2K1):c.*308C>A	MAP2K1|SNAPC5		not provided	VCV001257472	15	66783261	15	66490923	1257472	332760	rs14303	NC_000015.10:66490922:C:A	single nucleotide variant	3 prime UTR variant|intron variant	Benign	Jun 14, 2018	criteria provided, multiple submitters, no conflicts							
NM_002755.4(MAP2K1):c.*917dup	SNAPC5|MAP2K1		not provided|Cardio-facio-cutaneous syndrome|Noonan syndrome	VCV000316849	15	66783860 - 66783861	15	66491522 - 66491523	316849	323128	rs886051370	NC_000015.10:66491522:AAAAAAAAAA:AAAAAAAAAAA	Duplication	3 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Apr 1, 2022	criteria provided, conflicting classifications							
NM_002755.4(MAP2K1):c.*917del	MAP2K1|SNAPC5		Cardio-facio-cutaneous syndrome|Noonan syndrome	VCV000316850	15	66783861	15	66491523	316850	323126	rs886051370	NC_000015.10:66491522:AAAAAAAAAA:AAAAAAAAA	Deletion	3 prime UTR variant|intron variant	Uncertain significance	Jun 14, 2016	criteria provided, single submitter							
NC_000015.9:g.(?_66780810)_(66782933_?)del	MAP2K1|SNAPC5		RASopathy	VCV003243835	15	66780810 - 66782933			3243835	3404733			Deletion		Uncertain significance	Apr 17, 2023	criteria provided, single submitter							
NC_000015.9:g.(?_66679686)_(66729250_?)dup	MAP2K1		RASopathy	VCV003243834	15	66679686 - 66729250			3243834	3404732			Duplication		Uncertain significance	Jan 29, 2024	criteria provided, single submitter							
NC_000015.9:g.(?_66736974)_(66737065_?)dup	MAP2K1		RASopathy	VCV003243833	15	66736974 - 66737065			3243833	3404731			Duplication		Uncertain significance	Jun 18, 2023	criteria provided, single submitter							
GRCh37/hg19 15q22.31(chr15:66349832-66790693)x3	DIS3L|MAP2K1|MEGF11|SNAPC5|TIPIN		not provided	VCV002684761	15	66349832 - 66790693			2684761	2845796			copy number gain		Uncertain significance	Jan 4, 2023	criteria provided, single submitter							
NC_000015.9:g.(?_66679686)_(66679785_?)dup	MAP2K1		RASopathy	VCV002424528	15	66679686 - 66679785			2424528	1949606			Duplication		Uncertain significance	Jan 26, 2022	criteria provided, single submitter							
NC_000015.9:g.(?_66161924)_(69018313_?)dup	AAGAB|C15orf61|CALML4|CLN6|CORO2B|DIS3L|FEM1B|IQCH|ITGA11|LCTL|MAP2K1|MAP2K5|MEGF11|PIAS1|RAB11A|RNU6-1|RPL4|SKOR1|SMAD3|SMAD6|SNAPC5|TIPIN|ZWILCH		Neuronal ceroid lipofuscinosis	VCV001512687	15	66161924 - 69018313			1512687	1380780			Duplication		Uncertain significance	Apr 11, 2022	criteria provided, single submitter							
NC_000015.9:g.(?_66774083)_(66782963_?)dup	MAP2K1|SNAPC5		RASopathy	VCV001410689	15	66774083 - 66782963			1410689	1510126			Duplication		Uncertain significance	Jan 8, 2021	criteria provided, single submitter							
NC_000015.9:g.(?_32964879)_(91358519_?)dup	CGNL1|MAPDA|TBC1D21|TGM5|TGM7|TICRR|TIPIN|TLE3|TLN2|TLNRD1|THAP10|THBS1|THSD4|TBC1D2B|TCF12|TM6SF1|TERB2|TEX9|MFGE8|MGA|MIR184|MINAR1|MINDY2|MIR9-3|MAPK6|MNS1|MORF4L1|MPI|MRPL46|MRPS11|MAPKBP1|MEGF11|CKMT1B|CLK3|CHST14|CIAO2A|CIB1|CIB2|CHAC1|CHP1|CHRM5|CHRNA3|CILP|CIMAP1C|CKMT1A|CHRNA5|CHRNB4|AAGAB|ABHD17C|ABHD2|ACAN|ACSBG1|ACTC1|ADAM10|ADAMTS7|ADAMTSL3|ADPGK|AEN|AFG2B|AGBL1|AKAP13|ALDH1A2|ALPK3|ANKDD1A|ANKRD34C|ANKRD63|ANP32A|ANPEP|ANXA2|AP3B2|AP3S2|AP4E1|APH1B|AQP9|AQR|ARID3B|ARIH1|ARNT2|ARPIN|ARPIN-AP3S2|ARPP19|ATOSA|ATP8B4|AVEN|B2M|BAHD1|BBS4|BCL2A1|BCL2L10|BLM|BLOC1S6|BMF|BNC1|BNIP2|BTBD1|BUB1B|C15orf39|C15orf40|C15orf48|C15orf61|C15orf62|C2CD4A|C2CD4B|CA12|CALML4|CAPN3|CATSPER2|CCDC32|CCDC33|CCDC9B|CCNB2|CCNDBP1|CCPG1|CD276|CDAN1|CDIN1|CELF6|CEMIP|CEP152|CFAP161|CLN6|CLPX|COMMD4|COPS2|CORO2B|COX5A|CPEB1|CPLX3|CRABP1|CRTC3|CSK|CSNK1G1|CSPG4|CT62|CTDSPL2|CTSH|CTXN2|CYP11A1|CYP19A1|CYP1A1|CYP1A2|DAPK2|DENND4A|DET1|DIS3L|DISP2|DLL4|DMXL2|DNAAF4|DNAJA4|DNAJC17|DPH6|DPP8|DTWD1|DUOX1|DUOX2|DUOXA1|DUOXA2|DUT|EDC3|EFL1|EHD4|EID1|EIF2AK4|EIF3J|ELL3|EMC4|EMC7|EPB42|ETFA|EXD1|FAH|FAM219B|FAM227B|FAM81A|FAM98B|FANCI|FBN1|FBXL22|FBXO22|FEM1B|FGF7|FOXB1|FRMD5|FSD2|FSIP1|GABPB1|GALK2|GANC|GATM|GCHFR|GCNT3|GDPGP1|GJD2|GLCE|GLDN|GNB5|GOLGA6A|GOLGA6B|GOLGA6C|GOLGA6D|GOLGA8A|GOLGA8B|GOLM2|GPR176|GRAMD2A|GREM1|GTF2A2|HACD3|HAPLN3|HAUS2|HCN4|HDC|HERC1|HEXA|HMG20A|HOMER2|HYKK|HYPK|ICE2|IDH2|IDH3A|IGDCC3|IGDCC4|IL16|IMP3|INO80|INSYN1|INTS14|IQCH|IQGAP1|IREB2|ISG20|ISL2|ISLR|ISLR2|ITGA11|ITPKA|IVD|JMJD7|KATNBL1|KBTBD13|KIF23|KIF7|KLHL25|KNL1|KNSTRN|LACTB|LARP6|LCMT2|LCTL|LDHAL6B|LEO1|LINC00928|LINC02694|LINC02915|LINGO1|LIPC|LMAN1L|LOXL1|LPCAT4|LRRC49|LRRC57|LTK|LYSMD2|MAN2C1|MAP1A|MAP2K1|MAP2K5|MEIS2|MESD|MESP1|MESP2|MEX3B|MFAP1|MTFMT|MTHFS|MYEF2|MYO1E|MYO5A|MYO5C|MYO9A|MYZAP|NDUFAF1|NEDD4|NEIL1|NEO1|NGRN|NMB|NOP10|NOX5|NPTN|NR2E3|NRG4|NTRK3|NUSAP1|NUTM1|OAZ2|OIP5|ONECUT1|PAK6|PAK6-AS1|PAQR5|PARP16|PARP6|PATL2|PCLAF|PDCD7|PDE8A|PDIA3|PEAK1|PEX11A|PGBD4|PHGR1|PIAS1|PIERCE2|PIF1|PIGB|PKM|PLA2G4B|PLA2G4D|PLA2G4E|PLA2G4F|PLCB2|PLEKHO2|PLIN1|PML|POLG|POLR2M|PPCDC|PPIB|PPIP5K1|PPP1R14D|PRTG|PSMA4|PSTPIP1|PTPN9|PYGO1|RAB11A|RAB27A|RAB8B|RAD51|RAMAC|RASGRF1|RASGRP1|RASL12|RBPMS2|RCN2|REC114|RFX7|RHCG|RHOV|RLBP1|RMDN3|RNF111|RNU5A-1|RNU6-1|RORA|RPAP1|RPL4|RPLP1|RPP25|RPS17|RPS27L|RPUSD2|RSL24D1|RTF1|RYR3|SAXO2|SCAMP2|SCAMP5|SCAPER|SCARNA15|SCG3|SCG5|SEC11A|SECISBP2L|SEMA4B|SEMA6D|SEMA7A|SENP8|SERF2|SERINC4|SH2D7|SH3GL3|SHC4|SHF|SIN3A|SKIC8|SKOR1|SLC12A1|SLC12A6|SLC24A1|SLC24A5|SLC27A2|SLC28A1|SLC28A2|SLC30A4|SLC51B|SLTM|SMAD3|SMAD6|SNAP23|SNAPC5|SNUPN|SNX1|SNX22|SNX33|SORD|SPESP1|SPG11|SPG21|SPINT1|SPPL2A|SPRED1|SPTBN5|SQOR|SRP14|ST20|ST20-MTHFS|STARD5|STARD9|STOML1|STRA6|STRC|TMC3|TMCO5A|TMED3|TMEM202|TMEM266|TMEM62|TMEM87A|TMOD2|TMOD3|TNFAIP8L3|TP53BP1|TPM1|TRIM69|TRIP4|TRPM7|TSPAN3|TTBK2|TUBGCP4|TYRO3|UACA|UBAP1L|UBE2Q2|UBL7|UBR1|ULK3|UNC13C|USP3|USP50|USP8|VPS13C|VPS18|VPS39|WDR72|WDR73|WDR76|WDR93|WHAMM|ZFAND6|ZFYVE19|ZNF106|ZNF280D|ZNF592|ZNF609|ZNF710|ZNF770|ZNF774|ZSCAN2|ZSCAN29|ZWILCH		Familial colorectal cancer|Bloom syndrome	VCV001024934	15	32964879 - 91358519			1024934	1001750			Duplication		Uncertain significance	Feb 6, 2020	criteria provided, single submitter							
NC_000015.9:g.(?_66679676)_(66782963_?)dup	MAP2K1|SNAPC5		RASopathy	VCV000999571	15	66679676 - 66782963			999571	986551			Duplication		Uncertain significance	Jun 22, 2020	criteria provided, single submitter							
NC_000015.10:g.(?_66387328)_(66444727_?)dup	MAP2K1		RASopathy	VCV000831657	15	66679666 - 66737065			831657	820726			Duplication		Uncertain significance	Mar 14, 2019	criteria provided, single submitter							
Single allele	PDIA3|PEAK1|RMDN3|SPINT1|SPPL2A|USP8|WDR93|VPS13C|VPS18|WDR73|WDR76|ZSCAN29|WHAMM|ZFAND6|ZFYVE19|ZNF106|ZNF280D|VPS33B|VPS39|WDR72|ST8SIA2|THBS1|THSD4|TICRR|TIPIN|STARD5|TARS3|TBC1D21|TBC1D2B|RNF111|SAXO2|SCAMP2|SCAMP5|SCAPER|SCARNA15|SCG3|RNU5A-1|RNU6-1|RORA|RPAP1|RPL4|RPLP1|RPP25|PKM|PLA2G4B|PIERCE2|PGBD4|PGPEP1L|PHGR1|PIAS1|PIF1|PIGB|PEX11A|MPI|MIR211|MIR9-3|MNS1|MORF4L1|MRPL46|MRPS11|MTFMT|MTHFS|MTMR10|MYEF2|MYO1E|MYO5A|MYO5C|MYO9A|MYZAP|NDUFAF1|NEDD4|NEIL1|NEO1|NGRN|NMB|NOP10|NOX5|NPTN|NR2E3|NR2F2|NRG4|NTRK3|NUSAP1|NUTM1|OAZ2|OIP5|ONECUT1|OR4F6|OTUD7A|PAK6|PAK6-AS1|PAQR5|PARP16|PARP6|PATL2|PCLAF|PCSK6|PDCD7|PDE8A|PLA2G4D|PLA2G4E|PLA2G4F|PLCB2|PLEKHO2|PLIN1|PML|POLG|POLR2M|PPCDC|PPIB|PPIP5K1|PPP1R14D|PRC1|PRTG|PSMA4|PSTPIP1|PTPN9|PYGO1|RAB11A|RAB27A|RAB8B|RAD51|RAMAC|RASGRF1|RASGRP1|RASL12|RBPMS2|RCCD1|RCN2|REC114|RFX7|RGMA|RHCG|RHOV|RLBP1|RPS17|RPS27L|RPUSD2|RSL24D1|RTF1|RYR3|SCG5|SEC11A|SECISBP2L|SELENOS|SEMA4B|SEMA6D|SEMA7A|SENP8|SERF2|SERINC4|SH2D7|SH3GL3|SHC4|SHF|SIN3A|SKIC8|SKOR1|SLC12A1|SLC12A6|SLC24A1|SLC24A5|SLC27A2|SLC28A1|SLC28A2|SLC30A4|SLC51B|SLCO3A1|SLTM|SMAD3|SMAD6|SNAP23|SNAPC5|SNRPA1|SNUPN|SNX1|SNX22|SNX33|SORD|SPATA8|SPESP1|SPG11|SPG21|SPRED1|SPTBN5|SQOR|SRP14|ST20|ST20-MTHFS|STARD9|STOML1|STRA6|STRC|SV2B|SYNM|TCF12|TERB2|TEX9|TGM5|TGM7|THAP10|TLE3|TLN2|TLNRD1|TM2D3|TM6SF1|TMC3|TMCO5A|TMED3|TMEM202|TMEM266|TMEM62|TMEM87A|TMOD2|TMOD3|TNFAIP8L3|TP53BP1|TPM1|TRIM69|TRIP4|TRPM1|TRPM7|TSPAN3|TTBK2|TTC23|TUBGCP4|TYRO3|UACA|UBAP1L|UBE2Q2|UBL7|UBR1|ULK3|UNC13C|UNC45A|USP3|USP50|ZNF592|ZNF609|ZNF710|ZNF770|ZNF774|ZSCAN2|ZWILCH|AAGAB|ABHD17C|ABHD2|ACAN|ACSBG1|ACTC1|ADAM10|ADAMTS17|ADAMTS7|ADAMTSL3|ADPGK|AEN|AFG2B|AGBL1|AKAP13|ALDH1A2|ALDH1A3|ALPK3|ANKDD1A|ANKRD34C|ANKRD63|ANP32A|ANPEP|ANXA2|AP3B2|AP3S2|AP4E1|APH1B|AQP9|AQR|ARHGAP11A|ARID3B|ARIH1|ARNT2|ARPIN|ARPIN-AP3S2|ARPP19|ARRDC4|ASB7|ATOSA|ATP8B4|AVEN|B2M|BAHD1|BBS4|BCL2A1|BCL2L10|BLM|BLOC1S6|BMF|BNC1|BNIP2|BTBD1|BUB1B|C15orf32|C15orf39|C15orf40|C15orf48|C15orf61|C15orf62|C2CD4A|C2CD4B|CA12|CALML4|CAPN3|CATSPER2|CCDC32|CCDC33|CCDC9B|CCNB2|CCNDBP1|CCPG1|CD276|CDAN1|CDIN1|CELF6|CEMIP|CEP152|CERS3|CFAP161|CGNL1|CHAC1|CHD2|CHP1|CHRM5|CHRNA3|CHRNA5|CHRNA7|CHRNB4|CHST14|CHSY1|CIAO2A|CIB1|CIB2|CILP|CIMAP1C|CKMT1A|CKMT1B|CLK3|CLN6|CLPX|COMMD4|COPS2|CORO2B|COX5A|CPEB1|CPLX3|CRABP1|CRTC3|CSK|CSNK1G1|CSPG4|CT62|CTDSPL2|CTSH|CTXN2|CYP11A1|CYP19A1|CYP1A1|CYP1A2|DAPK2|DENND4A|DET1|DIS3L|DISP2|DLL4|DMXL2|DNAAF4|DNAJA4|DNAJC17|DPH6|DPP8|DTWD1|DUOX1|DUOX2|DUOXA1|DUOXA2|DUT|EDC3|EFL1|EHD4|EID1|EIF2AK4|EIF3J|ELL3|EMC4|EMC7|EPB42|ETFA|EXD1|FAH|FAM174B|FAM219B|FAM227B|FAM81A|FAM98B|FAN1|FANCI|FBN1|FBXL22|FBXO22|FEM1B|FES|FGF7|FOXB1|FRMD5|FSD2|FSIP1|FURIN|GABPB1|GALK2|GANC|GATM|GCHFR|GCNT3|GDPGP1|GJD2|GLCE|GLDN|GNB5|GOLGA6A|GOLGA6B|GOLGA6C|GOLGA6D|GOLGA8A|GOLGA8B|GOLGA8N|GOLGA8O|GOLM2|GPR176|GRAMD2A|GREM1|GTF2A2|HACD3|HAPLN3|HAUS2|HCN4|HDC|HDDC3|HERC1|HEXA|HMG20A|HOMER2|HYKK|HYPK|ICE2|IDH2|IDH3A|IGDCC3|IGDCC4|IGF1R|IL16|IMP3|INO80|INSYN1|INTS14|IQCH|IQGAP1|IREB2|ISG20|ISL2|ISLR|ISLR2|ITGA11|ITPKA|IVD|JMJD7|KATNBL1|KBTBD13|KIF23|KIF7|KLF13|KLHL25|KNL1|KNSTRN|LACTB|LARP6|LCMT2|LCTL|LDHAL6B|LEO1|LINC00928|LINC02694|LINC02915|LINGO1|LINS1|LIPC|LMAN1L|LOXL1|LPCAT4|LRRC28|LRRC49|LRRC57|LRRK1|LTK|LYSMD2|LYSMD4|MAN2A2|MAN2C1|MAP1A|MAP2K1|MAP2K5|MAPDA|MAPK6|MAPKBP1|MCTP2|MEF2A|MEGF11|MEIS2|MESD|MESP1|MESP2|MEX3B|MFAP1|MFGE8|MGA|MINAR1|MINDY2|MIR184		not provided	VCV000560049	15	31115047 - 102354857			560049	550765			Duplication		Pathogenic	Apr 5, 2018	criteria provided, single submitter							
GRCh37/hg19 15q11.2-26.3(chr15:22770422-102429112)x3	AAGAB|ABHD17C|ABHD2|ACAN|ACSBG1|ACTC1|ADAM10|ADAMTS17|ADAMTS7|ADAMTSL3|ADPGK|AEN|AFG2B|AGBL1|AKAP13|ALDH1A2|ALDH1A3|ALPK3|ANKDD1A|ANKRD34C|ANKRD63|ANP32A|ANPEP|ANXA2|AP3B2|AP3S2|AP4E1|APBA2|APH1B|AQP9|AQR|ARHGAP11A|ARHGAP11B|ARID3B|ARIH1|ARNT2|ARPIN|ARPIN-AP3S2|ARPP19|ARRDC4|ASB7|ATOSA|ATP10A|ATP8B4|AVEN|B2M|BAHD1|BBS4|BCL2A1|BCL2L10|BLM|BLOC1S6|BMF|BNC1|BNIP2|BTBD1|BUB1B|C15orf32|C15orf39|C15orf40|C15orf48|C15orf61|C15orf62|C2CD4A|C2CD4B|CA12|CALML4|CAPN3|CATSPER2|CCDC32|CCDC33|CCDC9B|CCNB2|CCNDBP1|CCPG1|CD276|CDAN1|CDIN1|CELF6|CEMIP|CEP152|CERS3|CFAP161|CGNL1|CHAC1|CHD2|CHP1|CHRFAM7A|CHRM5|CHRNA3|CHRNA5|CHRNA7|CHRNB4|CHST14|CHSY1|CIAO2A|CIB1|CIB2|CILP|CIMAP1C|CKMT1A|CKMT1B|CLK3|CLN6|CLPX|COMMD4|COPS2|CORO2B|COX5A|CPEB1|CPLX3|CRABP1|CRTC3|CSK|CSNK1G1|CSPG4|CT62|CTDSPL2|CTSH|CTXN2|CYFIP1|CYP11A1|CYP19A1|CYP1A1|CYP1A2|DAPK2|DENND4A|DET1|DIS3L|DISP2|DLL4|DMXL2|DNAAF4|DNAJA4|DNAJC17|DPH6|DPP8|DTWD1|DUOX1|DUOX2|DUOXA1|DUOXA2|DUT|EDC3|EFL1|EHD4|EID1|EIF2AK4|EIF3J|ELL3|EMC4|EMC7|ENTREP2|EPB42|ETFA|EXD1|FAH|FAM174B|FAM219B|FAM227B|FAM81A|FAM98B|FAN1|FANCI|FBN1|FBXL22|FBXO22|FEM1B|FES|FGF7|FOXB1|FRMD5|FSD2|FSIP1|FURIN|GABPB1|GABRA5|GABRB3|GABRG3|GALK2|GANC|GATM|GCHFR|GCNT3|GDPGP1|GJD2|GLCE|GLDN|GNB5|GOLGA6A|GOLGA6B|GOLGA6C|GOLGA6D|GOLGA6L2|GOLGA8A|GOLGA8B|GOLGA8H|GOLGA8J|GOLGA8M|GOLGA8N|GOLGA8O|GOLM2|GPR176|GRAMD2A|GREM1|GTF2A2|HACD3|HAPLN3|HAUS2|HCN4|HDC|HDDC3|HERC1|HERC2|HEXA|HMG20A|HOMER2|HYKK|HYPK|ICE2|IDH2|IDH3A|IGDCC3|IGDCC4|IGF1R|IL16|IMP3|INO80|INSYN1|INTS14|IPW|IQCH|IQGAP1|IREB2|ISG20|ISL2|ISLR|ISLR2|ITGA11|ITPKA|IVD|JMJD7|KATNBL1|KBTBD13|KIF23|KIF7|KLF13|KLHL25|KNL1|KNSTRN|LACTB|LARP6|LCMT2|LCTL|LDHAL6B|LEO1|LINC00928|LINC02694|LINC02915|LINGO1|LINS1|LIPC|LMAN1L|LOXL1|LPCAT4|LRRC28|LRRC49|LRRC57|LRRK1|LTK|LYSMD2|LYSMD4|MAGEL2|MAN2A2|MAN2C1|MAP1A|MAP2K1|MAP2K5|MAPDA|MAPK6|MAPKBP1|MCTP2|MEF2A|MEGF11|MEIS2|MESD|MESP1|MESP2|MEX3B|MFAP1|MFGE8|MGA|MINAR1|MINDY2|MIR184|MIR211|MIR9-3|MKRN3|MNS1|MORF4L1|MPI|MRPL46|MRPS11|MTFMT|MTHFS|MTMR10|MYEF2|MYO1E|MYO5A|MYO5C|MYO9A|MYZAP|NDN|NDUFAF1|NEDD4|NEIL1|NEO1|NGRN|NIPA1|NIPA2|NMB|NOP10|NOX5|NPAP1|NPTN|NR2E3|NR2F2|NRG4|NSMCE3|NTRK3|NUSAP1|NUTM1|OAZ2|OCA2|OIP5|ONECUT1|OR4F15|OR4F6|OTUD7A|PAK6|PAK6-AS1|PAQR5|PARP16|PARP6|PATL2|PCLAF|PCSK6|PDCD7|PDE8A|PDIA3|PEAK1|PEX11A|PGBD4|PGPEP1L|PHGR1|PIAS1|PIERCE2|PIF1|PIGB|PKM|PLA2G4B|PLA2G4D|PLA2G4E|PLA2G4F|PLCB2|PLEKHO2|PLIN1|PML|POLG|POLR2M|PPCDC|PPIB|PPIP5K1|PPP1R14D|PRC1|PRTG|PSMA4|PSTPIP1|PTPN9|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PYGO1|RAB11A|RAB27A|RAB8B|RAD51|RAMAC|RASGRF1|RASGRP1|RASL12|RBPMS2|RCCD1|RCN2|REC114|RFX7|RGMA|RHCG|RHOV|RLBP1|RMDN3|RNF111|RNU5A-1|RNU6-1|RORA|RPAP1|RPL4|RPLP1|RPP25|RPS17|RPS27L|RPUSD2|RSL24D1|RTF1|RYR3|SAXO2|SCAMP2|SCAMP5|SCAPER|SCARNA15|SCG3|SCG5|SEC11A|SECISBP2L|SELENOS|SEMA4B|SEMA6D|SEMA7A|SENP8|SERF2|SERINC4|SH2D7|SH3GL3|SHC4|SHF|SIN3A|SKIC8|SKOR1|SLC12A1|SLC12A6|SLC24A1|SLC24A5|SLC27A2|SLC28A1|SLC28A2|SLC30A4|SLC51B|SLCO3A1|SLTM|SMAD3|SMAD6|SNAP23|SNAPC5|SNORD115-1|SNORD116-1|SNRPA1|SNRPN|SNUPN|SNURF|SNX1|SNX22|SNX33|SORD|SPATA8|SPESP1|SPG11|SPG21|SPINT1|SPPL2A|SPRED1|SPTBN5|SQOR|SRP14|ST20|ST20-MTHFS|ST8SIA2|STARD5|STARD9|STOML1|STRA6|STRC|SV2B|SYNM|TARS3|TBC1D21|TBC1D2B|TCF12|TERB2|TEX9|TGM5|TGM7|THAP10|THBS1|THSD4|TICRR|TIPIN|TJP1|TLE3|TLN2|TLNRD1|TM2D3|TM6SF1|TMC3|TMCO5A|TMED3|TMEM202|TMEM266|TMEM62|TMEM87A|TMOD2|TMOD3|TNFAIP8L3|TP53BP1|TPM1|TRIM69|TRIP4|TRPM1|TRPM7|TSPAN3|TTBK2|TTC23|TUBGCP4|TUBGCP5|TYRO3|UACA|UBAP1L|UBE2Q2|UBE3A|UBL7|UBR1|ULK3|UNC13C|UNC45A|USP3|USP50|USP8|VPS13C|VPS18|VPS33B|VPS39|WDR72|WDR73|WDR76|WDR93|WHAMM|ZFAND6|ZFYVE19|ZNF106|ZNF280D|ZNF592|ZNF609|ZNF710|ZNF770|ZNF774|ZSCAN2|ZSCAN29|ZWILCH		See cases	VCV000442893	15	22770422 - 102429112			442893	436555			copy number gain		Pathogenic	Dec 2, 2014	no assertion criteria provided							
GRCh37/hg19 15q11.2-26.3(chr15:22770422-102429112)	NOX5|NPAP1|NPTN|NR2E3|NR2F2|NRG4|NSMCE3|NTRK3|NUSAP1|NUTM1|OAZ2|OCA2|OIP5|ONECUT1|OR4F15|OR4F6|OTUD7A|PAK6|PAK6-AS1|PAQR5|PARP16|PARP6|PATL2|PCLAF|PCSK6|PDCD7|PDE8A|PDIA3|PEAK1|PEX11A|PGBD4|PGPEP1L|PHGR1|PIAS1|PIERCE2|PIF1|PIGB|PKM|PLA2G4B|PLA2G4D|PLA2G4E|PLA2G4F|PLCB2|PLEKHO2|PLIN1|PML|POLG|POLR2M|PPCDC|PPIB|PPIP5K1|PPP1R14D|PRC1|PRTG|PSMA4|PSTPIP1|PTPN9|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PYGO1|RAB11A|RAB27A|RAB8B|RAD51|RAMAC|RASGRF1|RASGRP1|RASL12|RBPMS2|RCCD1|RCN2|REC114|RFX7|RGMA|RHCG|RHOV|RLBP1|RMDN3|RNF111|RNU5A-1|RNU6-1|RORA|RPAP1|RPL4|RPLP1|RPP25|RPS17|RPS27L|RPUSD2|RSL24D1|RTF1|RYR3|SAXO2|SCAMP2|SCAMP5|SCAPER|SCARNA15|SCG3|SCG5|SEC11A|SECISBP2L|SELENOS|SEMA4B|SEMA6D|SEMA7A|SENP8|SERF2|SERINC4|SH2D7|SH3GL3|SHC4|SHF|SIN3A|SKIC8|SKOR1|SLC12A1|SLC12A6|SLC24A1|SLC24A5|SLC27A2|SLC28A1|SLC28A2|SLC30A4|SLC51B|SLCO3A1|SLTM|SMAD3|SMAD6|SNAP23|SNAPC5|SNORD115-1|SNORD116-1|SNRPA1|SNRPN|SNUPN|SNURF|SNX1|SNX22|SNX33|SORD|SPATA8|SPESP1|SPG11|SPG21|SPINT1|SPPL2A|SPRED1|SPTBN5|SQOR|SRP14|ST20|ST20-MTHFS|ST8SIA2|STARD5|STARD9|STOML1|STRA6|STRC|SV2B|SYNM|TARS3|TBC1D21|TBC1D2B|TCF12|TERB2|TEX9|TGM5|TGM7|THAP10|THBS1|THSD4|TICRR|TIPIN|TJP1|TLE3|TLN2|TLNRD1|TM2D3|TM6SF1|TMC3|TMCO5A|TMED3|TMEM202|TMEM266|TMEM62|TMEM87A|TMOD2|TMOD3|TNFAIP8L3|TP53BP1|TPM1|TRIM69|TRIP4|TRPM1|TRPM7|TSPAN3|TTBK2|TTC23|TUBGCP4|TUBGCP5|TYRO3|UACA|UBAP1L|UBE2Q2|UBE3A|UBL7|UBR1|ULK3|UNC13C|UNC45A|USP3|USP50|USP8|VPS13C|VPS18|VPS33B|VPS39|WDR72|WDR73|WDR76|WDR93|WHAMM|ZFAND6|ZFYVE19|ZNF106|ZNF280D|ZNF592|ZNF609|ZNF710|ZNF770|ZNF774|ZSCAN2|ZSCAN29|ZWILCH|AAGAB|ABHD17C|ABHD2|ACAN|ACSBG1|ACTC1|ADAM10|ADAMTS17|ADAMTS7|ADAMTSL3|ADPGK|AEN|AFG2B|AGBL1|AKAP13|ALDH1A2|ALDH1A3|ALPK3|ANKDD1A|ANKRD34C|ANKRD63|ANP32A|ANPEP|ANXA2|AP3B2|AP3S2|AP4E1|APBA2|APH1B|AQP9|AQR|ARHGAP11A|ARHGAP11B|ARID3B|ARIH1|ARNT2|ARPIN|ARPIN-AP3S2|ARPP19|ARRDC4|ASB7|ATOSA|ATP10A|ATP8B4|AVEN|B2M|BAHD1|BBS4|BCL2A1|BCL2L10|BLM|BLOC1S6|BMF|BNC1|BNIP2|BTBD1|BUB1B|C15orf32|C15orf39|C15orf40|C15orf48|C15orf61|C15orf62|C2CD4A|C2CD4B|CA12|CALML4|CAPN3|CATSPER2|CCDC32|CCDC33|CCDC9B|CCNB2|CCNDBP1|CCPG1|CD276|CDAN1|CDIN1|CELF6|CEMIP|CEP152|CERS3|CFAP161|CGNL1|CHAC1|CHD2|CHP1|CHRFAM7A|CHRM5|CHRNA3|CHRNA5|CHRNA7|CHRNB4|CHST14|CHSY1|CIAO2A|CIB1|CIB2|CILP|CIMAP1C|CKMT1A|CKMT1B|CLK3|CLN6|CLPX|COMMD4|COPS2|CORO2B|COX5A|CPEB1|CPLX3|CRABP1|CRTC3|CSK|CSNK1G1|CSPG4|CT62|CTDSPL2|CTSH|CTXN2|CYFIP1|CYP11A1|CYP19A1|CYP1A1|CYP1A2|DAPK2|DENND4A|DET1|DIS3L|DISP2|DLL4|DMXL2|DNAAF4|DNAJA4|DNAJC17|DPH6|DPP8|DTWD1|DUOX1|DUOX2|DUOXA1|DUOXA2|DUT|EDC3|EFL1|EHD4|EID1|EIF2AK4|EIF3J|ELL3|EMC4|EMC7|ENTREP2|EPB42|ETFA|EXD1|FAH|FAM174B|FAM219B|FAM227B|FAM81A|FAM98B|FAN1|FANCI|FBN1|FBXL22|FBXO22|FEM1B|FES|FGF7|FOXB1|FRMD5|FSD2|FSIP1|FURIN|GABPB1|GABRA5|GABRB3|GABRG3|GALK2|GANC|GATM|GCHFR|GCNT3|GDPGP1|GJD2|GLCE|GLDN|GNB5|GOLGA6A|GOLGA6B|GOLGA6C|GOLGA6D|GOLGA6L2|GOLGA8A|GOLGA8B|GOLGA8H|GOLGA8J|GOLGA8M|GOLGA8N|GOLGA8O|GOLM2|GPR176|GRAMD2A|GREM1|GTF2A2|HACD3|HAPLN3|HAUS2|HCN4|HDC|HDDC3|HERC1|HERC2|HEXA|HMG20A|HOMER2|HYKK|HYPK|ICE2|IDH2|IDH3A|IGDCC3|IGDCC4|IGF1R|IL16|IMP3|INO80|INSYN1|INTS14|IPW|IQCH|IQGAP1|IREB2|ISG20|ISL2|ISLR|ISLR2|ITGA11|ITPKA|IVD|JMJD7|KATNBL1|KBTBD13|KIF23|KIF7|KLF13|KLHL25|KNL1|KNSTRN|LACTB|LARP6|LCMT2|LCTL|LDHAL6B|LEO1|LINC00928|LINC02694|LINC02915|LINGO1|LINS1|LIPC|LMAN1L|LOXL1|LPCAT4|LRRC28|LRRC49|LRRC57|LRRK1|LTK|LYSMD2|LYSMD4|MAGEL2|MAN2A2|MAN2C1|MAP1A|MAP2K1|MAP2K5|MAPDA|MAPK6|MAPKBP1|MCTP2|MEF2A|MEGF11|MEIS2|MESD|MESP1|MESP2|MEX3B|MFAP1|MFGE8|MGA|MINAR1|MINDY2|MIR184|MIR211|MIR9-3|MKRN3|MNS1|MORF4L1|MPI|MRPL46|MRPS11|MTFMT|MTHFS|MTMR10|MYEF2|MYO1E|MYO5A|MYO5C|MYO9A|MYZAP|NDN|NDUFAF1|NEDD4|NEIL1|NEO1|NGRN|NIPA1|NIPA2|NMB|NOP10		See cases	VCV000442892	15	22770422 - 102429112			442892	436554			copy number gain		Pathogenic	Jul 14, 2015	no assertion criteria provided							
GRCh37/hg19 15q11.2-26.3(chr15:20733395-102511616)x4	CHRFAM7A|CHRM5|CHRNA3|CHRNA5|CHRNA7|CHRNB4|CHST14|CHSY1|CIAO2A|CIB1|CIB2|CILP|CIMAP1C|CKMT1A|CKMT1B|CLK3|CLN6|CLPX|COMMD4|COPS2|CORO2B|COX5A|CPEB1|CPLX3|CRABP1|CRTC3|CSK|CSNK1G1|CSPG4|CT62|CTDSPL2|CTSH|CTXN2|CYFIP1|CYP11A1|CYP19A1|CYP1A1|CYP1A2|DAPK2|DENND4A|DET1|DIS3L|DISP2|DLL4|DMXL2|DNAAF4|DNAJA4|DNAJC17|DPH6|DPP8|DTWD1|DUOX1|DUOX2|DUOXA1|DUOXA2|DUT|EDC3|EFL1|EHD4|EID1|EIF2AK4|EIF3J|ELL3|EMC4|EMC7|ENTREP2|EPB42|ETFA|EXD1|FAH|FAM174B|FAM219B|FAM227B|FAM81A|FAM98B|FAN1|FANCI|FBN1|FBXL22|FBXO22|FEM1B|FES|FGF7|FOXB1|FRMD5|FSD2|FSIP1|FURIN|GABPB1|GABRA5|GABRB3|GABRG3|GALK2|GANC|GATM|GCHFR|GCNT3|GDPGP1|GJD2|GLCE|GLDN|GNB5|GOLGA6A|GOLGA6B|GOLGA6C|GOLGA6D|GOLGA6L1|GOLGA6L2|GOLGA6L6|GOLGA8A|GOLGA8B|GOLGA8H|GOLGA8J|GOLGA8M|GOLGA8N|GOLGA8O|GOLM2|GPR176|GRAMD2A|GREM1|GTF2A2|HACD3|HAPLN3|HAUS2|HCN4|HDC|HDDC3|HERC1|HERC2|HEXA|HMG20A|HOMER2|HYKK|HYPK|ICE2|IDH2|IDH3A|IGDCC3|IGDCC4|IGF1R|IL16|IMP3|INO80|INSYN1|INTS14|IPW|IQCH|IQGAP1|IREB2|ISG20|ISL2|ISLR|ISLR2|ITGA11|ITPKA|IVD|JMJD7|KATNBL1|KBTBD13|KIF23|KIF7|KLF13|KLHL25|KNL1|KNSTRN|LACTB|LARP6|LCMT2|LCTL|LDHAL6B|LEO1|LINC00928|LINC02694|LINC02915|LINGO1|LINS1|LIPC|LMAN1L|LOXL1|LPCAT4|LRRC28|LRRC49|LRRC57|LRRK1|LTK|LYSMD2|LYSMD4|MAGEL2|MAN2A2|MAN2C1|MAP1A|MAP2K1|MAP2K5|MAPDA|MAPK6|MAPKBP1|MCTP2|MEF2A|MEGF11|MEIS2|MESD|MESP1|MESP2|MEX3B|MFAP1|MFGE8|MGA|MINAR1|MINDY2|MIR184|MIR211|MIR9-3|MKRN3|MNS1|MORF4L1|MPI|MRPL46|MRPS11|MTFMT|MTHFS|MTMR10|MYEF2|MYO1E|MYO5A|MYO5C|MYO9A|MYZAP|NDN|NDUFAF1|NEDD4|NEIL1|NEO1|NGRN|NIPA1|NIPA2|NMB|NOP10|NOX5|NPAP1|NPTN|NR2E3|NR2F2|NRG4|NSMCE3|NTRK3|NUSAP1|NUTM1|OAZ2|OCA2|OIP5|ONECUT1|OR4F15|OR4F4|OR4F6|OR4M2|OR4N4|OTUD7A|PAK6|PAK6-AS1|PAQR5|PARP16|PARP6|PATL2|PCLAF|PCSK6|PDCD7|PDE8A|PDIA3|PEAK1|PEX11A|PGBD4|PGPEP1L|PHGR1|PIAS1|PIERCE2|PIF1|PIGB|PKM|PLA2G4B|PLA2G4D|PLA2G4E|PLA2G4F|PLCB2|PLEKHO2|PLIN1|PML|POLG|POLR2M|POTEB|POTEB2|PPCDC|PPIB|PPIP5K1|PPP1R14D|PRC1|PRTG|PSMA4|PSTPIP1|PTPN9|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PYGO1|RAB11A|RAB27A|RAB8B|RAD51|RAMAC|RASGRF1|RASGRP1|RASL12|RBPMS2|RCCD1|RCN2|REC114|RFX7|RGMA|RHCG|RHOV|RLBP1|RMDN3|RNF111|RNU5A-1|RNU6-1|RORA|RPAP1|RPL4|RPLP1|RPP25|RPS17|RPS27L|RPUSD2|RSL24D1|RTF1|RYR3|SAXO2|SCAMP2|SCAMP5|SCAPER|SCARNA15|SCG3|SCG5|SEC11A|SECISBP2L|SELENOS|SEMA4B|SEMA6D|SEMA7A|SENP8|SERF2|SERINC4|SH2D7|SH3GL3|SHC4|SHF|SIN3A|SKIC8|SKOR1|SLC12A1|SLC12A6|SLC24A1|SLC24A5|SLC27A2|SLC28A1|SLC28A2|SLC30A4|SLC51B|SLCO3A1|SLTM|SMAD3|SMAD6|SNAP23|SNAPC5|SNORD115-1|SNORD116-1|SNRPA1|SNRPN|SNUPN|SNURF|SNX1|SNX22|SNX33|SORD|SPATA8|SPESP1|SPG11|SPG21|SPINT1|SPPL2A|SPRED1|SPTBN5|SQOR|SRP14|ST20|ST20-MTHFS|ST8SIA2|STARD5|STARD9|STOML1|STRA6|STRC|SV2B|SYNM|TARS3|TBC1D21|TBC1D2B|TCF12|TERB2|TEX9|TGM5|TGM7|THAP10|THBS1|THSD4|TICRR|TIPIN|TJP1|TLE3|TLN2|TLNRD1|TM2D3|TM6SF1|TMC3|TMCO5A|TMED3|TMEM202|TMEM266|TMEM62|TMEM87A|TMOD2|TMOD3|TNFAIP8L3|TP53BP1|TPM1|TRIM69|TRIP4|TRPM1|TRPM7|TSPAN3|TTBK2|TTC23|TUBGCP4|TUBGCP5|TYRO3|UACA|UBAP1L|UBE2Q2|UBE3A|UBL7|UBR1|ULK3|UNC13C|UNC45A|USP3|USP50|USP8|VPS13C|VPS18|VPS33B|VPS39|WDR72|WDR73|WDR76|WDR93|WHAMM|ZFAND6|ZFYVE19|ZNF106|ZNF280D|ZNF592|ZNF609|ZNF710|ZNF770|ZNF774|ZSCAN2|ZSCAN29|ZWILCH|AAGAB|ABHD17C|ABHD2|ACAN|ACSBG1|ACTC1|ADAM10|ADAMTS17|ADAMTS7|ADAMTSL3|ADPGK|AEN|AFG2B|AGBL1|AKAP13|ALDH1A2|ALDH1A3|ALPK3|ANKDD1A|ANKRD34C|ANKRD63|ANP32A|ANPEP|ANXA2|AP3B2|AP3S2|AP4E1|APBA2|APH1B|AQP9|AQR|ARHGAP11A|ARHGAP11B|ARID3B|ARIH1|ARNT2|ARPIN|ARPIN-AP3S2|ARPP19|ARRDC4|ASB7|ATOSA|ATP10A|ATP8B4|AVEN|B2M|BAHD1|BBS4|BCL2A1|BCL2L10|BLM|BLOC1S6|BMF|BNC1|BNIP2|BTBD1|BUB1B|C15orf32|C15orf39|C15orf40|C15orf48|C15orf61|C15orf62|C2CD4A|C2CD4B|CA12|CALML4|CAPN3|CATSPER2|CCDC32|CCDC33|CCDC9B|CCNB2|CCNDBP1|CCPG1|CD276|CDAN1|CDIN1|CELF6|CEMIP|CEP152|CERS3|CFAP161|CGNL1|CHAC1|CHD2|CHP1		See cases	VCV000395145	15	20733395 - 102511616			395145	382038			copy number gain		Pathogenic		no assertion criteria provided							
GRCh37/hg19 15q15.1-26.3(chr15:41745084-102354798)x4	ALDH1A2|ALDH1A3|CAPN3|CATSPER2|DIS3L|DMXL2|GLCE|KIF7|MORF4L1|POLG|POLR2M|SCG3|SEC11A|PPCDC|SECISBP2L|SELENOS|CCDC33|CCNB2|DNAAF4|GLDN|KLHL25|LACTB|MPI|ALPK3|ANKDD1A|ANKRD34C|CCNDBP1|CCPG1|DNAJA4|DPP8|DTWD1|GNB5|LARP6|LCMT2|MRPL46|PPIB|PPIP5K1|SEMA4B|SEMA6D|SEMA7A|SH2D7|SHF|SH3GL3|SHC4|SENP8|SERF2|SERINC4|RAB8B|RAMAC|RBPMS2|PSMA4|PSTPIP1|PTPN9|PYGO1|RAB11A|RASGRF1|RASL12|PRC1|PRTG|MYZAP|NEDD4|NEIL1|NPTN|NR2E3|MTHFS|MYEF2|MYO1E|NEO1|NGRN|NMB|NOX5|RAB27A|LEO1|LINC00928|LMAN1L|LOXL1|LRRC28|LRRC49|LRRC57|LRRK1|LINGO1|LINS1|MRPS11|MTFMT|MYO5A|MYO5C|MYO9A|LIPC|GOLGA6A|GOLGA6B|HMG20A|HOMER2|HACD3|HAPLN3|HAUS2|GOLGA6C|GOLGA6D|LTK|LYSMD2|LCTL|LDHAL6B|GOLM2|GRAMD2A|GTF2A2|HCN4|HDC|HDDC3|DUOX2|DUOX1|DUOXA2|DUT|EDC3|HERC1|HEXA|EFL1|EHD4|EID1|EIF3J|CIMAP1C|CKMT1A|ELL3|CD276|CDAN1|DUOXA1|CELF6|CFAP161|CGNL1|CIB1|CKMT1B|CLK3|ARPIN|CEMIP|CEP152|CERS3|CIB2|CILP|ANP32A|AP4E1|APH1B|ARIH1|ARNT2|ANPEP|ANXA2|AP3B2|AP3S2|AQP9|ARID3B|AAGAB|ABHD17C|ABHD2|ACAN|ACSBG1|ADAM10|ADAMTS17|ADAMTS7|ADAMTSL3|ADPGK|AEN|AFG2B|AGBL1|AKAP13|ARPIN-AP3S2|ARPP19|ARRDC4|ASB7|ATOSA|ATP8B4|B2M|BBS4|BCL2A1|BCL2L10|BLM|BLOC1S6|BNC1|BNIP2|BTBD1|C15orf32|C15orf39|C15orf40|C15orf48|C15orf61|C2CD4A|C2CD4B|CA12|CALML4|CHD2|CHRNA3|CHRNA5|CHRNB4|CHSY1|CIAO2A|CLN6|CLPX|COMMD4|COPS2|CORO2B|COX5A|CPEB1|CPLX3|CRABP1|CRTC3|CSK|CSNK1G1|CSPG4|CT62|CTDSPL2|CTSH|CTXN2|CYP11A1|CYP19A1|CYP1A1|CYP1A2|DAPK2|DENND4A|DET1|EPB42|ETFA|FAH|FAM174B|FAM219B|FAM227B|FAM81A|FANCI|FBN1|FBXL22|FBXO22|FEM1B|FES|FGF7|FOXB1|FRMD5|FSD2|FURIN|GABPB1|GALK2|GANC|GATM|GCNT3|GDPGP1|HYKK|HYPK|ICE2|IDH2|IDH3A|IGDCC3|IGDCC4|IGF1R|IL16|IMP3|INSYN1|INTS14|IQCH|IQGAP1|IREB2|ISG20|ISL2|ISLR|ISLR2|ITGA11|ITPKA|JMJD7|KBTBD13|KIF23|LYSMD4|MAN2A2|MAN2C1|MAP1A|MAP2K1|MAP2K5|MAPDA|MAPK6|MAPKBP1|MCTP2|MEF2A|MEGF11|MESD|MESP1|MESP2|MEX3B|MFAP1|MFGE8|MGA|MINAR1|MINDY2|MIR184|MIR9-3|MNS1|NR2F2|NRG4|NTRK3|OAZ2|ONECUT1|OR4F6|PAQR5|PARP16|PARP6|PATL2|PCLAF|PCSK6|PDCD7|PDE8A|PDIA3|PEAK1|PEX11A|PGPEP1L|PIAS1|PIERCE2|PIF1|PIGB|PKM|PLA2G4B|PLA2G4D|PLA2G4E|PLA2G4F|PLEKHO2|PLIN1|PML|RCCD1|RCN2|REC114|RFX7|RGMA|RHCG|RLBP1|RNF111|RNU5A-1|RNU6-1|RORA|RPAP1|RPL4|RPLP1|RPP25|RPS17|RPS27L|RSL24D1|RTF1|SAXO2|SCAMP2|SCAMP5|SCAPER|SCARNA15|SIN3A|SKIC8|SKOR1|SLC12A1|SLC24A1|SLC24A5|SLC27A2|SLC28A1|SLC28A2|SLC30A4|SLC51B|SLCO3A1|SLTM|SMAD3|SMAD6|SNAP23|SNAPC5|SNRPA1|SNUPN|SNX1|SNX22|SNX33|SORD|SPATA8|SPESP1|SPG11|SPG21|SPPL2A|SPTBN5|SQOR|ST20|ST20-MTHFS|ST8SIA2|STARD5|STARD9|STOML1|STRA6|STRC|SV2B|SYNM|TARS3|TBC1D21|TBC1D2B|TCF12|TERB2|TEX9|TGM5|TGM7|THAP10|THSD4|TICRR|TIPIN|TLE3|TLN2|TLNRD1|TM2D3|TM6SF1|TMC3|TMED3|TMEM202|TMEM266|TMEM62|TMEM87A|TMOD2|TMOD3|TNFAIP8L3|TP53BP1|TPM1|TRIM69|TRIP4|TRPM7|TSPAN3|TTBK2|TTC23|TUBGCP4|TYRO3|UACA|UBAP1L|UBE2Q2|UBL7|UBR1|ULK3|UNC13C|UNC45A|USP3|USP50|USP8|VPS13C|VPS33B|VPS39|WDR72|WDR73|WDR76|WDR93|WHAMM|ZFAND6|ZNF106|ZNF280D|ZNF592|ZNF609|ZNF710|ZNF774|ZSCAN2|ZSCAN29|ZWILCH		See cases	VCV000394887	15	41745084 - 102354798			394887	381780			copy number gain		Pathogenic		no assertion criteria provided							
GRCh37/hg19 15q22.1-26.3(chr15:59297293-102480888)x3	WHAMM|CCNB2|FAH|FAM174B|IL16|MIR9-3|MORF4L1|MPI|MRPL46|MRPS11|MTFMT|MTHFS|MYO1E|MYO9A|NEIL1|NEO1|INTS14|IQCH|FBXL22|FBXO22|FEM1B|FES|FOXB1|FSD2|FAM81A|FURIN|FANCI|IMP3|INSYN1|IQGAP1|IREB2|ISG20|ISL2|ISLR|ISLR2|CD276|CIB1|CIB2|CILP|ANXA2|AP3B2|ADAMTSL3|ADPGK|AEN|CLN6|CLPX|CFAP161|CIMAP1C|CLK3|CELF6|CEMIP|CERS3|ITGA11|KBTBD13|ZFAND6|FAM219B|ADAMTS7|ALPK3|ANKDD1A|AGBL1|AKAP13|ALDH1A3|ANKRD34C|ANP32A|ANPEP|WDR73|WDR93|ZNF592|ZNF609|ZNF710|ZNF774|ZSCAN2|ZWILCH|AAGAB|ABHD17C|ABHD2|ACAN|ACSBG1|ADAMTS17|AP3S2|APH1B|ARID3B|ARIH1|ARNT2|ARPIN|ARPIN-AP3S2|ARRDC4|ASB7|BBS4|BCL2A1|BLM|BNC1|BNIP2|BTBD1|C15orf32|C15orf39|C15orf40|C15orf61|C2CD4A|C2CD4B|CA12|CALML4|CCDC33|CHD2|CHRNA3|CHRNA5|CHRNB4|CHSY1|CIAO2A|COMMD4|CORO2B|COX5A|CPEB1|CPLX3|CRABP1|CRTC3|CSK|CSNK1G1|CSPG4|CT62|CTSH|CYP11A1|CYP1A1|CYP1A2|DAPK2|DENND4A|DET1|DIS3L|DNAJA4|DPP8|EDC3|EFL1|ETFA|GCNT3|GDPGP1|GLCE|GOLGA6A|GOLGA6B|GOLGA6C|GOLGA6D|GRAMD2A|GTF2A2|HACD3|HAPLN3|HCN4|HDDC3|HERC1|HEXA|HMG20A|HOMER2|HYKK|ICE2|IDH2|IDH3A|IGDCC3|IGDCC4|IGF1R|KIF23|KIF7|KLHL25|LACTB|LARP6|LCTL|LDHAL6B|LINC00928|LINGO1|LINS1|LMAN1L|LOXL1|LRRC28|LRRC49|LRRK1|LYSMD4|MAN2A2|MAN2C1|MAP2K1|MAP2K5|MCTP2|MEF2A|MEGF11|MESD|MESP1|MESP2|MEX3B|MFGE8|MINAR1|MIR184|NGRN|NMB|NOX5|NPTN|NR2E3|NR2F2|NRG4|NTRK3|OAZ2|OR4F15|OR4F4|OR4F6|PAQR5|PARP16|PARP6|PCLAF|PCSK6|PDCD7|PDE8A|PEAK1|PEX11A|PGPEP1L|PIAS1|PIF1|PKM|PLEKHO2|PLIN1|PML|POLG|PPCDC|PPIB|PRC1|PSMA4|PSTPIP1|PTPN9|RAB11A|RAB8B|RAMAC|RASGRF1|RASL12|RBPMS2|RCCD1|RCN2|REC114|RGMA|RHCG|RLBP1|RNF111|RNU5A-1|RNU6-1|RORA|RPL4|RPLP1|RPP25|RPS17|RPS27L|SAXO2|SCAMP2|SCAMP5|SCAPER|SCARNA15|SEC11A|SELENOS|SEMA4B|SEMA7A|SENP8|SH2D7|SH3GL3|SIN3A|SKIC8|SKOR1|SLC24A1|SLC28A1|SLC51B|SLCO3A1|SMAD3|SMAD6|SNAPC5|SNRPA1|SNUPN|SNX1|SNX22|SNX33|SPATA8|SPESP1|SPG21|ST20|ST20-MTHFS|ST8SIA2|STARD5|STOML1|STRA6|SV2B|SYNM|TARS3|TBC1D21|TBC1D2B|THAP10|THSD4|TICRR|TIPIN|TLE3|TLN2|TLNRD1|TM2D3|TM6SF1|TMC3|TMED3|TMEM202|TMEM266|TPM1|TRIP4|TSPAN3|TTC23|UACA|UBAP1L|UBE2Q2|UBL7|ULK3|UNC45A|USP3|VPS13C|VPS33B		not provided	VCV000369835	15	59297293 - 102480888			369835	354051			copy number gain		Likely pathogenic	Jul 31, 2016	criteria provided, single submitter							
GRCh37/hg19 15q22.31(chr15:66643638-66745287)x1	TIPIN|MAP2K1		See cases	VCV000253805	15	66643638 - 66745287			253805	248253			copy number loss		Uncertain significance	Jan 20, 2016	criteria provided, single submitter							
GRCh37/hg19 15q22.31-26.3(chr15:64637227-102509910)x3	AAGAB|ABHD17C|ABHD2|ACAN|ACSBG1|ADAMTS17|ADAMTS7|ADAMTSL3|ADPGK|AEN|AGBL1|AKAP13|ALDH1A3|ALPK3|ANKDD1A|ANKRD34C|ANP32A|ANPEP|AP3B2|AP3S2|ARID3B|ARIH1|ARNT2|ARPIN|ARPIN-AP3S2|ARRDC4|ASB7|BBS4|BCL2A1|BLM|BNC1|BTBD1|C15orf32|C15orf39|C15orf40|C15orf61|CALML4|CCDC33|CD276|CELF6|CEMIP|CERS3|CFAP161|CHD2|CHRNA3|CHRNA5|CHRNB4|CHSY1|CIB1|CIB2|CILP|CIMAP1C|CLK3|CLN6|CLPX|COMMD4|CORO2B|COX5A|CPEB1|CPLX3|CRABP1|CRTC3|CSK|CSNK1G1|CSPG4|CT62|CTSH|CYP11A1|CYP1A1|CYP1A2|DENND4A|DET1|DIS3L|DNAJA4|DPP8|EDC3|EFL1|ETFA|FAH|FAM174B|FAM219B|FANCI|FBXO22|FEM1B|FES|FSD2|FURIN|GDPGP1|GLCE|GOLGA6A|GOLGA6B|GOLGA6C|GOLGA6D|GRAMD2A|HACD3|HAPLN3|HCN4|HDDC3|HEXA|HMG20A|HOMER2|HYKK|IDH2|IDH3A|IGDCC3|IGDCC4|IGF1R|IL16|IMP3|INSYN1|INTS14|IQCH|IQGAP1|IREB2|ISG20|ISL2|ISLR|ISLR2|ITGA11|KBTBD13|KIF23|KIF7|KLHL25|LARP6|LCTL|LINC00928|LINGO1|LINS1|LMAN1L|LOXL1|LRRC28|LRRC49|LRRK1|LYSMD4|MAN2A2|MAN2C1|MAP2K1|MAP2K5|MCTP2|MEF2A|MEGF11|MESD|MESP1|MESP2|MEX3B|MFGE8|MINAR1|MIR184|MIR9-3|MORF4L1|MPI|MRPL46|MRPS11|MTFMT|MTHFS|MYO9A|NEIL1|NEO1|NGRN|NMB|NOX5|NPTN|NR2E3|NR2F2|NRG4|NTRK3|OAZ2|OR4F15|OR4F4|OR4F6|PAQR5|PARP16|PARP6|PCLAF|PCSK6|PDCD7|PDE8A|PEAK1|PEX11A|PGPEP1L|PIAS1|PIF1|PKM|PLEKHO2|PLIN1|PML|POLG|PPCDC|PRC1|PSMA4|PSTPIP1|PTPN9|RAB11A|RAMAC|RASGRF1|RASL12|RBPMS2|RCCD1|RCN2|REC114|RGMA|RHCG|RLBP1|RNU5A-1|RNU6-1|RPL4|RPLP1|RPP25|RPS17|SAXO2|SCAMP2|SCAMP5|SCAPER|SCARNA15|SEC11A|SELENOS|SEMA4B|SEMA7A|SENP8|SH2D7|SH3GL3|SIN3A|SKIC8|SKOR1|SLC24A1|SLC28A1|SLC51B|SLCO3A1|SMAD3|SMAD6|SNAPC5|SNRPA1|SNUPN|SNX33|SPATA8|SPESP1|SPG21|ST20|ST20-MTHFS|ST8SIA2|STARD5|STOML1|STRA6|SV2B|SYNM|TARS3|TBC1D21|TBC1D2B|THAP10|THSD4|TICRR|TIPIN|TLE3|TLNRD1|TM2D3|TM6SF1|TMC3|TMED3|TMEM202|TMEM266|TRIP4|TSPAN3|TTC23|UACA|UBAP1L|UBE2Q2|UBL7|ULK3|UNC45A|VPS33B|WDR73|WDR93|WHAMM|ZFAND6|ZNF592|ZNF609|ZNF710|ZNF774|ZSCAN2|ZWILCH		See cases	VCV000253516	15	64637227 - 102509910			253516	247964			copy number gain		Pathogenic	Jan 20, 2016	criteria provided, single submitter							
